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Abstract 
UV light is acknowledged to be the main carcinogen involved in the formation of skin 
cancer. It generates a range of biological responses in the skin, which includes adaptive, 
inflammatory and immunological reactions.  In this thesis we exposed cultures of 
keratinocyte-derived cell lines (HEK cells-primary keratinocytes, HaCaT                       
cells-immortalized keratinocytes and Colo 16 cells-squamous cell carcinoma cell line) to 
UVA and/or UVB radiation and observed the effect this had on a number of cellular 
processes. The UV dose used throughout the thesis was equivalent to the UV component 
observed in one medial erythemal dose which was 40 kJ/m2 UVA and 2 kJ/m2 UVB.  
In HEK cells, the viability of attached sham-irradiated cultures was 92%. UVA radiation 
had no effect on cell viability when compared to sham-irradiated controls. In HaCaT and 
Colo 16 cells, exposure to UVA reduced cell viability by 11% and 7%, respectively. In 
HEK cells, the attached viable cells were more sensitive to UVB and UVAB radiation as 
the cell viability was reduced by 46% and 33%, respectively. When HaCaT cells were 
exposed to UVAB radiation (cell viability was reduced by 32%), the result had 
characteristics similar to that seen for those cells irradiated by either UVA or UVB 
where the viability was reduced by 10% and 20%, respectively. In Colo 16 cells, the 
viability of attached cells in UVB- (49%) and UVAB-irradiated cells (49%) was reduced 
when compared to the sham-irradiated cultures (90%). The viability of the detached 
viable cells was low (<5%) for all UV types and doses. The Colo 16 cells were more 
sensitive to UVR than were HEK or HaCaT cells.  
Furin levels in UV-irradiated HEK cells did not change 24 h post-irradiation unlike that 
seen for HaCaT or Colo 16 cells. Higher furin expression was seen in UVAB-irradiated 
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HaCaT cells (12x) and UVB-irradiated Colo 16 cells (7.5x) when compared to                        
un-irradiated controls. Furin mRNA levels were shown to be maximal after 24 h in 
HaCaT cells (91-fold) and 12 h for Colo 16 cells (1.5-fold) exposed to UVB-irradiation.  
There was a moderate correlation between furin mRNA and protein levels in irradiated 
HaCaT cells (r2 = 0.581) compared to that of Colo 16 cells (r2 = 0.399) 24 h                            
post-irradiation. The turnover of furin protein was longer in Colo 16 cells compared to 
HaCaT cells (T½ = 17.0 h and 5.6 h, respectively). IL-1 had
 
a slightly additive effect on 
furin expression and activity in HEK cells but a slightly suppressive effect on HaCaT 
and Colo 16 cells.   
The level of MMP-2 and -9 activity in HaCaT cells did not change in the 72 h period 
following exposure to UVR.  Maximal MMP-2 and -9 activity was seen at 12 h (13489.9 
and 15392.0 au/mg cell protein, respectively) in UVB-irradiated HEK cells.  While high 
levels of MMP-2 activity was observed at 24 h (1998.1 au/mg cell protein) in                  
UVB-irradiated Colo 16 cells, levels of MMP-9 were highest  at 24 and 72 h (6512.8 
and 2605.9 au/mg cell protein), respectively in these cells. In HaCaT cells, the 
expression of proMMP-2 in UVB- (63%) and UVAB-irradiated cells (64%) were similar 
to that of sham-irradiated controls. Active MMP-2 expression was higher in                   
UVB-irradiated HaCaT cells (41%).  In Colo 16 cells the highest induction of pro and 
active MMP-2 protein was seen in UVA-irradiated cells (139% and 112%, respectively). 
The level of active MMP-9 protein was only elevated in HaCaT cells exposed to either 
UVA (80%) or UVAB radiation (121%). This result was not seen in Colo 16 cells. 
Addition of IL-1 significantly increased MMP-9 activity, protein and mRNA 
expression in HaCaT and Colo16 cells. The mRNA levels for MMP-2 (73-fold) and -9 
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(330-fold) were maximal 24 h post UVB-irradiation in HaCaT cells. In Colo 16 cells, 
maximal mRNA expression was seen at 0 h for MMP-2 and 12 h for MMP-9 (17-fold). 
There was a strong and positive correlation between furin and MMP mRNA levels in 
HaCaT cells but not in Colo 16 cells. 1, 10 phe and MMPI significantly decreased the 
activity of MMP-2 and -9 shed from UV-irradiated cells. When Dec RVKR cmk was 
added to HaCaT and Colo 16 cells, there was a loss of MMP-9 activity in the media of 
the UV-irradiated cells. In the presence of these inhibitors migration of the HaCaT and 
Colo 16 cells were also decreased.  
The effect of UVR on the release of TNF
 
from human keratinocyte-derived cells was 
also examined. The addition of IL-1 increased the release of TNF in sham-irradiated 
HEK (2763.73 ng/mg cell protein), HaCaT cells (935.5 ng/mg cell protein) and Colo 16 
cells (81.9 ng/mg cell protein) when compared to untreated controls. UVAB-irradiated 
cells treated with IL-1 induced the greatest increase in TNF release in all cell lines 
(32.9-, 4.2- and 7.7-fold in HEK, HaCaT and Colo 16 cells, respectively) compared to 
treated sham-irradiated cells.  Addition of 1, 10 phe caused an inhibition of ~97% in           
IL-1 treated UVAB-irradiated HaCaT and Colo 16 cells. 95% in HaCaT cells and 87% 
in Colo 16 cells The level of TNF released from Dec RVKR cmk treated                    
UVAB-irradiated cells was significantly reduced by 95% in HaCaT cells and 87% in 
Colo 16 cells.  MMPI also inhibited TNF release from HaCaT and Colo 16 cells.  The 
maximal mRNA levels post UVB-irradiation for TNF (59-fold) were at 16 h in HaCaT 
cells and 8 h (12.1-fold) in Colo 16 cells. The level of TACE mRNA was relatively 
constant in both these cells for up to 32 h post-irradiation.  
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The results obtained suggest that UVR up-regulates furin mRNA and protein expression 
in these keratinocyte-derived cells. Colo 16 cells harbor furin protein for a much longer 
time which may contribute to increasing their metastatic nature as one of the proteases 
they process, MMP is known to cleave the ECM, allowing metastasis to occur. The 
results of this study suggest that (1) the changes in TACE activity are due to the 
conversion of pTACE to mTACE mediated by furin, and (2) TACE is the main enzyme 
involved in the release of TNF but MMPs may also be involved. The three keratinocyte 
cell lines respond differently when exposed to UVR. The response of HaCaT cells to 
UVR differs to that of HEK which suggest that these immortalized cell lines may not be 
a suitable model to study keratinocytes. Colo 16 exhibits a completely different profile 
to that of both HaCaT and HEK which most likely reflects its carcinogenic nature of 
these cells which may contribute to their metastatic potential, through changes in MMP 
and TACE activity.   
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2 Materials and Methods 
2.1 Materials 
2.1.1 Cell lines 
Human epidermal keratinocytes (HEK) cells were purchased from Invitrogen 
(Melbourne, Australia). HaCaT (221) and Colo 16 (222) cell lines were kindly donated 
by Drs Peter Parsons and Glen Boyle from the Queensland Institute of Medical 
Research (QIMR), Brisbane, Australia.   
2.1.2 Tissue culture material 
Roswell Park Memorial Institute (RPMI) 1640 medium, penicillin-streptomycin-
glutamine, EpiLife medium, 100X human keratinocyte growth supplement (HKGS), 
Phosphate-Buffered Saline (PBS), Trypsin-EDTA solution and Hank s Buffered Salt 
Solution (HBSS) were purchased from Invitrogen; 60 mm diameter petri dishes, 6-well 
plates, 96-well plates, centrifuge tubes (15 and 50 ml), pipette tips and Barrier pipette 
tips were obtained from Greiner-Bioone (Interpath Services, Melbourne, Australia) and 
tissue culture flasks (25 cm2 and 75 cm2) were purchased from Corning (Melbourne, 
Australia).   
2.1.3 Chemicals and biochemicals 
Bicinchoninic acid solution (BCA), Trypan Blue solution, Bromophenol Blue, 
Coomasie Blue, Ponceau S, Ethidium bromide (EtBr) Orange 6 loading buffer,                  
Tween-20, Ammonium Persulfate, Sodium azide, ZnCl2 and CaCl2 were bought from 
Sigma (Sydney, Australia); Agarose 1 (Biotechnology grade), 50 bp PCR DNA marker 
Plus, Lysis buffer, Laemmli s sample buffer (223), glycine, Triton X-100, and Tris were 
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purchased from Astral Scientific (Sydney, Australia); Gelatin, NaOH, NaHCO3, and 
CH3COOH were purchased from BDH Biochemicals (Sydney, Australia). Glycerol, 
DEPC RNase-free water and SYBR® Green ERTM qPCR Supermix were supplied by 
Invitrogen; Kaleidoscope Prestained Standards, Acrylamide Bis solution and TEMED 
were obtained from Bio-Rad (Sydney, Australia). Foetal Bovine Serum (FBS) and 
Bovine Serum Albumin (BSA) were purchased from Bovogen (Melbourne, Australia). 
HPLC grade Methanol and Molecular Biology-grade Ethanol were supplied by Merck 
(Melbourne, Australia) and protease inhibitor was bought from Roche (Melbourne, 
Australia).  
The ADAM 17 antibody was obtained from Abcam (Sydney, Australia); furin 
convertase (human) was from Alexis biochemicals (Sydney, Australia); Rabbit               
anti-MMP-2 antibody and mouse monoclonal anti- -actin antibodies were from Sigma 
and Rabbit polyclonal MMP-9 antibody was obtained from Sapphire Biosciences 
(Sydney, Australia). Sheep HRP conjugated anti-rabbit immunoglobin antibody was 
from Chemicon (Melbourne, Australia).  
Decanoyl-Arg-Val-Lys-Arg-chloromethylketone (Dec RVKR cmk) (furin convertase 
inhibitor) was obtained from Sapphire Bioscienes; 1, 10 phenanthroline (1, 10 phe) 
(metalloprotease inhibitor) was from Sigma; Cycloheximide (CHX) inhibitor and 2R-2-
[(4-Biphenylsulfonyl) amino]-3-phenylpropionic acid (specific MMP-2/-9 inhibitor) 
(MMPI) were obtained from Merck.  
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2.1.4 Primers 
The primers used in this study were commercially synthesized by GeneWorks 
(Adelaide, Australia).  
2.2 Methods 
2.2.1 Cell culture 
HEK were grown in EpiLife medium supplemented with 100X HKGS,  0.5 ml of   0.09 
M CaCl2, 1% (v/v) Penicillin-Streptomycin-Glutamine (10,000 units/ml penicillin G 
sodium, 10,000 g/ml streptomycin sulphate and 2 mM L-glutamine), in a 37°C 
incubator containing an atmosphere of 5% CO2. HaCaT and Colo 16 cells were cultured 
with RPMI medium 1640 supplemented with 5% (v/v) FBS and 1%                             
Penicillin-Streptomycin-Glutamine in 75 cm2 cell culture flasks which were placed in a 
5% CO2 cell incubator at 37°C. Spent media was removed every three to four days and 
the cells given fresh pre-warmed EpiLife or RPMI media depending on the cultured cell 
line. EpiLife media used was pre-warmed by placing the container at RT for 40 min. 
The RPMI media used in cell culturing was pre-warmed at 37ºC prior to use. Unless 
mentioned otherwise the temperature of EpiLife media and RPMI used in cell culturing 
was at RT and 37°C, respectively.  
2.2.2 Cell Passaging 
2.2.2.1 HEK cells 
The HEK cells reached confluency between seven to ten days. Confluence was 
monitored visually using an inverted microscope (Olympus CK2). The spent culture 
media was aspirated and the cells washed once with pre-warmed (37ºC) sterile             
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Trypsin-EDTA solution [0.214 M trypsin (1:250), 0.005 M EDTA 4Na, 0.142 M NaCl 
made in sterile PBS]. After which, the cells were incubated with 2 ml of sterile  
Trypsin-EDTA solution for 2-3 min. Cells were dislodged upon gentle tapping of the 
flask. The cell suspension was added into 4 ml of 1% (v/v) FBS in PBS and centrifuged 
(200 g for 5 min at 20°C) in a Universal 16 R centrifuge (HD scientific, Melbourne, 
Australia). After centrifugation, the supernatant was discarded and the cell pellet 
resuspended by repeated pipetting in 1 ml EpiLife media. An aliquot [three to four 
drops (~ 0.15-0.20 ml)] of the cell suspension was added to a new cell culture flask 
containing 20 ml of pre-warmed EpiLife media. The flasks were capped and sprayed 
with 70% ethanol before being placed flat in the 5% CO2 incubator. 
                                       
2.2.2.2   HaCaT and Colo 16 cells 
The HaCaT and Colo 16 cell cultures usually reached confluency between four to five 
days. Confluence was monitored visually using an inverted microscope (Olympus 
CK2). The spent culture media was aspirated and the cells washed thrice with                 
pre-warmed (37ºC) sterile PBS and twice with pre-warmed (37ºC) sterile Trypsin 
EDTA solution. After which, the cells were incubated in the 5% CO2 incubator with 2 
ml of sterile Trypsin-EDTA solution for 2-3 minutes. Cells were dissociated by gentle 
tapping of the flask after which, an aliquot of the cell suspension was added to a new 
cell culture flask containing 20 ml of pre-warmed RPMI media. 
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2.3 UV-irradiation 
2.3.1 UV-irradiation of cells 
Cells used in the experiments described in this thesis were either grown in 60 mm 
diameter petri dishes or 6-well plates. Once the cultures in the 75 cm2 flask reached 
confluency (Section 2.2.2), cells were dislodged from their respective flasks using 
trypsin as described (Section 2.2.2) The trysinized cells were resuspended in their 
respective media (cells from one flask was suspended in ~ 20 ml tissue culture media), 
and 2ml of which was added to a 60 mm petri dish and 1 ml in a well of a 6-well plate.  
Once the cultures in the petri dishes or 6-well plates reached 70-75% confluency, the 
spent media was discarded and the cells were gently washed twice with pre-warmed 
(37ºC) PBS. After which, the PBS was discarded and 1.5 ml of phenol-red free HBSS 
was added carefully to the side of the petri dish or 1 ml to the side of the well in a                 
6-well plate. Media was always added to the side of the petri dish or 6-well plate to 
avoid direct contact with the cells which could cause them to become dislodged. The 
petri dish or 6-well plate was then placed in the middle of the top shelf in the UV 
cabinet without their respective lids and were exposed to UVA and/or UVB-irradiation. 
The cells were exposed to the type and dose of UV radiation as outlined in Table 2.1. In 
order to ensure that the cells were not exposed to any UVB light emitted by the UVA 
lamps a sheet of 10 mm thick glass plate was placed over the culture vessels.  
Immediately after irradiation, the HBSS was aspirated from the petri dish and 2 ml 
(petri dishes) or 1 ml (6-well plates) fresh pre-warmed tissue culture media was gently 
added. This media was added to the irradiated cells as described in the results section. 
The petri dishes or 6-well plates were returned to the cell incubator for various time 
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points (0-72 h). Sham-irradiated (control) cells were treated in the same manner, except 
that they were not exposed to UVR.   
2.3.2 Inhibitor studies 
In order to inhibit the activation of furin, cells were treated with 100 µM Decanoyl-Arg-
Val-Lys-Arg-chloromethylketone (Dec-RVKR-cmk) (furin convertase inhibitor) for the 
times listed in the results section. Metalloprotease enzyme activity was inhibited by 
adding 100 M 1, 10 phenanthroline (1, 10 phe) (metalloprotease inhibitor) for the 
times listed in the results section. Protein synthesis was inhibited when 100 M 
 
cycloheximide (CHX) was added to the cells. In all cases, the inhibitors used above 
were added to the cells for 24 h prior to the cells being UV-irradiated. Following 
irradiation cells were growth in the presence of the inhibitors for the times listed in the 
results section.  
MMP-2 and -9 activity was inhibited by the addition of 5 M 2R-2-[(4-
Biphenylsulfonyl) amino]-3-phenylpropionic acid (for simplicity in this thesis it will be 
called MMPI) (dissolved in DMSO) for 1 h prior to the cells being irradiated. Following 
UV-irradiation cells were grown in the presence of 5 M MMP inhibitor for the times 
listed in the results section.  
Following treatment with the above mentioned inhibitors and UV-irradiation, in some 
cultures IL-1 was added as it is known to stimulate TNF release from the cells (77). 
Thereafter the media with inhibitor was removed and kept aside and replaced with 1.5 
ml of HBSS for petri dishes or 1 ml HBSS for 6-well plates after which the petri dishes 
or 6-well plates were exposed to UV-irradiation as described in section 2.3.1. Following 
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UV-irradiation HBSS was removed and replaced with the same media containing the 
specific inhibitors with or without addition of IL-1
 
(10 ng/ml) and the cultures 
incubated for up to 24 h as described in the results section. Following the incubation 
period, the cells in the culture were either used for cell viability determination (Section 
2.4) or used to prepare lysates for western blotting (Section 2.5) or for protein 
determination (Section 2.5.3). At the end of the experiment, a 0.5 ml aliquot of the 
media was placed in a 1.5 ml microfuge tube and stored at -80°C prior to being assayed 
for TNF (Section 2.6).  
2.3.3 UV variance 
The UV cabinet (Wayne Electronics, Sydney, Australia) housed 6 UV fluorescent 
lamps: 3 UVA (maximal output 354 nm) (Cosmolux 15504 40W; Cosmedico, Stuttgart, 
Germany) and 3 UVB lamps (maximal output 312 nm) (Philips Ultraviolet 8 TL 
20W/01 RS lamps; Philips, Eindhoven, Holland) (Figure 2.1).   
                         
  
Figure 2.1 UV cabinet. 
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The variation in the output (W/cm2) of the UV lamps was measured using the relevant 
UV filter and detector (UVA or UVB) attached to an International light IL-1400A 
Traceable Photometer (Newburyport, USA) (Appendix A.2). The output of the UVA 
and UVB lamps in the middle and the sides of the cabinet on the top shelf were 
measured, with the highest doses observed in the middle region of this shelf. By 
knowing this information, the cultures could be placed on the top shelf, where the 
output of the UV lights were maximal, thereby minimizing the exposure times.   
2.3.4 UV type, dose and exposure time 
The cells were exposed to either UVA and/or UVB radiation as described in the results 
section. The outputs of UV lamps were measured (Section 2.3.1) and the following UV 
doses were calculated (Appendix A.2 and Table 2.1). The UVA and UVB dose used in 
this thesis represents the respective UVA and UVB component found in one minimal 
erythemal dose (1 MED) (174, 224). One MED is defined as the level of UVR that 
causes skin reddening in caucasian skin (types II-III) and has been calculated to be 
approximately 40 kJ/m2 UVA and 2 kJ/m2 UVB (174, 224).  
                                                
        
     Table 2.1 UV types, doses and exposure times used in the experiments  
                      outlined in this thesis. 
UV Type UV Dose (kJ/m2) Exposure Time (s) 
UVA 40 770 
UVB 2 185 
UVA+B (40+2) (770+185) 
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2.4 Cell viability 
The viability of the cell cultures (control and treated) were determined using the trypan 
blue exclusion method 24 h post-irradiation. In brief, the media in the petri dish or well 
of a 6-well plate was removed and placed in a 10 ml centrifuge tube. The cultures were 
then washed twice with pre-warmed PBS and the washings added to the 10 ml 
centrifuge tube. The tubes were centrifuged (200 g for 5 min at 4°C), after which the 
supernatant was discarded and the pellet resuspended in 1 ml PBS. A 50 l aliquot of 
cell suspension was added to 50 l of 0.4% (v/v) trypan blue solution in a microfuge 
tube and mixed well by pipetting. A 50 l aliquot from the microfuge tube was added to 
a haemocytometer and the cells were counted using an Olympus BH2 light microscope. 
This count represented the number of detached cells in the culture.  
The attached cells on the petri dish or 6-well plate were washed with ~2 ml pre-warmed 
Trypsin-EDTA after which the cells were suspended by adding 1 ml of pre-warmed 
Trypsin-EDTA solution and incubated for 4-5 min. The cells were gently dislodged 
from the base of the petri dish using a pipette. The suspended cells were transferred to a 
10 ml centrifuge tube that contained 4 ml of 5% (v/v) FBS in PBS. The dish was 
washed twice with 1 ml of PBS to remove any remaining cells and the washings were 
added to the tube. The tubes were centrifuged (200 g for 5 min at 4°C), after which the 
supernatant was removed and the cell pellet resuspended in 3 ml PBS. A 50 l aliquot
 
of the cell suspension was added to a microfuge tube containing 50 l of 0.4% (v/v) 
trypan blue solution. Following mixing, a 50 l aliquot was added to a haemocytometer 
and the cells counted. This count represented the number of attached cells in the culture. 
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Cell viability was determined as a percentage of the total cell population. The total cell 
population represented the total number of live and dead cells found in both the attached 
and detached sub-populations (Appendix A.3).  
2.5 Western blotting 
2.5.1 Cell lysates preparation 
2.5.1.1 Detached cells    
At the end of the incubation period, the detached cells present in the tissue culture 
media in the petri dish or well of a 6-well plate were transferred into a centrifuge tube 
and centrifuged (200 g for 5 min at 4°C). The cell pellet was then resuspended in 100 l 
ice-cold (4°C) lysis buffer [20 mM Hepes pH 7.4, 2 mM EGTA, 50 mM  
-glycerophosphate, 1 mM Dithiothreitol, 1 mM Na3VO4, 1% Triton X-100, 10% (v/v) 
Glycerol, 0.5 mM PMSF, 0.5 mM NaF, 2% (w/v) protease inhibitor] and transferred 
into a 1.5 ml microfuge tube that was placed on a rocking platform for 20 min at 4°C. 
This fraction represented the protein lysates from detached cells. A 5 l aliquot was 
used to determine the protein concentration (Section 2.5.2). The supernatant was 
collected and placed in a microfuge tube on ice. This was treated as described in section 
2.5.1.3.  
2.5.1.2 Attached cells    
The attached cells in the petri dish or well of a 6-well plate were washed twice with  
ice-cold (4°C) PBS. After which, 100 l of ice-cold (4°C) lysis buffer  was added and 
the cells were dislodged with a scrapper before the dish was placed on a rocking 
platform (Ratek Instruments, Australia) for 20 min at 4°C. The cell lysates were 
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collected in a 1.5 ml microfuge tube and centrifuged (8,500 g for 15 min at 4°C). This 
fraction represented the protein lysates from attached cells. A 5 l aliquot was used to 
determine the protein concentration (Section 2.5.2). The supernatant was collected and 
placed in a microfuge tube on ice. This was treated as described in section 2.5.1.3.  
2.5.1.3 Western blot sample preparation    
Laemmli s sample buffer [0.5 M Tris, 100 mM Dithiothreitol, 8.2% (w/v) Sodium 
Dodecyl Sulfate (SDS), 0.1% (v/v) Bromophenol Blue and 40% (v/v) Glycerol] (223) 
(223) was added to the supernatant from the attached and detached cell fractions                                  
(Cell lysate : Laemmli s sample buffer, 4:1) and boiled for 5 min at 95°C. The samples 
were then stored at -80°C until they were used for SDS PAGE gel electrophoresis 
(Section 2.5.3).   
2.5.2  Protein concentration determination 
The level of protein in samples was determined using BCA as per the manufacturer s 
instructions with BSA as the standard. Briefly, duplicate 10 µl protein standards (0-10 
µg) and 5 µl aliquots of the cellular extract were placed in a 96-well flat-bottomed plate. 
After which 200 µl BCA solution was added to each well. The plate was left to incubate 
for 1 h at 37°C and read at 560 nm using a Perkin Elmer Victor3 plate reader (Wallac, 
Turku, Finland). The level of protein in each sample was calculated from the standards 
run on the plate.   
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2.5.3 SDS PAGE gels 
The SDS PAGE gels were set in a Mini Protean II Multicasting Chamber (Bio-Rad) and 
consisted of a 10% running gel [3.35 ml of 30% (v/v) Acrylamide Bis solution, 4 ml 
H2O, 2.5 ml 1.5 M Tris (pH 8.8), 0.1 ml 10% (w/v) SDS, 0.1 ml 10% (w/v) Ammonium 
Persulfate and 0.01 ml TEMED]. Once the running gel had set, the stacking gel [0.43 
ml 30% Acrylamide Bis solution, 1.7 ml H2O, 0.32 ml 1.5 M Tris (pH 8.8), 0.025 ml 
10% (w/v) SDS, 0.025 ml 10% (w/v) Ammonium Persulfate and 0.005 ml of TEMED] 
was overlaid on top. After which the combs were placed within the cast to form 10 
wells. Once the stacking gel had set, the sample comb was removed and the gel 
chamber was immersed in a tank containing Running buffer [25 mM Tris (pH 8.8), 192 
mM Glycine and 3.5 mM SDS]. In each gel, 5 l of Kaleidoscope Prestained Standards 
was added to the first lane while 50 g protein lysate extracts were added to each 
subsequent lane. The gel was run for 1 h at a constant voltage of 120 V.  
2.5.4 Immunoblotting 
When the gel electrophoresis was completed, the proteins were electro-transferred onto 
a pre-wet nitrocellulose membrane (Amersham Biosciences, Sydney, Australia), which 
had been pre-soaked (10 min) in cold transfer buffer (4°C) [25 mM Tris, 192 mM 
Glycine, 20% (v/v) Methanol], using a semi-dry transfer unit (Bio-Rad), at a constant 
amperage of 0.06 mA for 90 min for each gel. The efficiency of the semi-dry transfer 
was determined by visually observing the nitrocellulose membrane which had been 
soaked in Ponceau S solution [0.1% (w/v) Ponceau S in 0.05% (v/v) acetic acid] for 2 
min and that had been rinsed with water.   
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The nitrocellulose membrane was then placed in a dish containing blotto [5% (w/v) 
skim milk powder in TBST (20 mM Tris, 138 mM NaCl, 0.05% (v/v) Tween-20, pH 
7.6)] and agitated on a rocker for 2 h at RT. After which the membrane was placed in a 
dish with 10 ml of 5% Blotto containing the relevant primary antibody and placed on a 
rocker, overnight at 4°C. The next day, the nitrocellulose membrane was washed thrice 
(10 min per wash) with TBST at RT, after which it was placed in a dish containing 10 
ml of 5% blotto containing the relevant secondary antibody for 1 h at RT. After this, the 
nitrocellulose membrane was washed thrice (10 min per wash) with TBST at RT.   
2.5.5 Western blot protein detection 
After the final TBST wash (Section 2.5.4), the nitrocellulose membrane was exposed to 
2 ml chemiluminescent solution (Chemilucent, Chemicon, Melbourne, Australia) for 3 
min. The membrane was then placed in a Chemidox XRS unit and the 
chemiluminescence detected using a CCD camera connected to the Chemidox XRS unit 
and a digital image was obtained. The digital image was analysed for densitometry 
using Quantity One Digital Imaging Software Version 4.5.1 (Bio-Rad). The protein 
levels in untreated control sample were expressed as 100% while those in UV-irradiated 
and/or treated samples were expressed as a percentage of this value.   
2.6 ELISA 
Aliquots of media samples (0.5 ml) from the experiments were placed in 1.5 ml 
microfuge tubes and stored at -80°C prior to being used for the TNF ELISA assay 
(AccuKine, Apollo Cytokine Research, NSW, Australia).  
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Once the media samples had thawed out, they were first concentrated at 4°C using 
Microcon YM-10 microconcentrators (10 kDa MW cut-off filters) as per the 
manufacturer s instructions. These microconcentrated samples were assayed as 
described below. 
Wells of a 96-well plate were first coated with capture antibody (100 l) per well and 
washed thrice with wash buffer [0.05% (v/v) Tween-20 in PBS]. The plate was then 
blocked with 200 l of assay diluent (10% FBS in PBS) per well for 1 h at RT.
 
Then the 
wells were washed thrice with wash buffer. After which, 100 l of TNF standards                   
(0-500 pg/ml) and duplicate microconcentrated media samples were added to wells and 
incubated for 2 h at RT. The plate was then washed five times with wash buffer before 
100 l of working detector (detection antibody) was added to each well and the plate 
incubated for 1 h at RT.  After which, the wells were washed seven times with wash 
buffer for 30 s per wash. Then 100 l of substrate solution was added to each well and 
incubated for 30 min at RT in the dark. Once the assay was completed the absorbance 
was read at 450 nm using the Perkin Elmer Victor3 plate reader. The level of TNF in 
the cultured media of irradiated cells was calculated from the standard curve and was 
expressed as a function of cell protein level in order to determine the amount of TNF
secreted by the cell.  
2.7 Gelatin-Zymography 
2.7.1 Treatment of the cells 
Cells in 60 mm petri dishes or 6-well plates were pre-treated with the inhibitors as 
described in section 2.3.2.  In the zymogen assays, serum-free media was used (EpiLife 
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for HEK cells or RPMI 1640 for HaCaT and Colo 16 cells). After which, the petri 
dishes or 6-well plates were exposed to UV-irradiation as described in section 2.3.3. 
Following UV-irradiation HBSS was removed and replaced with serum-free media 
containing inhibitors (see results section 4.2.2) and the cultures incubated for 0-72 h. 
Sham-irradiated (control) cells were treated in the same manner, except that they were 
not irradiated. After which, 1 ml aliquot of supernatant was placed in a 1.5 ml 
microfuge tube and stored at -80°C prior to being used for the Zymogen assay (Section 
2.7.3). The attached cells in the petri dish were washed with ice-cold (4°C) PBS after 
which, 1 ml of 0.1 M NaOH was added to dissolve cell protein. The cells were 
dislodged with a scrapper before the dish was placed on a rocking platform for 30 min 
at RT. The cell proteins were collected in a 1.5 ml microfuge tube and centrifuged 
(8,500 g for 15 min at 4°C). A 5 l aliquot of the supernatant was used to determine the 
protein concentration (Section 2.5.2).   
After incubation, 1 ml of the conditioned media was removed from petri dish or 6-well 
plate and added to a 1.5 ml microfuge tube and was stored at -20°C prior to being 
assayed. These media samples were concentrated at 4°C for 30 min using a Microcon 
YM-10 microconcentrator. Sample buffer [0.5 ml H2O, 2.5 ml 0.5 M Tris-HCl (pH 6.8), 
2.0 ml 40% Glycerol, 4.0 ml 10% SDS, 0.1 mg Bromophenol Blue] was added to the 
microconcentrated conditioned media (microconcentrated conditioned media : sample 
buffer, 5:1) and the samples were stored at -20°C until they were used for zymogen gel 
electrophoresis (Section 2.7.3).  
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2.7.2 Zymography gel 
The SDS PAGE gels were prepared as described in section 2.5.4. Gelatin (0.125%) was 
added to a 10% running gel (Section 2.5.4) along with 0.05 ml 10% (w/v) Ammonium 
Persulfate. In the first lane, 10 l of Kaleidoscope Prestained Standards was added 
while 50 l of microconcentrated conditioned media (Section 2.7.1) was added to the 
other lanes. The gel was run for 40 min at a constant voltage of 200 V. 
On completion of electrophoresis, the gel was rinsed using distilled water and incubated 
(15 min) twice in wash buffer [12.5 ml of 2.5% (v/v) Triton X-100 in 500 ml dH2O] 
followed by an incubation between 16-20 h at 37°C in substrate buffer [50 mM Tris (pH 
7.0), 5 mM CaCl2 1 µM ZnCl2, 0.5% (v/v) Triton X-100, 0.01% (v/v) Sodium azide]. 
At the end of this period, the gel was washed twice with distilled water (5 min between 
each wash). The gel was then stained with Coomassie brilliant blue stock solution [0.5 g 
Coomasie Blue, 25% (v/v) methanol, 5% (v/v) Acetic Acid] for 45 min and destained 
using the destain solution [7% (v/v) acetic acid and 25% (v/v) methanol] for 2-3 h with 
regular changes of the destain solution every hour to visualise bands of proteolytic 
activity. 
After the final wash, the destained gel was placed in a Gel-Doc image analysis system 
and a digital image was captured. This image was inverted using the inverted display 
option and analysed for densitometry using Quantity One Digital Imaging Software 
Version 4.5.1. The level of activity in non-irradiated control sample was expressed as 
100% while those in the treated samples were expressed as a percentage of this value.   
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2.8 Cell Migration  
2.8.1 Cell Passaging and Preparation 
When cultures grown in 6-well plates reached ~ 90% confluency (Section 2.2.2), the 
cell culture media was aspirated and the cells washed thrice with pre-warmed (37°C) 
sterile PBS. After which, 1 ml of serum-free media was added to the wells and the 
plates were returned to a 5% CO2 cell incubator at 37°C for 2 h. After which, the plates 
were removed from the incubator and the cell monolayer was scraped in a straight line 
to create a scratch using a sterile 10 µl pipette tip. Removal of the debris and edge of 
the scratch was smoothed by washing the cells with 1 ml pre-warmed PBS. The cultures 
were either incubated for 24 h at 37°C in the presence or absence of inhibitors (100 µM 
Dec RVKR cmk or 100 µM 1, 10 phe) or for 1 h at 37°C (5 µM specific MMP 
inhibitor) in serum-free culture medium.  
At the end of this incubation period, the cells were washed twice with pre-warmed 
sterile PBS and 1 ml HBSS gently added to the cells. The culture was then exposed to 
UV-irradiation (Section 2.3.3). Following UV-irradiation, HBSS was removed and the 
cells were grown in same serum-free media containing the specific inhibitors for either 
24 or 48 h. At the end of this period, a 0.5 ml aliquot of the tissue culture media was 
placed in a 1.5 ml microfuge tube and stored at -80°C prior to being used for the 
zymogen assays (Sections 2.7.2 and 2.7.4). The attached cells were then washed twice 
with ice-cold PBS before being fixed with 1 ml of ice-cold ethanol. The 6-well plate 
was then placed on an ice-bath for 10 min after which analysis was done as described 
below in section 2.8.2.    
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2.8.2 Cell scratch image analysis 
After 10 min, the ethanol was aspirated from the cells and replaced with 1 ml ice-cold 
PBS. Phase contrast images of the cell cultures in the 6-well plates were obtained using 
20X objective of Olympus CK2 microscope and an Olympus DP10 digital camera, a 
representation of which is shown in Figure 2.2. The images of 10 fields per condition 
were analyzed.  
 
Figure 2.2 Time course of cell migration of Colo 16 cells. The culture was scratched at 
0 h (a) and viewed at 24 h (b) and 48 h (c).  
In order to obtain the same field during the image acquisition, markings were created 
which were used as reference points close to the scratch. The reference points were 
made by etching the plate lightly with a razor blade on the outer bottom of the plate or 
with an ultrafine tip marker. After the reference points were made, the plate was placed 
under a phase-contrast microscope; the reference mark was left outside the capture 
image field but within the eye-piece field of view.  
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The first image of the scratch was thus acquired. The plate was then placed under a 
phase-contrast microscope, the reference point was matched, the photographed region 
acquired in the previous step was aligned and a second image was acquired. This 
procedure was repeated until 5 images were obtained. Digital prints of the images were 
made and distance between one side of scratch and the other was measured at defined 
intervals. Cell migration was quantified by measuring the readings of distance for each 
sample and each experiment was repeated three times. An average of the readings was 
calculated and the results were represented as the distance (in mm) the cells migrated 
compared to that travelled by untreated controls (Appendix A.4).  
2.9 Real-Time PCR (qRT-PCR) 
2.9.1 Treatment of the cells 
Cells were grown in 60 mm diameter petri dishes and UV-irradiated as described in 
section 2.3.1. After irradiation, the HBSS was removed from the petri dish and 2 ml 
fresh pre-warmed (37°C) tissue culture media with or without IL-1
 
(10 ng/ml) was 
gently added to the cells. The petri dish was returned to the cell incubator for defined 
time points (0-48 h). At the end of this period, the experiment was terminated, the cells 
were washed and the RNA was extracted as described in section 2.9.2. Sham-irradiated 
(control) cells were treated in the same manner, except that they were not exposed to 
UVR.   
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2.9.2 RNA Extraction and quantitation 
RNA was extracted using a Pure Link RNA mini-kit as per the manufacturer s 
instructions (Pure Link RNA mini-kit, Invitrogen). A 1:70 dilution of pure RNA was 
made by adding 2 µl to 138 µl RNase-free H2O and the absorbance spectroscopically 
determined at 260 nm (Appendix A.5). The concentration and purity of RNA in each of 
the samples were determined using matched quartz cuvettes (Bio-Rad). The isolated 
RNA was stored at -20°C until required for Reverse Transcription (Section 2.9.3).  
2.9.3 Reverse Transcription 
Each RNA sample was diluted 1:5 with RNase-free water. The diluted RNA was 
incubated a in a Gene Amp PCR system 2400 (Perkin Elmer) for 2 min at 50°C. The 
samples were then reverse-transcribed using SuperScript® III First Strand Synthesis 
Supermix for qRT-PCR (Invitrogen). A 10 µl reaction contained up to 1 µg of RNA 
(depending on the quantification of RNA samples), 10 µl of Reaction Mix (includes 
oligo(dt)20 (2.5 µM), randon hexamers (2.5 ng/µl), 10 mM MgCl2 and dNTPs), 2 µl of 
the RT-Enzyme (Includes SuperScriptTM III RT and RNaseOUTTM), which was made 
up to 20 µl with RNase-free water. The reverse transcription reaction underwent the 
following conditions using a Perkin Elmer Gene Amp PCR system 2400; 10 min at 
25°C, 30 min at 50°C and 5 min at 95°C to stop the reaction. The cDNA samples were 
then placed on a bed of ice for 1 min and 1 µl of E. coli RNase H enzyme added to each 
one of the reactions after which the subsequent cDNA was stored at -20°C until 
required for qRT-PCR.  
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2.9.4 SYBR®GreenTM qReal-Time PCR  
All primers used in this thesis were as previously described by Skiba et al. (136). 
Primers for MMP-2 were designed using Genbank NCBI database. The primers to the 
genes described in this thesis (Table 2.2), were reconstituted before use (Appendix A.6). 
Each cDNA sample was loaded in triplicate wells of a 96-well microtitre plate.  
Each reaction (total volume 20 µl) contained 25 ng cDNA, 10 µl SYBR® Green ERTM 
qPCR Supermix (Invitrogen), 2 µl forward primer, 2 µl reverse primer, 2 µl cDNA 
sample and 4 µl of RNase-free H2O. In all reactions, 20 µl of RNase-free H2O was used 
as the negative control. PCR amplification was performed using an iCycler iQ Real 
Time Detection System version 3.021 (iCycler, Bio-Rad). The thermal cycling 
parameters used were 2 min at 50°C, 8 min at 95°C followed by 55 cycles of: 95ºC for 
15 sec and 60ºC for 60 sec. The melting curve analysis was done according the  
parameters: 95°C for 1 min, 55°C for 1 min and 80 cycles of: 55°C ± 0.5°C/cycle. 
Standard curve of amplication efficiencies (Appendix A.7) were obtained for both, the 
gene of interest and the reference genes for each of the cell lines.  
The relative expression of the target genes (TNF , TACE, Furin, MMP-2 and MMP-9) 
for each sample was calculated using the Pfaffl Correction method (225).  actin was 
used as the reference gene. Post qRT-PCR samples were stored at -20ºC until they were 
used for DNA agarose gel electrophoresis (Section 2.10) to verify the integrity of these 
samples.     
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2.10 DNA agarose gel electrophoresis 
2.10.1 Agarose gel preparation  
Agarose was prepared as follows: 2.5 g agarose was dissolved into 100 ml of Tris-
Acetate EDTA (TAE) buffer [Tris-base 48.4 g (pH: 8.3), glacial acetic acid 10.9 g, 
EDTA 2.92 g in 1000 ml of dH2O] in a 250  ml conical flask. The conical flask was 
placed in the microwave (Sharp, Melbourne, Australia) and the solution                  
microwaved for about 1 min to dissolve the agarose. After 45 seconds, the conical flask 
was removed and the contents were stirred. Following this, the flask was left on the 
bench for 5 min to allow the contents to cool to about 60°C. The open ends of the Gel 
casting trays (Bio-Rad) were closed with tape while the gel was cast, and were removed 
prior to electrophoresis. Sample combs, were then inserted around which molten 
agarose was poured to form sample wells in the gel. The gel was left to solidify for 
about 45min after which, the comb and the tape were removed and the gel slided into 
the electrophoresis chamber. After this, TAE buffer (running buffer) was poured into 
the chamber to submerge the gel to 2-5 mm depth.   
2.10.2 Sample preparation  
DNA samples were mixed with the loading buffer usually at a ratio of about 3:1 Here, 
5µl of the 50 bp DNA molecular weight marker was mixed with the 2 µl of the loading 
buffer (Orange 6, Promega). This was then loaded into the first lane of every gel. 
Similarly, 5 µl of each post qRT-PCR sample was mixed with 2 µl of the loading buffer 
which was then transferred to the subsequent lanes in the gel using a pipette. Care was 
taken to ensure the samples were loaded into each well. The gel tank was then closed, 
and the gels run at 30 V/cm for 3 h. The progress of the gel was monitored by reference 
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to the marker dye and was stopped when the Orange 6 loading buffer had run ~ 3/4 the 
length of the gel.    
2.10.3 Ethidium bromide staining  
Once the electrophoresis was completed, the gel was removed from the chamber and 
placed in the ethidium bromide (EtBr) stain [5.25 mg/ml H2O] box for 10 min. After 
which, the gel was transferred to a clear tray and dH2O was run over the gel for ~30 
min. The gel was then photographed using a CCD camera connected to the Chemidox 
XRS unit and a digital image obtained under UV light transmission.  Once the digital 
images of the gels were acquired, presence of the post qRT-PCR products were noted 
and the size (length of the DNA molecule) of the product was quantified by referencing 
against the kbp migration of the DNA molecular weight marker.  
2.11 Statistical analysis 
Statistical analysis of the effects of treatments on different aspects of cell function was 
performed and included UV wavelength (UVA and/or UVB), treated vs untreated cell 
cultures and timepoints (0, 6, 12, 24, 48 and 72 h post-irradiation), depending upon the 
relevant experiments. A control (untreated culture) was included in all experiments. All 
data points are expressed as the mean ± SEM for 3 replicates. All results were graphed 
using the Graph Pad Prism® 5 for Windows (GraphPad Software Inc., San Diego, USA) 
and analyzed using the one-way Anova test. As many comparisons were made a 
Bonferroni s correction of the p value was calculated. The data were considered 
significant if p<0.05. 
 Effect of UVR on furin activity in 
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3.1 Introduction 
Furin is a Ca2+-dependant serine protease (144, 153, 156, 158) and is a member of the 
proprotein convertase (PC) family (156). In the epidermis, furin can exist either as: (a) a 
mature 97 kDa membrane bound enzyme or (b) a smaller 75 kDa form that lacks the 
transmembrane domain and reactivity with the c-FUR antibody specific for the                       
C-terminus (144). It is localized to the constitutive secretory pathway (144, 226). Furin 
and other PC family members are proteases that play a key role in the maintenance of 
cell and tissue homeostasis  by activating inactive precursor proteins to their functional 
or mature form via limited proteolysis in a timely and spatial fashion (227). These 
molecules include growth receptors, growth factors, hormones, plasma proteins, MMPs 
and ECM components (144, 146, 156, 167).  
The role PCs play in the metastatic process is not clear. It is believed that for tumour 
progression to occur, the finely regulated autocrine/paracrine mechanism of growth 
factors and growth factor receptors expression and/or activation has to be deregulated. 
The abnormal production of those factors is a critical step in promoting the growth and 
malignant behavior of cancerous cells (227). In this context, PCs may be involved in the 
neoplastic process due to their inherent ability to process and activate these factors and 
receptors (227). Furin/PC expression and processing can increase the incidence and 
severity of the cancer phenotype (167). 
PCs have also been shown to proteolytically cleave a number of ADAM family 
members including TACE (167, 169) and its maturation occurs while it transits through 
the late golgi compartment which that prodomain removal is performed by a furin-type 
proprotein convertase (154, 161). In contrast, inhibition of furin in epidermal 
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organotypic cultures leads to premature differentiation of keratinocytes, possibly via its 
effects on the Notch pathway (156). Inhibition of furin has been shown to reduce levels 
of mature TACE in both COS-7 cells (151) and keratinocytes (156).  
Furin has been detected in keratinocytes and melanocytes (156) but the effect UVR has 
on its activity and/or expression and that of the proteases it activates in human 
keratinocyte cell lines is unknown. Furin mRNA, protein and enzyme activity has been 
observed in human epidermal keratinocytes (136, 151, 156, 173). Skiba et al. (136) 
found that UVA and UVB radiation increased furin mRNA levels immediately 
following exposure in HaCaT cells. Significant dose-dependent furin mRNA induction 
was detected 24 h after UVA-irradiation and 4 h post-UVB exposure (136).  
Huynh et al. (174) showed that furin levels were unchanged in Colo 16 cells                        
post-UVA-irradiation while those in HaCaT cells fell post-UVB-irradiation. Higher 
levels of furin were seen in Colo 16 cells compared to HaCaT cells. This agrees with 
that seen in other studies, where furin levels are higher in tumour cells compared to 
non-tumorous counterparts (144, 174, 227). It is unknown whether this change in furin 
levels was that of the immature and/or mature enzyme. While furin mRNA expression 
has been shown to be induced  by UVR, its protein expression has not been investigated 
(136).   
3.1.1 Aim and hypothesis 
While furin is known to be expressed in skin cells, the effect UVR has on its expression 
and/or activity in human keratinocyte cell lines is poorly understood.  We wish to 
observe if the cellular expression of furin is associated with its mRNA levels. 
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Therefore, the aim of this study is to investigate the effect of UVR on protein 
expression and/or activity of furin and whether UVA and/or UVB radiation induces the 
same response. 
The UVA (40 kJ/m2) and UVB (2 kJ/m2) dose used in this thesis represents the 
respective UVA and UVB component found in one MED (174, 224). Therefore, the 
effects of singular (UVA or UVB) and concurrent (combination of UVA and UVB 
mimicking solar light, herein referred to as UVAB for simplicity) exposures of UVR 
were examined. In order to understand the effects of UVR on different                    
keratinocyte-derived cell lines; primary keratinocytes (HEK), spontaneously 
immortalized keratinocytes (HaCaT) and SCC-derived (Colo16) cells were examined.  
HaCaT cells are often used as a substitute for primary keratinocytes (228, 229) and both 
cell lines were used to see if furin activity in HaCaT cells was similar to that observed 
in primary keratinocytes. It is unknown if the activity and expression of this protease is 
increased as a result of tumorigenesis, and as such Colo 16 (a SCC cell line) was used in 
comparative studies.    
3.2 Results 
3.2.1 Effects of UVR on keratinocyte-derived cell viability 
The effect of UVA- and/or UVB-irradiation on HEK, HaCaT and Colo 16 cell viability 
was determined 24 h post-irradiation using the trypan blue exclusion assay (Section 2.4) 
(Figure 3.1). 
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In HEK cells, the viability of attached sham-irradiated cultures was 93.3% (Figure 3.1i). 
UVA radiation had no effect on cell viability when compared to sham-irradiated 
controls. The attached viable cells were more sensitive to UVB and UVAB radiation as 
the cell viability was lower at 47% and 61%, respectively. The percentage of attached 
dead cells was highest in UVB- (49.3%) and UVAB-irradiated cells (38%) compared to                       
sham-irradiated controls (7%). The percentage of the detached viable and dead cells 
was <5% for all UV types and doses. The results suggest that when HEK cells are 
exposed to UVAB, the viability profile is similar to that of UVB and not UVA 
radiation. 
In HaCaT cells, the viability of attached sham-irradiated cultures was 92.4% (Figure 
3.1ii). UVA radiation caused a slight drop in cell viability (81.1%). However, the 
number of attached viable cells was lower in UVB- (72%) and UVAB-irradiated 
cultures (60%) compared to the sham-irradiated controls. A significant (p<0.05) number 
of attached dead cells (~20%) was observed in UVA- and UVAB-irradiated cultures 
when compared to sham-irradiated cultures (8%). The percentage of detached viable 
cells was low for all UV types and doses. There were less dead detached cells observed 
in UVA-irradiated cells compared with those exposed to either UVB- (18%) or              
UVAB-irradiation (18%). The results suggest that when HaCaT cells were exposed to 
UVAB radiation, the result had characteristics similar to that seen for those cells 
irradiated by either UVA or UVB.  
In Colo 16 cells, the viability of attached sham-irradiated cultures was 90% (Figure 
3.1iii). UVA radiation caused a slight reduction in attached viable cells (83%).  The  
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Figure 3.1 Effect of UVR on the viability of keratinocyte-derived cell cultures. HEK 
(i), HaCaT (ii) and Colo 16 cells (iii) were exposed to sham-irradiation or 
controls (C), UVA (A), UVB (B) or UVAB (AB) radiation and cell viability 
was determined 24 h post-irradiation. Results expressed are the mean ± 
SEM for three separate experiments. Statistical significance of the effect of 
UVR on the cell groups is represented as p<0.05 (*).      
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viability of attached cells in UVB- (49%) and UVAB-irradiated cells (49%) was 
significantly (p<0.05) reduced when compared to the sham-irradiated cultures. A 
significant (p<0.05) number of attached dead cells (16.4, 15 and 17%) was observed in 
UVA-, UVB- and UVAB-irradiated cultures when compared to the unexposed controls 
(9%). The percentage of detached viable cells was low for all UV types and doses. The 
highest numbers of dead detached cells (35%) were observed in cells exposed to either 
UVB- or UVAB-irradiation. These results suggest that when Colo16 cells are exposed 
to UVAB radiation, the viability profile is similar to that of UVB. The effect of UVR on 
Colo 16 cell viability was different to that seen in HaCaT and HEK cells.  The 
morphology of the irradiated cells appeared to be slightly altered as a response to being 
exposed to UVR as represented in the phase contrast images seen in Figure 3.2.  
3.2.2 Cellular expression of furin protein 
The mature form of furin (97 kDa) has been detected in foreskin epidermal extracts and 
cultured keratinocytes (156) and HNSCCs (173). The purpose of this study was to 
determine the effect UVR has on the levels of furin in keratinocyte-derived cell lines 
(HEK, HaCaT and Colo 16 cells).  
In order to quantify changes in furin levels in the cells, western blots (Section 2.5) of 50 
µg cell lysates were run and probed with a furin convertase antibody. -actin was used 
to quantify the level of protein added to each lane. Representative blots of the effect of   
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Figure 3.2 Effect of UVR on the morphology of Colo 16 cell cultures. Phase contrast 
images of Colo 16 cells were observed 24 h after being exposed to no           
UV-irradiation (sham-irradiated or controls) (i), UVA (40 kJ/m2) (ii), UVB 
(2 kJ/m2) (iii) and UVAB (40 kJ/m2 UVA + 2 kJ/m2 UVB) (iv) radiation.     
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UVR on furin levels in HEK, HaCaT and Colo 16 cells are seen in Figure 3.3. The level 
of furin in the treated cell was calculated as a ratio to that seen in untreated controls 
which was assigned a value of one.                 
    
 
Figure 3.3 Representative western blots to show the effect of UVR on the expression 
of furin in HEK (i), HaCaT (ii) and Colo 16 cells (iii). The cells were 
exposed to no irradiation (controls) (C), UVA (A), UVB (B) and UVAB 
(AB) radiation and after 24 h, 50 µg of cell lysates were run on western 
blots. -actin was used as a loading control.  
3.2.2.1 Effects of UVR 
The level of furin in HEK cells remained unchanged in response to UVR irrespective of 
the type or dose used (Figure 3.4). Furin levels in HaCaT cells were elevated when the 
cells were exposed to UVR (Figure 3.4). The levels were 6x higher in UVA-irradiated 
cells and 12x and 15x in UVB- and UVAB-irradiated cells, respectively when 
compared to the untreated controls.   
In Colo 16 cells, furin was elevated in response to UVR. The levels of furin were 2x, 
7.5x and 6.2x times higher in UVA-, UVB- and UVAB-irradiated cells, respectively 
3. Effect of UVR on furin activity in human keratinocyte cell lines 
80  
when compared to the untreated controls. The greatest increase in furin levels in both 
HaCaT and Colo 16 cells were seen in these cells which were exposed to either UVB or 
UVAB radiation. 
When the level of furin in sham-irradiated (control) cell lines were compared (Figure 
3.5), it can be seen that HaCaT cells expressed the highest amounts followed by Colo 
16 cells with HEK having the lowest levels. Compared to HEK cells, furin levels were 
10.9x higher in HaCaT cells and 5.7x higher in Colo 16 cells.    
3.2.2.2 Effects of CHX  
Cycloheximide (CHX) has been used in many studies to inhibit de novo protein 
synthesis (230-232). We used it in this study to determine the half-life of furin protein 
expression in the keratinocyte-derived cell lines. However, before we could determine 
the half-life of furin, the effect of CHX on cell viability needed to be determined.   
3.2.2.2.1 Cell viability 
The effect of CHX on cell viability of UV-irradiated HaCaT and Colo 16 cells was 
determined 24 h post-irradiation using the trypan blue exclusion assay (Section 2.4) 
(Figure 3.6). 
In HaCaT cells, the viability of attached cells in untreated controls was 92.5%, 
however, in the presence of CHX, this fell to 77% (Figure 3.6i). The viability of 
untreated UVAB-irradiated attached cells (60%) fell slightly to 57% in the presence of 
CHX. The level of attached dead cells was <10% across all treatments and conditions 
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Figure 3.4 Effect of UVR on the expression of furin in HEK, HaCaT and Colo 16 
cells. Cells were exposed to no irradiation or controls (C), UVA (A), UVB 
(B) and UVAB (AB) radiation and furin levels determined 24 h                              
post-irradiation. The level of furin in each cell was expressed as a ratio to 
that seen in untreated controls which was given the value of 1. Results 
expressed are the mean ± SEM for three separate experiments. Statistical 
significance of the effect of UVR on furin levels was shown as p<0.05 (*).      
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Figure 3.5 Comparison of the expression of furin in untreated cultures of HEK, HaCaT 
and Colo 16 cells. On a western blot, 50 µg of cell lysates were run and             
-actin was used as a loading control (i). Quantification of the level of furin 
in HEK, HaCaT and Colo 16 cells (ii). Results expressed are the mean ± 
SEM for three separate experiments. Statistical significance of furin levels 
in different cell types was shown as p<0.05 (* HEK vs other cells) and                 
(^ HaCaT vs Colo 16) (ii).      
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except for untreated UV-irradiated cells (20%). The number of detached viable cells 
was <5% in response to the different treatments and does. There were less dead 
detached cells observed in the untreated controls compared to CHX-treated controls and 
UV-irradiated cells (20%). The results show that 100 µM CHX did not significantly 
affect the viability of HaCaT cells.  
In Colo 16 cells, the viability of attached cells in the untreated controls was 90% 
whereas this fell to 80% when CHX was added to these cells (Figure 3.6ii). The 
viability of untreated UVAB-irradiated attached cells was 50% and in the presence of 
CHX, it fell slightly to 48.2%. The number of attached dead cells was ~20% under all 
treatments and conditions except that it was ~30% in the untreated and treated           
UVAB-irradiated cells. The percentage of detached viable cells was negligible (<5%) in 
all experimental conditions.  
In general, CHX at 100 µM had a minimal effect on cell viability of sham- and              
UVAB-irradiated HaCaT and Colo 16 cells and therefore, this dose was used to 
determine the half-life of furin protein expression.   
3.2.2.2.2 Time course furin protein expression 
A time course (0-24 h) of the level of furin expressed in HaCaT and Colo 16 cells was 
investigated. In order to investigate the half-life (T1/2) of furin protein expression, the 
cells were either treated with or without CHX in UVAB-irradiated cells (Appendix 
A.9). The cells were irradiated with UVAB as it stimulated maximal furin expression in 
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Figure 3.6 Effect of CHX on the viability of UVAB-irradiated HaCaT (i) and Colo 16 
cells (ii). Cells were exposed to sham-irradiation or controls (C) or UVAB 
(AB) radiation in the presence (+) or absence (-) of CHX. Cell viability was 
determined 24 h post-irradiation. Results expressed are the mean ± SEM for 
three separate experiments. Statistical significance of the effect of CHX on 
the cell populations was represented as p<0.05 (*).    
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HaCaT and Colo 16 cells (Figure 3.4). The effect of 100 µM CHX on furin levels in 
UVAB-irradiated HaCaT and Colo 16 cells was used as it was shown to have a minimal 
effect on cell viability (Figure 3.6). Western blots of cell lysates from the treated cells 
were quantified (Section 2.5) and the results are shown in Figures 3.7 (HaCaT cells) and 
3.8 (Colo 16 cells). 
In HaCaT cells, the expression of furin in the untreated controls was constant over a 24 
h period (Figure 3.7). On the other hand, furin protein levels in the corresponding             
CHX-treated cells decreased over the same period falling from 100% at 0 h to 10% by 
24 h. Furin levels in the UVAB-irradiated HaCaT cells steadily increased following 
exposure reaching a maximal value of 15x that of sham-irradiated controls at 24 h. This 
was similar to that seen previously (Figure 3.4). However when CHX was added to the 
UVAB-irradiated cultures the furin levels was lower. There was a steady decline of 
furin expression in these cells from 100% at 0 h to 55% at 4 h and 5% by 24 h. The 
calculated half-life of furin in the un-irradiated HaCaT cells was 6.0 h while in the 
UVAB-irradiated cells, it was 5.6 h (Figure 3.7).  
In Colo 16 cells, furin expression in the untreated controls was constant throughout the 
24 h period (Figure 3.8). Furin protein levels in the corresponding CHX-treated cells 
were slightly elevated at 4 h (107%) before it fell to 77% at 8 h and 37% by 24 h. Furin 
levels in UVAB-irradiated HaCaT cells showed a steady increase with respect to time 
reaching 6.5x that of the sham-irradiated controls by 24 h. The level of furin in these 
irradiated cells at 24 h was similar to that seen previously (Figure 3.4). On the other 
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Figure 3.7 The effect of CHX on furin expression in UVAB-irradiated HaCaT cells. 
Cells were exposed to sham-irradiation or controls (C), or UVAB radiation 
(UVAB) in the presence (+) or absence (-) of CHX. The level of furin 
expression was measured up to 24 h post-irradiation. The calculated              
half-life of furin was represented as dotted lines. The level of protein in 
sham-irradiated (control) cells was given a value of unity. Results expressed 
are the mean ± SEM for three separate experiments.                                                       
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hand, furin levels were much lower in the CHX-treated UVAB-irradiated cultures 
compared to their untreated counterparts. There was a steady decrease of furin 
expression over the course of the experiment falling to ~20% by 24 h. The calculated 
half-life of furin in the un-irradiated Colo 16 cells was 17.0 h while in the                     
UVAB-irradiated cells, it was much shorter at 8.1 h (Figure 3.8).  
3.2.2.3 Effects of IL-1 
 
Exposure to UV light induces many changes to the skin microenvironment, including 
the production of cytokines (233-235). IL-1 is a major epidermal cytokine that is 
constitutively synthesized by keratinocytes in response to stimuli like UV-irradiation 
(236, 237). Several growth factors and cytokines induce IL-1 expression in epidermal 
keratinocytes, these include TNF (238, 239), TGF (239) and also IL-1 (240).  
Bashir et al. (77) recently showed that IL-1 stimulates the secretion of TNF from
UVB-irradiated keratinocytes. TNF is cleaved from its proform by the action of TACE 
(125, 137, 138). TACE is activated by the action of furin (151, 156, 158). As IL-1 
stimulates TNF release from irradiated cells, I investigated if this cytokine increased 
TNF release from the cells by enhancing TACE and/or furin levels (see Chapter 5). As 
a result, the effect of IL-1 (10 ng/ml) on the expression of furin in cells exposed to 
UVR was investigated.   
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Figure 3.8 The effect of CHX on the expression of furin in UVAB-irradiated Colo 16 
cells. Cells were exposed to sham-irradiation or controls (C), or UVAB 
radiation (UVAB) in the presence (+) or absence (-) of CHX.  Furin levels 
were determined over a period of 24 h post-irradiation. Protein half-life is 
represented as dotted lines. The level of protein in sham-irradiated (control) 
cells was given a value of unity. Results expressed are the mean ± SEM for 
three separate experiments.  
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3.2.2.3.1 Furin protein expression 
The effect of IL-1 on the expression of furin in UV-irradiated cells was determined 24 
h post-irradiation using western blots of cell lysates (Section 2.5). In HEK cells, the        
IL-1 was shown to have no pronounced effects on furin expression in the                      
UV-irradiated cells (Figure 3.9i).  
In HaCaT cells, furin expression was elevated 5.9x in UVA-irradiated cells, 10.5x in 
UVB-irradiated cells and 15x in UVAB-irradiated cells when compared to the              
sham-irradiated controls (Figure 3.9ii). The addition of IL-1 to these irradiated cells 
caused a slight reduction in the observed furin levels.  
In Colo 16 cells, furin levels were significantly elevated in UVB- and UVAB-irradiated 
cells compared to sham-irradiated cells (Figure 3.9iii). The increases seen in Colo 16 
cells were less than that seen for the same UV dose in HaCaT cells.  However, when  
IL-1 was added to the irradiated cells, there was a slight reduction in the observed 
levels of furin.  
In summary, IL-1 had
 
a slight additive effect in HEK cells but a slight suppressive 
effect on furin expression in HaCaT and Colo 16 cells.   
3.2.2.3.2 Combined effects of CHX and IL-1
IL-1 has been shown to have a slightly suppressive effect on furin levels in                    
UV-irradiated HaCaT and Colo 16 cells (Figure 3.9). Therefore the effect of CHX and           
IL-1 on the level of furin expressed in UVAB-irradiated HaCaT and Colo 16 cells was 
investigated in a time course (0-24 h) experiment. In order to investigate the half-life of 
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Figure 3.9 Effect of IL-1 on the expression of furin in UV-irradiated HEK (i), HaCaT 
(ii) and Colo 16 cells (iii). Cells were exposed to sham-irradiation or 
controls (C), UVA (A),  UVB (B) and UVAB (AB) radiation in the 
presence (+) or absence (-) of IL-1 . Furin levels were determined 24 h 
post-irradiation. The furin levels were expressed as a ratio to that seen in 
untreated controls which was given a value of 1. Results expressed are the 
mean ± SEM for three separate experiments. Statistical significance of the 
effect of IL-1 on furin levels was shown as p<0.05 (*).     
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furin protein expressed in these cells, the cells were either treated with or without CHX 
in UVAB-irradiated cells in the presence of IL-1
 
(Appendix A.9). The cells were 
irradiated with UVAB as it stimulates maximal furin expression in HaCaT and Colo 16 
cells (Figure 3.4). Western blots of cell lysates from the treated cells were quantified 
(Section 2.5) and the results shown in Figures 3.10 (HaCaT cells) and 3.11 (Colo 16 
cells).  
In HaCaT cells, the expression of furin in IL-1 treated UV-irradiated cells increased 
with respect to time and reached 15x that of untreated un-irradiated controls by 24 h 
(Figure 3.10). This result was similar to that seen previously (Figure 3.7). However, 
when CHX was added to the UV-irradiated cultures, furin levels fell 50% by 4 h before 
reaching <5% after 24 h. The calculated half-life of furin in the CHX-treated                      
UV-irradiated HaCaT cells grown in the presence of IL-1 was calculated to be 4.3 h 
(Figure 3.10). The corresponding half-life of furin in CHX-treated controls was 6.0 h 
while in UVAB-irradiated cells it was 5.6 h (Figure 3.8). 
In Colo 16 cells, the expression of furin in the IL-1 treated UV-irradiated cells 
increased with respect to time and reached 6.2x that of the untreated un-irradiated cells 
at 24 h (Figure 3.11). This was similar to that seen previously (Figure 3.8). However, 
when CHX was added to the IL-1 treated UV-irradiated cultures, furin levels fell to 
70% after 4 h before reaching 10% by 24 h. The half-life of furin in the CHX-treated                    
UV-irradiated Colo 16 cells grown in the presence of IL-1 was calculated to be 8.3 h  
(Figure 3.11). It can be seen that in UV-irradiated Colo 16 cells, the half-life of furin  
(in the presence or absence of IL-1 was 8.3 and 8.1 h, respectively) which was much 
less than that seen in un-irradiated cells (17.0 h). 
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Figure 3.10 The effect of CHX on the expression of furin in IL-1 treated                  
UVAB-irradiated HaCaT cells. Cells were exposed to sham-irradiation or 
controls (C) or UVAB radiation (UVAB) in the presence of IL-1 (IL) 
and/or CHX (CHX). Furin levels were determined over a period of 24 h 
post-irradiation. Protein half-life is represented as dotted lines. The level of 
protein in sham-irradiated (control) cells was given a value of unity. Results 
expressed are the mean ± SEM for three separate experiments. 
3. Effect of UVR on furin activity in human keratinocyte cell lines 
93  
In conclusion, these results show that IL-1
 
has no significant effect on the half-life of 
furin in UVAB-irradiated HaCaT or Colo 16 cells compared to that seen in the 
irradiated cells.   
3.2.3 Furin mRNA expression 
An investigation of the effect of UVR on furin gene expression was undertaken to see if 
changes in mRNA levels corresponded to changes in its protein levels. Skiba et al. 
(136) showed that UVA (2 kJ/m2) and UVB (2 kJ/m2)-irradiation induced a significant 
increase in furin mRNA, with higher levels seen in the UVB-irradiated cells.  
The aim of this study was to observe the changes in furin mRNA levels in                     
UVB-irradiated HaCaT and Colo 16 cell lines over 32 h. Skiba et al. (136) used             
qRT-PCR to quantitate changes of mRNA levels in cultured HaCaT cells following  UV 
exposure. In order to quantify the gene expression of furin, qRT-PCR was used because 
of the low levels of mRNA seen in these tissues(136).  
3.2.3.1 Time course gene induction  
Following exposure to UVB-irradiation, samples were taken at various time points over 
32 h from the HaCaT and Colo 16 cells and the mRNA levels measured using                
qRT-PCR (Section 2.9). While Skiba et al. (136) used the TaqManTM qRT-PCR 
protocol and  CT method for analysis, SYBR®Green ERTM qRT-PCR protocol and 
Pfaffl correction method was used in this study  (Appendix A.8) (225). In this method, 
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Figure 3.11 The effect of CHX on the expression of furin in UVAB-irradiated Colo 16 
cells treated with IL-1 . Cells were exposed to sham-irradiation or controls 
(C), or UVAB radiation (UVAB) in the presence of IL-1 (IL) and/or CHX 
(CHX). Furin levels were determined over a period of 24 h post-irradiation. 
Protein half-life is represented as dotted lines. The level of protein in          
sham-irradiated (control) cells was given a value of unity. Results expressed 
are the mean ± SEM for three separate experiments. 
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the relative expression of the internal control gene ( actin) and target gene
 
(furin) for 
each UV-irradiated sample was compared against un-irradiated sample. Results from 
this study shows that in  UVB-irradiated HaCaT cells, a significant (p<0.05) increase in 
furin mRNA levels compared to untreated controls was not detected until 8 h (1.5-fold), 
after which it increased reaching a maximal level at 24 h (91-fold) before it falling to 
3.3-fold by 32 h (Figure 3.12).   
In Colo 16 cells furin mRNA expression in UVB-irradiated Colo 16 cells remained 
constant for the first 8 h before it increased to its maximal value (1.5-fold) at 12 h.  
After this it fell slightly at 16 h (1.2-fold) and remained constant until 24 h before 
falling to undetectable levels at 32 h. It can be seen from these cells that furin mRNA 
levels following UVB radiation differs between HaCaT and Colo 16 cells. The Colo 16 
cells have an earlier peak but a lower level of furin mRNA expression than do HaCaT 
cells.   
3.2.3.2 Effects of UVR 
Furin mRNA was shown to be induced by UVB-irradiation in both HaCaT and Colo 16 
cells (Figure 3.12). We extended that study to see if other UV types had an effect on 
furin mRNA levels in the cell. We chose the time point of 24 h post-irradiation to 
perform this study.  
In HaCaT cells, maximum induction of furin mRNA was observed in UVB-irradiated 
cells (91-fold) (Figure 3.13). Furin mRNA levels were also increased 40- and 52-fold in 
the UVA- and UVAB-irradiated HaCaT cells, respectively when compared to that seen 
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Figure 3.12 Effect of UVB on time course furin mRNA induction/expression in HaCaT 
and Colo 16 cells. Cells were exposed to UVB-irradiation and mRNA 
expression determined over a 32 h period. Control mRNA levels found in 
un-irradiated cells (=1) are represented as dotted lines. Results expressed 
are the mean ± SEM for three separate experiments. Statistical significance 
of the effect of UVB on furin mRNA levels against sham-irradiated 
(control) cells was shown as p<0.05 (*).   
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in the sham-irradiated controls. However, maximal induction of furin mRNA was 
induced in UVB-irradiated cells which agreed with that seen previously (136).  
In Colo 16 cells, furin mRNA expression was relatively constant following                  
UV-irradiation (Figure 3.13). Furin expression was slightly higher in UVB-irradiated 
cells (~2-fold) compared to the un-irradiated controls. This was similar to that seen 
previously (Figure 3.12).  Furin gene expression was much greater in HaCaT cells 
compared to that seen in Colo 16 cells, while UVB-irradiation induced the highest 
levels in both cells.   
3.2.3.2.1 Furin mRNA vs protein levels  
Correlation studies were performed by comparing the levels of furin mRNA (Figure 
3.13) and protein (Figure 3.4) seen in the HaCaT and Colo 16 cells 24 h                           
post-irradiation. The level of mRNA and protein in the un-irradiated controls was given 
the value of unity.  
The values for both mRNA and protein in the irradiated cells are expressed as a ratio of 
that seen in their respective un-irradiated controls. The results were plotted and a line of 
best fit was calculated for each UV type (Figure 3.14).  
There was a moderate correlation (r2 = 0.581) between furin mRNA and protein levels 
in the irradiated HaCaT cells. However in Colo 16 cells this correlation was weaker                  
(r2 = 0.399). While there appears to be a correlation between furin mRNA and protein 
levels at 24 h in these cells, this correlation may be more pronounced at other time 
points.  
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Figure 3.13 Effect of UVR on furin mRNA induction/expression in HaCaT and Colo 16 
cells. Cells were exposed to control (no irradiation), UVA, UVB and 
UVAB radiation and mRNA expression determined 24 h                           
post-irradiation. Control mRNA levels found in un-irradiated cells (=1) are 
represented as dotted lines. Results expressed are the mean ± SEM for three 
separate experiments. Statistical significance of the effect of UVR on furin 
mRNA levels against sham-irradiated (control) cells was shown as p<0.05 
(*).          
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Figure 3.14 Correlation between furin protein and mRNA levels 24 h                              
post-irradiation in HaCaT (i) and Colo 16 cells (ii). Cells were exposed to 
sham irradiation or controls (C), UVA, UVB and UVAB radiation and the 
protein levels and mRNA expression of furin in the cell extracts for each 
UV type were expressed as a ratio to that observed in sham-irradiated cells, 
which were given the value of unity.   
3.2.3.3 Effect of CHX  
We have shown earlier that CHX inhibits the synthesis of furin protein in HaCaT 
(Figure 3.7) and Colo 16 cells (Figure 3.8). In order to look at the effect CHX (100 µm)  
had on furin mRNA levels. We used UVAB-irradiated HaCaT and Colo 16 cell lines at 
0 and 24 h post-UVAB-irradiation.   
In HaCaT cells, the furin mRNA expression was similar in sham-irradiated cells or 
CHX-treated cells 0 and 24 h after the commencement of the experiment. Furin mRNA 
levels immediately decreased by 50% in both untreated and CHX-treated                    
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UVAB-irradiated cells. However, at 24 h, the furin mRNA levels increased to 52-fold 
compared to that seen in untreated controls at 0 h. The addition of CHX to these 
UVAB-irradiated cells had no effect on furin mRNA expression at either time point 
(Figure 3.15i).  
In Colo 16 cells, the furin mRNA levels did not change in either the controls or             
CHX-treated cells 0 or 24 h after the commencement of the experiment. Furin mRNA 
levels immediately increased ~2-fold post-irradiation in both untreated and CHX-treated 
UVAB-irradiated cells. However, at 24 h, the furin mRNA levels had fallen to only 
70% of that seen in untreated controls at 0 h (Figure 3.15ii). The addition of CHX to 
these UVAB-irradiated cells had no effect on furin mRNA expression at either time 
point.  
In both cell lines CHX was shown to have no effect on furin mRNA expression.   
3.2.3.4 Effects of IL-1 
 
Earlier we found the addition of IL-1 to UV-irradiated cells resulted in a reduction of 
furin protein expression in HaCaT and Colo 16 cells (Figure 3.9). In this experiment, 
the effect of IL-1 on furin mRNA expression in UVAB-irradiated HaCaT and Colo 16 
cells was examined to see if this change might be due to altered mRNA levels.   
Immediately following exposure to UVAB-irradiation, IL-1 was added to HaCaT and 
Colo 16 cells and samples were collected over the next 24 h. The mRNA levels were 
measured using qRT-PCR (Section 2.9). In this method, the relative expression of the 
internal control gene ( actin) and target gene (furin) for each UV-irradiated sample  
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Figure 3.15 Effect of CHX on the mRNA expression of furin in UVAB-irradiated 
HaCaT and Colo 16 cells. Furin mRNA induction/expression was measured 
in HaCaT (i) and Colo 16 cells (ii) compared with controls either at 0 or 24 
h post-irradiation. Cells were exposed to sham irradiation or controls (C) 
and UVAB-irradiation (AB) in the presence (+) or absence (-) of CHX. 
Control mRNA levels found in un-irradiated cells (=1) are represented as 
dotted lines. Results expressed are the mean ± SEM for three separate 
experiments. Statistical significance for effect of CHX on furin mRNA 
levels against sham-irradiated (control) cells was shown as p<0.05 (*).    
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with IL-1
 
at different time points was compared against the un-irradiated sample with 
IL-1 at 0 h. This was calculated using the Pfaffl Correction method (Appendix A.8) 
(225). UVAB-irradiation was shown to induce maximum furin protein levels 24 h                    
post-irradiation in HaCaT cells (15x) (Figure 3.4) and Colo 16 cells (6.2x) when 
compared to un-irradiated controls. The addition of IL-1 to these irradiated cells 
caused a slight suppression of furin levels in these cells (Figure 3.9).  In this study, we 
irradiated the cells with UVAB, so the effect of IL-1 on furin mRNA expression could 
be examined.  
In HaCaT cells, the effect of UVAB plus IL-1 on the expression of furin mRNA levels 
fell post-irradiation reaching a minimal value (60%) at 4 and 8 h before increasing to a 
peak (5.3x) at 16 h after which it fell back to 4.2x that of the treated un-irradiated 
controls at 24 h.   
In Colo 16 cells, under the same conditions, furin mRNA levels increased immediately 
at 4 h (2.6-fold) compared to the treated un-irradiated controls after which it remained 
constant between 8 and 12 h (~similar to controls) before it  fell by 70% at 16 and 24 h 
(Figure 3.16).  
In conclusion, over a 24 h time period, addition of IL-1 initially decreased furin 
mRNA expression over the first 12 h before dramatically increasing over the next 4 h in 
UVAb-irradiated HaCaT cells. In the Colo 16 cells there was an initial increase in furin 
mRNA expression peaking at 4 h before it fell steadily.     
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Figure 3.16 Time course of the effect of IL-1 on furin mRNA induction/expression in 
UVAB-irradiated HaCaT and Colo 16 cells. Cells were exposed to 
UVA+UVB (UVAB) radiation and mRNA expression was determined at 
different time points over a 24 h period. Control mRNA levels found in         
un-irradiated cells (=1) are represented as dotted lines. The relative 
expression of the furin gene for each IL-1 treated sample was compared 
against the treated un-irradiated controls and calculated using the Pfaffl 
Correction method (Appendix A.8). Results expressed are the mean ± SEM 
for three separate experiments. Statistical significance of the effect of IL-1 
on furin mRNA induction/expression was shown as p<0.05 (*) for           
UVAB-irradiated HaCaT cells and (^) for UVAB-irradiated Colo 16 cells. 
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3.2.4 Summary 
In this study, I investigated the effect UVR had on furin activity, protein and mRNA 
expression in the keratinocyte-derived cell lines (HEK, HaCaT and Colo 16 cells). Cell 
viability using trypan blue exclusion showed that the cells in general were more 
sensitive to UVB than UVA radiation (Figure 3.1). UVR increased furin protein 
expression in both HaCaT and Colo 16 cells but not in HEK cells (Figure 3.4).           
UVAB-irradiation stimulated the greatest increase of furin levels in HaCaT while in 
Colo 16 it was due to UVB. The turnover of furin protein was longer in Colo 16 cells 
compared to HaCaT cells (T½ = 17.0 h and 5.6 h, respectively) (Figures 3.7 and 3.8).  
The addition of IL-1 had a suppressive effect on furin expression when the cells 
(HaCaT and Colo 16 but not HEK cells) were exposed to UVR (Figure 3.9).   
In general, furin mRNA expression was higher in UV-irradiated HaCaT cells compared 
to Colo 16 cells. Maximal furin mRNA levels were observed at 24 h in HaCaT cells and 
12 h in Colo 16 cells following UVB-irradiation (Figure 3.12).  There was a weak 
correlation between furin mRNA and protein levels in Colo 16 cells, but it was stronger 
in HaCaT cells (Figure 3.14). CHX had no effect on furin mRNA expression in         
UVAB-irradiated HaCaT and Colo 16 cells (Figure 3.15). The addition of IL-1 in a 
time course study increased furin mRNA levels in UV-irradiated HaCaT cells but 
reduced them in Colo 16 cells compared to that in treated un-irradiated controls (Figure 
3.16).  
In conclusion these results show that UVR up-regulates both furin protein and mRNA 
expression, although there was not a strong correlation between the two. While addition 
of IL-1 had a slightly suppressive effect on furin protein expression, it increased furin 
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mRNA levels in HaCaT cells. On the other hand, in Colo 16 cells, effect of IL-1 
caused reduction of both furin protein and mRNA levels.     
3.3 Discussion 
Furin is a member of the PC family and is expressed at low levels in a wide range of 
human tissues (173). PCs are proteases that play a key role in the maintenance of cell 
and tissue homeostasis by activating protein precursors via proteolysis in a timely and 
spatial fashion (227). While furin is known to be expressed in skin cells, the effect UVR 
has on its expression and/or activity and that of its substrates in human keratinocyte is 
unknown.   
UV light is intricately linked to the functional status of the cutaneous immune system. 
In susceptible individuals, UVR can activate pathogenic inflammatory pathways leading 
to allergy or autoimmunity (241). It is a major environmental factor that affects 
pigmentation in human skin and can eventually result in various types of UV-induced 
skin cancers (242). Much emphasis has been placed on the role of UVB in skin 
carcinogenesis but not on UVA. However, a large body of evidence now points to a role 
for UVA in skin carcinogenesis (242-246). Unlike UVB, which is absorbed in the 
epidermis, UVA radiation penetrates into the underlying dermis causing a reduction in 
the number of superficial dermal fibroblasts (16). Although the magnitude of UVA is 
less carcinogenic than UVB (247, 248), chronic UVA exposure has been shown to 
induce photoageing  (249) and skin tumours (squamous cell carcinomas) in 
experimental animals (247, 250, 251). 
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The predominance of UVA mutations in the basal cell layer of the epidermis reinforces 
the pivotal role UVA may play in the malignant transformation of human skin cells 
(252). UVA radiation also induces epidermal lipid peroxidation, which stimulates LC 
migration from the epidermis, thus contributing to UV-induced immunosuppression 
(244). Therefore, in this study, UVA and/or UVB were used in all experiments, as they 
are the components of UV light that reach the Earth s surface (7, 253). As UVC is 
unable to penetrate the ozone layer (253), it was not used  in this study as it was not of 
physiological relevance (30). In this study some of the cellular changes elicited by UVA 
and UVB on furin activity and/or expression in cultured keratinocyte-derived cell lines 
were investigated.   
Three keratinocyte cell lines were used in this study; primary human keratinocytes 
(HEK), immortalized (HaCaT) and SSC-derived (Colo16) cells. HaCaT cell line were 
chosen as it is a non-tumorigenic, fully differentiated and potentially immortalized  
model for primary keratinocytes (221). Previous studies comparing the effect of 
treatments between HaCaT and primary keratinocyte cultures, or human keratinocytes 
in vivo, reported that the results were comparable and a good correlation existed 
between the two cell lines (228, 229). Therefore, based on such findings, we chose 
HaCaT cells as a model to study the effects of UV-irradiation in keratinocytes. Where 
possible, we also repeated the experiments using HEK cells to observe if the results 
seen in HaCaT cells were similar to that of primary keratinocytes. Colo 16 cells were 
isolated from a SCC and were used to observe the effects of UVR has on a                  
tumour-derived keratinocyte  (222). Hence by using the three cell lines we can evaluate 
(a) if HaCaT cells are a suitable substitute for HEK to investigate the effect of UVR on 
3. Effect of UVR on furin activity in human keratinocyte cell lines 
107  
cell function and (b) are these cellular processes affected as a result of carcinogenic 
transformation.  
It is important while examining activity, cellular and mRNA expression in skin cells 
that the UV doses used do not induce cell death, as it is only the surviving cells in vivo 
that can become carcinogenic (174). Therefore, in this study, the UVA dose (40 kJ/m2) 
and the UVB dose (2 kJ/m2) represented the respective UVA and UVB components 
found in one minimal erythemal dose (MED) (224). One MED is the amount of UVR 
that causes perceptible erythemal or edema, generally called sunburn (48). The UVAB 
used in this study is a combination of the respective UVA and UVB doses in one MED. 
The doses (Section 2.3.4 and Table 2.1) used in this study was chosen because they 
represent the dose most people would receive in a single exposure period when they are 
outdoors (174). While the cumulative daily UV dose some people would receive may be 
higher, this study was designed to observe the cellular effects elicited from a single 
exposure, and as such these doses were chosen (174).  
For all experiments used in this study, keratinocyte-derived cell cultures were exposed 
to a bank of UVA and UVB lamps (Section 2.3.3). In order to ensure cultures were not 
exposed to any UVB emitted by the UVA lamps, a 10 mm thick glass plate was placed 
over the cultures. The glass blocked penetration by UVB light therefore ensuring the 
cultures were only exposed to UVA radiation. The effects of both heat and dehydration 
when the cells were exposed to UVA and/or UVB were minimal in these studies due to 
short exposure periods.  In this study, the confluency of the cultures used in all 
experiments was ~75%. This was preferred as cell growth was still maximal and the 
cellular physiological processes were optimal. When the cultures reach confluency, 
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many cellular processes slow down and if they are used, the results obtained may not 
correctly reflect what may occur (254).   
The purpose of the viability experiment was to show the effect UVR has on cell 
viability. We observed that cells exposed to UVA had a higher cell viability compared 
to those irradiated by UVB or UVAB (Figure 3.1). The difference could be due to the 
fact that UVA radiation is absorbed by chromophores that give rise to the production of 
reactive oxygen species (ROS) and ROS-dependent DNA lesions are repaired quickly 
and have low mutagenicity (255). These results agreed to previous studies by Skiba et 
al. (136) who showed that cell survival rates was ~85% in both sham- and UVA (2 and 
8 kJ/m2)-irradiated HaCaT cells.  It is likely that the higher doses of UVA used in this 
study could be more cytotoxic. Budai et al. (256) determined that in human fibroblasts, 
at small UVA doses (<80 kJ/m2) a smaller level of damage was observed but with 
increasing dose (150-200 kJ/m2), higher level of damages were seen where the viability 
detected was 20%. Thus UVA at higher doses can be strongly mutagenic because of the 
formation of oxidative DNA damage (257) and thus could play a pivotal role in the 
malignant transformation of human skin. 
Interestingly, when HEK and Colo 16 cells were irradiated with UVAB radiation their 
viability was similar to that observed in UVB-irradiated cells (Figure 3.1). These results 
were similar to that seen in studies by Huynh et al. (174) who showed that when Colo 
16 cells were exposed to UVAB radiation (20 kJ/m2 and 2 kJ/m2), the cell viability 
profile was similar to that of UVB and not UVA. This suggests that UVB has a more 
profound effect on the cells than does UVA. As UVB radiation is of higher energy level 
compared to UVA, a high dose can cause more lesions ((6-4)-photoproducts) as well as 
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a degeneration of inner and outer cellular membranes (258). These lesions are repaired 
more slowly and may give rise to mutations (255). If DNA damage is severe and the 
cells are beyond repair, multiple death pathways are activated resulting in the 
elimination of these compromised cells  (42). In general these cell lines were more 
sensitive to the UVB component of one MED and not the UVA component. 
In comparison to HEK and HaCaT cells, Colo 16 cells had less attached viable cells and 
a slight increase in detached viable cells when exposed to either UVB- or                    
UVAB-radiation (Figure 3.1). Takasawa et al. (259) and Huynh et al. (174) showed that 
these detached viable cells (HaCaT and Colo 16 cells, respectively) were unable to           
re-adhere when they were transferred to fresh media and eventually died in culture. 
Colo 16 cells had less attached dead cells and a corresponding increase in detached dead 
cells following UVB- and UVAB-radiation compared to un-irradiated controls. This 
could also be due to the fact that the Colo 16 cells grow at a faster rate and as such the 
rate of cell death was also high (259). 
Although cell viability determination using trypan blue exclusion is a relatively easy, 
fast and cost-efficient method, there are limitations to this method. Trypan blue stains 
dead cells blue as the cells tend to lose their membrane integrity. However, it does not 
help differentiate between apoptotic and necrotic cells. The trypan blue dye is cytotoxic 
and can cause cell death if there as a delay in performing viability counts. Similarly, 
cells in early stage of apoptosis are not stained blue as the plasma membrane is still 
intact (260). Therefore, this can give rise to inaccurate results.  
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Armeni et al. (261) determined keratinocyte viability 24 h post UVA-irradiation using 
annexin V-labelled flow cytometry. Other staining methods which could be used in 
flow cytometry include acridine orange and ethidium bromide (EtBr) (270) or Hoechst 
33342 and propidium iodide (260, 262). Liegler et al. (260) demonstrated that acridine 
orange-EtBr stained cells is more sensitive and accurate than that seen using other 
methods like trypan blue exclusion and DNA fragmentation. Thus use of these methods 
may help differentiate and quantify the number of viable, apoptotic, late-stage apoptotic 
and necrotic cells in the UV-irradiated cultures.  
UVR is known to induce the activation of stress-inflammation signal transduction 
pathways (263), and to induce the activity of many proteases in skin cells (174). Though 
furin is expressed in skin cells (156), it is not known what effect UVR has on its 
activity. When Bassi et al. (173) looked at human SCC cell lines (A 253, Detroit 562, 
SCC9, SCC 12 and SCC 15), they observed that highest furin expression was seen in 
the most invasive cell lines.  In order to investigate the effect of UVR on furin protein 
expression, western blots were performed (Figure 3.4). UVR increased furin protein 
expression in both HaCaT and Colo 16 cells but not in HEK cells. Endogenous furin 
protein expression was higher in HaCaT cells compared to that of Colo 16 cells (Figure 
3.5ii). The greatest increases in furin levels were observed in HaCaT cells irradiated 
with UVAB (15x) and in Colo 16 exposed to UVB (7.5x). Huynh et al. (174) found that 
in Colo 16 cells, both UVB and UVAB radiation increased furin levels 24 h                      
post-irradiation, but not in HaCaT cells where furin levels fell in response to UVR. The 
results obtained in this study agree with that seen for Colo 16 cells but were different to 
that observed for HaCaT cells. These differences may be attributed to the fact that 
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Huynh et al. (174) combined attached and detached cells whereas only attached cells 
were examined in this study.  
The results from this study suggest that furin expression increases in the immortalized 
(HaCaT) and tumour (Colo 16) cells but not in the primary (HEK) cells. It has been 
shown by others that furin levels are higher in tumour cells compared to their                   
non-tumorous counterparts (144, 227). While Colo 16 cells has higher furin levels than 
HEK cells, which agrees with that seen in other studies (144, 227) the reasons for the 
high levels observed in HaCaT cells are not clear. HaCaT cells are an immortalized cell 
line but are not metastatic (221, 259, 264) and the high furin levels observed in these 
cells may have arisen as a result of immortalization. Bassi et al. (173) also showed 
moderate to high levels of furin expressed in HNSCC cell lines. They showed an 
association between tumour cell invasiveness and PC levels in these cell lines (173). 
Higher furin levels observed in tumour cells reflect these cell s metastatic potential as 
one of the proteases they activate, the MMPs, cleave the ECM, allowing metastasis to 
occur (265). This increase in furin can subsequently activate other proteases that furin is 
known to processes, including MMP and TACE, which in turn, when activated, process 
a wide range of biological molecules crucial for cell function and growth (151, 169, 
266, 267).  
The results from this study also show that there are differences between the effect of 
UV types and doses on cell function in the keratinocyte-derived cell lines examined in 
this study. While, UVAB-irradiation (Figure 3.1) had a stronger effect on HaCaT cells, 
UVB-irradiation induced maximum furin expression in Colo 16 cells. This was 
probably due to the fact that when cells were irradiated with UVB (2 kJ/m2) (alone) or 
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in combination with UVA, (40 + 2 kJ/m2), UVB-irradiation appeared to be of 
predominance, dominating the effect of UVA. This suggests that following UV 
exposure, the level of furin is elevated as its potential to cleave enzymes such as TACE, 
MMPs, TGF , PDGF and other growth factors thereby increasing inflammation, the 
ability of the cell to degrade the ECM, tumour cell proliferation, motility, invasiveness 
and adhesiveness (168, 268). 
In order to determine the half-life of furin in the cells, we used CHX. This inhibitor 
inhibits new protein synthesis and interferes with the translocation step in protein 
synthesis thus blocking translational elongation (230-232, 269). Thus, by measuring the 
level of furin in the cells over a period of time, we can calculate its half-life of this 
protein. Before undertaking these experiments, I investigated the effect CHX had on 
cell viability (Figure 3.6).  The purpose of this was to ensure that the dose (100 µM) 
used was not cytotoxic to the cells. The cells were exposed to UVAB-irradiation in the 
presence or absence of CHX. The cells were irradiated with UVAB as it stimulated 
maximal furin expression in the cells (Figure 3.4). As cell viability was similar to that  
of untreated controls, we used CHX at 100 µM in this study.  
The calculated half-life of furin in the un-irradiated HaCaT and Colo 16 cells was 6.0 h 
and 17.0, respectively. While the calculated half-life of furin in the UVAB-irradiated 
HaCaT cells was 5.6 h, it was much shorter in UVAB-irradiated Colo 16 cells (8.1 h) 
(Figures 3.7 and 3.8). This result suggests that furin is turned over more rapidly in 
HaCaT cells compared to Colo 16 cells and its levels may respond to external stimuli 
much faster than seen in the SCC cell line. Further studies on this may yield useful 
information on the effect of UVR on these cellular processes. Secondly, UVR has no 
3. Effect of UVR on furin activity in human keratinocyte cell lines 
113  
effect on the half-life of furin in HaCaT cells which differed to that seen in Colo 16 
cells. It is unclear if UV has an effect on furin turnover, and further experiments would 
be needed to confirm if this is the case. Of interest is that in a study performed by Yu et 
al. furin levels in A6 (distal nephron cells) were unaffected by CHX treatment (270).  
It has been shown that furin processes and activates enzymes such as TACE (151, 156, 
158) and MMPs (151, 169, 266, 267). TACE is in turn known to be involved in the 
processing of TNF
 
(125, 136-138, 271). While MMPs are elevated when these cells 
have been exposed to UVB radiation, and their  expression is further  enhanced if either 
IL-1 (MMP-9) (217) or TNF (MMP-2) (216) is present. IL-1 is a major epidermal 
cytokine that is constitutively synthesized by keratinocytes and released following 
injurious stimuli like UV-irradiation (236, 237, 272-274).  Recently Bashir et al. (77) 
showed that IL-1 synergistically induced TNF in both UVB-irradiated keratinocytes 
and fibroblasts. As IL-1 stimulates TNF release from irradiated cells (77, 275-277), I 
investigated if this cytokine increased TNF release from the cells by either increasing 
the cellular levels of TNF and/or TACE (Chapter 5) or by enhancing furin levels.
 
The results showed that IL-1 had a suppressive effect on furin expression in HaCaT 
and Colo 16 cells but additive effect in HEK cells (Figure 3.9). When IL-1 was added 
to the UVAB-irradiated cells in the presence of CHX, the half-life of furin protein was 
similar to that seen with CHX-treated UVAB-irradiated cells.  The calculated half-life 
of furin in HaCaT (Figure 3.10) and Colo 16 cells (Figure 3.11) grown in the presence 
of IL-1 were calculated to be 4.3 h and 8.3 h, respectively. From the results obtained, it 
appears that neither UV and/or IL-1 affects the rate of furin turnover in these cells.  
While the results from HaCaT cells (Figures 3.7 and 3.10) support this suggestion, 
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results from Colo16 cells (Figures 3.8 and 3.11) do not. The value determined for the 
un-irradiated controls need to be re-examined to see if these values are correct. If it is, it 
suggests that UV stimulates the turnover of furin in these cells. The significance of 
which is not clear and further studies on this process would be warranted.  
The effects of various wavelengths of UV on melanocytes and other types of skin cells 
in culture have been studied, but little is known about gene expression patterns 
following exposure of human skin to different types of UVR (242). In order to observe 
if an increase in mRNA induction was associated with increased protein expression, I 
investigated furin gene expression in these cells using qRT-PCR.  qRT-PCR is a highly 
sensitive and reproducible method and thus was used to analyze mRNA levels of furin 
in HaCaT and Colo 16 cells following exposure to UVR. Pearton et al. (156) observed 
the mRNA from furin and other PC family members in foreskin epidermis and 
keratinocyte cell cultures. Skiba et al. (136) showed that UVA (2 kJ/m2) and UVB (2 
kJ/m2)-irradiation caused a significant increase in furin mRNA in HaCaT cells, with 
higher levels seen for UVB-irradiation.  
A time course of the effect of UVB on furin mRNA expression in HaCaT and Colo 16 
cell lines was examined (Figure 3.12). Furin mRNA levels were found to be maximal at 
24 h in HaCaT cells and 12 h for Colo 16 cells.  This differed to results obtained by 
Skiba et al. (136) who showed that peak furin mRNA levels were detected immediately 
at 0 h (~6 fold) post UVB  (2 kJ/m2) exposure in HaCaT cells. Though the dose of UVB 
radiation and the primer sequences were was same, the difference in results may be 
because of the following (i) the different methods (SYBR ® Green ERTM qRT-PCR used 
in this study compared to the TaqManTM RT-PCR method used by Skiba et al. (136)) 
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and (ii) the different methods of analysis (Pfaffl correction method used in my study 
compared to the CT method) used in earlier studies.  
While little is known about the effect of UVR on furin mRNA, its expression has been 
seen in cells and tissues. Schalken et al. (278) observed a high furin expression in 
advanced lung tumours, specifically in non-small-cell lung carcinoma (non-SCLCs) but 
not in SCLCs. Mbikay et al. (279) showed that the level of furin mRNA in SCC and 
adenosarcomas was ~3-fold higher than in SCLCs. Cheng et al. (280) showed that furin 
mRNA was readily detected by RT-PCR in human breast cancer cells but was 
undetectable in normal breast tissues. Recently, Spencer et al. (281) confirmed furin 
mRNA expression by RT-PCR in epidermal keratinocytes and melanocytes.  
I also investigated the effect other UV types and doses had on furin gene expression            
24 h post-irradiation (Figure 3.13). It can be seen that UVB induced maximum furin 
mRNA levels in both HaCaT and Colo 16 cells compared to that of UVA- and                         
UVAB-irradiation. Of interest is that UVB-irradiation also results in the greater 
stimulation of furin protein levels in the cells (Figure 3.4). The levels of furin protein 
are much higher in UV-irradiated HaCaT than in Colo 16 cells. Furin mRNA levels 
were also higher in HaCaT cells compared to Colo 16 cells. Therefore, these results 
suggest that following exposure to UVB-irradiation (24 h post exposure), increased 
furin protein levels may be due to the corresponding increased furin mRNA levels. 
Although UVR has an effect on furin gene expression, a weak correlation was apparent 
between furin protein expression and its corresponding mRNA levels in both HaCaT  
(r2 = 0.581) and Colo 16 (r2 = 0.399) cells 24 h post-irradiation (Figure 3.14).  
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While it was seen at 24 h that the correlation between furin mRNA and protein levels 
was weak, it is unknown if there was a stronger correlation at other time points. 
Therefore, this confirms that increased mRNA induction may be an important 
determinant in cellular responses to UVR  (136). This may closely reflect recent studies 
by Choi et al. (242) who showed that gene expression patterns induced by UVA or 
UVB are distinct-UVB eliciting dramatic increase in a large number of genes involved 
in pigmentation as well as in other cellular functions, whereas UVA had little or no 
effect on these. The expression patterns characterize the distinct responses of the skin to 
UVA or UVB, and identify several potential previously unidentified factors involved in 
UV-induced responses of human skin. Paracrine factors expressed by keratinocytes 
and/or fibroblasts that affect skin pigmentation and other skin inflammatory conditions 
might be regulated differently by UV, as might their corresponding receptors expressed 
on melanocytes (242). 
In my study, furin mRNA levels were unaffected by CHX (Figure 3.15). This was 
expected as CHX affects only protein synthesis of furin and not mRNA transcription. 
Finally the effect of IL-1 on furin mRNA expression was also investigated post                 
UVAB-irradiation (Figure 3.16). UVAB dose was chosen because it induced highest 
furin protein levels in HaCaT cells (Figure 3.4). The addition of IL-1 slightly reduced 
these levels in HaCaT and Colo 16 cells (Figure 3.9). IL-1 added to UVAB-irradiated 
cells increased furin mRNA levels at 16 h (5.7-fold) in HaCaT cells (Figure 3.16) and 4 
h (2.6-fold) in Colo 16 cells compared to treated un-irradiated controls. Of interest is 
that furin mRNA levels in IL-1
 
treated UVAB-irradiated cells was 10-fold less than 
that seen in the same irradiated cells (Figure 3.13) which suggests that IL-1 suppresses 
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furin mRNA expression. Furin mRNA levels in IL-1
 
treated sham-irradiated cells were 
reduced by 29% when compared to that of untreated corresponding cells (results not 
shown). Further studies on the effect of IL-1 on furin mRNA expression needs to be 
undertaken in order to fully understand the effect it has on this process.   
3.3.1 Conclusion 
3.3.1.1 Effect of UVR on furin  
Furin is a ubiquitously expressed proprotein convertase (PC) that plays a vital role in 
numerous disease processes including cancer metastasis, bacterial toxin and viral 
propagation (144, 146, 156, 167, 280, 282). Previous reports have shown that UVR 
induced furin mRNA expression but its protein expression had not been investigated 
(136). Skiba et al. (136) showed that mRNA alterations of putative genes involved in 
the UV response pathway were wavelength- and dose-dependent. In this study, we 
further investigated the effect of UVR on protein expression under different treatment 
and conditions (UVR and/or IL-1 ) and expanded on the mRNA expression of furin in 
keratinocyte-derived cell lines.  
In this study we observed that UVR up-regulates furin mRNA and protein expression in 
these keratinocyte-derived cells. The half-life of this protein was much longer in Colo 
16 cells which suggests that these tumour cells harbor furin protein for much longer 
which may contribute to increasing its metastatic potential (174). Higher furin levels 
observed in tumour cells reflect these cell s metastatic potential as one of the proteases 
they activate, the MMPs, cleave the ECM, allowing metastasis to occur (265). Addition 
of the pro-inflammatory cytokine, IL-1 had a slightly suppressive effect on furin 
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protein and mRNA levels in HaCaT and Colo 16 cells. These results suggest that 
increase in TNF
 
released from UV-irradiated cells grown in the presence of IL-1 is 
due to increased transcription of this cytokine (77) and not because of increase in furin 
protein levels.   
Of interest is that apart from UVAB-, UVB-irradiation also results in the greater 
stimulation of furin protein levels in the cells. The levels of furin protein and mRNA 
levels are much higher in HaCaT cells than in Colo 16 cells which suggest that 
following exposure to UVB-irradiation (24 h post exposure), increased furin protein 
levels may be due to increased furin mRNA levels. In order to achieve complete 
inhibition of protein/mRNA expression of furin and to see the subsequent effect this 
may have in the cells, siRNA (small interfering RNA) should be investigated. The 
ability of siRNA to reduce furin levels in the cell may in turn decrease the activation of 
TACE which may in turn reduce the release of TNF . Tellier et al. (171) have used 
siRNAs strategies targeting furin and other genes which resulted in the significant 
inhibition of the activation of their proposed signalling pathway.  
In order to investigate the effect of various treatments on the activity of furin in 
processing various biological substrates (TACE and/or MMP and other growth factors), 
the fluorogenic tetrapeptide boc-Arg-Val-Arg-Arg-MCA (Boc-RVRR-MCA) should be 
used (283-286). These experiments will confirm if changes in activity in the irradiated 
cells are due to corresponding changes in the levels of furin in the cell or its kinetic 
parameters.  
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3.3.1.2 Comparing cell types 
There are also differences between the effect of UV types and doses on furin expression 
in the keratinocyte cell lines examined in this study as shown in Table 3.1.   
3.3.1.2.1 HaCaT vs HEK cells 
The effect of UVB-irradiation on cell viability was more sensitive on HEK than HaCaT 
cells. While furin protein levels were much higher in HaCaT cells than in HEK, the 
effect of IL-1
 
was slightly suppressive in HaCaT cells and had the opposite effect in 
HEK cells. In the studies done in this chapter, the response of HaCaT cells to UVR 
differs to that of HEK which suggests that these immortalized cell lines may not be a 
suitable model for studying keratinocytes. HEK cells were not available in sufficient 
quantities and future studies should repeat some of these experiments in order to obtain 
a better understanding on what is happening to keratinocytes located in situ on the skin.   
3.3.1.2.2 Colo 16 vs HEK cells 
HEK cells exhibit a different profile to that of the Colo 16 cells which is a SCC cell 
line. The effect of UVB-irradiation on cell viability was most sensitive in the Colo 16 
cells than HEK cells. While moderate furin levels were observed in Colo 16 cells, very 
little was seen in HEK cells. The effect of IL-1 was suppressive on the furin protein
levels in Colo 16 cells with the opposite effect seen in HEK cells.    
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3.3.1.2.3 HaCaT vs Colo 16 cells 
The profile of HaCaT cells in response to UVR more closely resembled that of Colo 16 
cells than HEK cells. Colo 16 cells were shown to be more sensitive to UVB radiation 
than were HaCaT cells. While HaCaT cells expressed the highest amounts of furin 
protein followed by Colo 16 cells, IL-1 had
 
a slight suppressive effect on furin 
expression in both cell lines. While furin mRNA expression was higher in                          
UVB-irradiated HaCaT and Colo 16 cells (24 h post-exposure), the highest levels were 
observed in HaCaT cells (24 h) compared to Colo 16 cells (12 h).  Addition of IL-1 
increased furin mRNA expression in UVAB-irradiated HaCaT cells but caused the 
opposite effect in Colo 16 cells.  Since no significant effect of IL-1 was observed on 
furin levels, it suggests that this cytokine does not directly act on furin but may do so on 
either TACE or TNF of the proposed pathway (Figure 6.1). There was a moderate 
correlation between furin mRNA and protein levels in Colo 16 cells, but it was stronger 
in HaCaT cells.  
The reason for the similarities between HaCaT and Colo 16 cells could be because 
HaCaT cells have a defective p53 and as such the direct effects of UVB on DNA and 
the related cellular repair mechanisms did not result in the cell stopping at the G1 cell 
cycle checkpoint until this damage had been repaired (287). There is a possibility of the 
HaCaT cells being a precancerous cell and higher furin levels could have occurred as 
part of the immortalization of these cells. With regard to the tested parameters in this 
study, the profile of the HaCaT cells, which are themselves non-cancerous, can 
potentially lead to malignant skin cancers such as SCC as in case of solar keratosis. The 
profile of the Colo 16 cells suggests that differences in furin protein and/or mRNA are a 
3. Effect of UVR on furin activity in human keratinocyte cell lines 
122  
result of tumorigenesis. By drawing a comparison of the effect of UVR on the 
expression and/or activity of furin in different SCC cell lines (HNSCC) to that of HEK 
cells would help in determining the cell s metastatic nature and invasiveness since furin 
is ubiquitously distributed in cells (144, 288). Subsequent studies on MMPs (Chapter 4) 
and TACE and/or TNF
 
(Chapter 5) will look further on the role of furin in the cells.  
Effect of UVR on furin activation of 
MMPs in human keratinocyte cell lines  
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5.1 Introduction 
UV light is a physical carcinogen and UV-irradiation from sunlight has profound effects 
on the human skin, causing various biological events such as sunburn, inflammation, 
cellular/tissue injury, cell death, and skin cancer (253, 339). Much attention has been 
focused on the increasing rates of skin cancer due to excessive UV exposure in humans 
(40). UVR is also involved in the release of pro-inflammatory cytokines, of which 
TNF has been implicated in tumorigenic activities (5). While, TNF is known to be 
cytotoxic to some tumour cell lines, it can mediate UV-induced tumorigenesis in others 
(30, 118). Up-regulation of TNF is a key early response to UVB by keratinocytes, and 
represents an important component of the inflammatory cascade in skin (77, 276). 
Bashir et al. (77) found that IL-1 , a cytokine also present in irradiated skin, 
substantially and synergistically enhanced the induction of TNF by UVB
 
radiation. 
The induction of TNF by UVB with IL-1 is mediated through increased gene 
transcription (77). Previous studies have reported that UVA and UVB radiation appear 
to be significant inducers of TNF transcription in epidermal cells in vitro and in vivo 
(115, 277, 340). 
TNF is released from the cells by proteolytic cleavage of its membrane-anchored 
precursor (341). TACE is the main protease responsible for the ectodomain shedding of 
TNF (341). Black et al. (126) showed impaired shedding of TNF from                        
TACE-deficient mice which confirmed TACE s role in the processing this cytokine. As 
TNF plays a major role in some acute as well as chronic inflammatory diseases, TACE 
represents an important and novel target for the design of specific synthetic inhibitors 
that might be used in a variety of inflammatory and immunological therapies (146, 
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219). Because of the wide physiological and pathological importance of TACE, much 
attention has been paid to its mechanism of activation (158).  
Peiretti et al. (151) reported that furin is the major PC involved in TACE maturation 
and activation. TACE possesses the putative PC recognition sequence (RVKR), which 
is thought to be used to generate the mature enzyme (126, 147). In order to test the 
possibility whether PCs were involved in the maturation of TACE, Endres et al. (154) 
used the synthetic inhibitor Dec RVKR cmk and observed reduced levels of mature 
TACE in treated HEK293 cells compared to untreated cells.  The development of 
selective inhibitors of PC may result in them being used in preventing or treating 
tumours (227). Existing evidence suggests that furin inhibitors may be useful 
chemotherapeutic agents (227, 266). 
Although the role of TNF in UV-induced skin has been well documented, the 
expression profile of genes involved in this proposed pathway has not been 
investigated. Skiba et al. (136) suggested that time-distinct gene induction of furin and 
TNF may be involved in UV-induced cellular responses, but not for TACE. The effect 
UVR has on the expression and/or activity of furin and that of the proteases it activates 
in human keratinocyte cell lines is not known.  
In this study the effect of UVA and/or UVB radiation on furin and TACE expression 
and/or activity and of the molecules they cleave in keratinocyte-derived cell lines was 
investigated.    
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5.1.1 Aim and Hypothesis 
Some metalloproteases have been reported to be activated in epidermal cells following 
UV-irradiation (136, 262, 342). It is not known if UV-irradiation regulates the 
expression of TACE in the membrane of skin cells. Therefore, the aim of this study is to 
investigate the effect of UVR on the furin activation of TACE and to investigate if 
changes in activity are related to changes in furin expression and/or activity. Secondly, 
does UV light directly modulate the changes in expression and/or activity of TACE, 
thereby increasing TNF
 
release. The effect UV type and dose has on the release of 
TNF from human keratinocyte-derived cells has also been examined as part of this 
study.  
The effects of singular (UVA or UVB) and concurrent (combination of UVA and UVB 
herein referred to as UVAB) exposures of UVR were examined. In order to understand 
the effects of UVR on different keratinocyte-derived cell lines; primary keratinocytes 
(HEK), immortalized keratinocytes (HaCaT) and SCC-derived (Colo16) cells were 
examined. Based on previous findings (228, 229), we chose to use HaCaT cells as a 
model to study the effects of UV-irradiation on primary keratinocytes and draw a 
comparison between these two cell lines. As it is unknown if these pathways are 
increased as a result of tumorigenesis, Colo16 cells, a SCC cell line was also examined 
as part of this study.     
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5.2 Results 
5.2.1 TNF release
 
5.2.1.1 Effect of IL-1
The up-regulation of TNF is a key early response to UVB by keratinocytes, and 
represents an important component of the inflammatory cascade in the skin (77). 
Recently, Bashir et al. (77) found that IL-1 induced TNF in UVB-irradiated 
keratinocytes and fibroblasts. Media samples were collected 24 h post-irradiation, and 
the level of TNF present was calculated from the standard curve and was expressed as 
a function of cell protein level. The level of TNF in the media of the irradiated cells 
was determined using ELISA (Section 2.6). The level of IL-1 supplementation (10 
ng/ml) on the secretion of TNF in cells exposed to UVR is seen in Figure 5.1. 
In HEK cells, 223.6 ng/mg cell protein of TNF was secreted from untreated control 
cells. However, when these cells were exposed to UVR, TNF levels increased 1.3-fold, 
3.4-fold and 14.1-fold in response to UVA-, UVB- and UVAB-irradiation, respectively. 
In sham-irradiated cells, the addition of IL-1 resulted in 2763.73 ng/mg cell protein of 
TNF being secreted from these cells. This represented a 12.4-fold increase of that seen 
in untreated un-irradiated controls. However, following the addition of IL-1 to the   
UV-irradiated cells, the increase of TNF secreted from the cells compared to                
sham-irradiated treated cells were 7.9-fold, 10.8-fold and 32.9-fold in response to    
UVA-, UVB- and UVAB-irradiation, respectively.  
In HaCaT cells, low levels of TNF were produced in untreated sham-irradiated 
controls (410.7 ng/mg cell protein). Following UVA-irradiation there was a reduction in 
the level of TNF shed from the cell. There was an increase in the level of TNF 
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Figure 5.1 Effect of IL-1 (10 ng/ml) on TNF shed from UV-irradiated HEK, HaCaT 
and Colo 16 cells. The cells were exposed to sham-irradiation or controls 
(C), UVA (A), UVB (B) and UVAB (AB) radiation in the presence (+) 
and/or absence (-) of IL-1 . Media samples were collected 24 h  
post-irradiation. Results expressed are the mean ± SEM for three separate 
experiments. Statistical significance of the effect of IL-1 on TNF release 
is represented as p<0.05 for (*).   
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released from the cells following exposure to UVB- (1.1-fold) and UVAB-irradiation 
(1.9-fold) (Figure 5.1). The addition of IL-1
 
to the sham-irradiated cells, resulted in 
935.5 ng/mg cell protein of TNF being secreted from these cells which were 2.3-fold 
that seen in the untreated cells. UVA-irradiation induced similar levels of TNF , 
compared to treated sham-irradiated cells. Higher levels of this cytokine were secreted 
following exposure to UVB- (2.2-fold) followed by a significant (p<0.05) increase in 
response to UVAB-irradiation (4.2-fold) compared to treated sham-irradiated cells.  
In Colo 16 cells, 8.6 ng/mg cell protein of TNF was secreted from the untreated 
control cells (Figure 5.1). Following exposure to UVA radiation, TNF levels fell 80% 
compared to the un-irradiated controls. In cells exposed to UVB-or UVAB-irradiation 
TNF levels increased 4.2-fold and 21.7-fold, respectively compared to the                         
un-irradiated controls.  In the sham-irradiated cells, the addition of IL-1 resulted in 
81.9 ng/mg cell protein of TNF being secreted which was 9.5-fold that seen in the 
untreated cells. Following UV-irradiation, the increase of TNF secreted from the cells 
treated with IL-1 were 1.7-fold, 5.8-fold and 7.7-fold in response to UVA- and             
UVB- and UVAB-irradiation, respectively when compared to the sham-irradiated 
treated cells.  
IL-1 increased the release of TNF in sham-irradiated HEK and HaCaT cells but not 
Colo 16 cells. The greatest increase in TNF release in all cell lines was induced by 
UVAB-irradiated cells treated with IL-1 .  HEK cells shed the most TNF while Colo 
16 cells shed the least under all the examined conditions.   
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5.2.1.2 Effects of inhibitors 
In order to investigate further the mechanisms by which IL-1
 
induces TNF release 
from the irradiated cells, various inhibitors were tested. These were the protein 
synthesis inhibitor (CHX), metalloprotease inhibitor (1, 10 phe), furin inhibitor (Dec 
RVKR cmk) and 2R-2-[(4-Biphenylsulfonyl) amino]-3-phenylpropionic acid (MMPI). 
Each of the experiments was performed from the same batch of HaCaT and Colo 16 
cells and was run simultaneously. The results were written up per individual inhibitor 
rather than as part of a larger group and as such the amount of TNF released from 
sham-irradiated (controls) in the presence and/or absence of IL-1 was similar for all 
the four findings. In this study UVAB-irradiated cells were used as they were shown to 
secrete the greatest level of TNF from the cells (Figure 5.1).   
5.2.1.2.1 Effect of CHX on TNF release
It has been shown previously that CHX at 100 µM had a minimal effect on cell viability 
of sham- and UVAB-irradiated HaCaT and Colo 16 cells (Figure 3.6). Therefore, CHX 
was added to the cells to determine if the cell contains a reservoir of pTNF or 
continuously synthesizes this cytokine. If there was no significant reduction in the 
levels of TNF released from the CHX-treated cells, it would suggest that the cell 
contains a reservoir of this cytokine.  
The cells were pre-treated with CHX (100 µM) for 24 h prior to being exposed to 
UVAB radiation (Section 2.4.3), after which  IL-1 (10 ng/ml) was added and the level 
of TNF in the culture media 24 h post-irradiation was measured using an ELISA and 
expressed as a function of cellular protein levels.   
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Figure 5.2 Effect of CHX on the release of TNF from UVAB-irradiated HaCaT and 
Colo 16 cells treated with IL-1 . Cells were exposed to sham-irradiation or 
controls (C) and UVAB-irradiation (AB) in the presence (+) or absence (-) 
of CHX (100 µM) and/or IL-1 (IL) (10 ng/ml). Media samples were 
collected 24 h post-irradiation. Results expressed are the mean ± SEM for 
three separate experiments. Statistical significance of the effect of CHX on 
TNF release is represented as p<0.05 (*).   
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In HaCaT cells, the amount of TNF
 
released from sham-irradiated cells was 410.7 
ng/mg cell protein. When CHX was added to sham-irradiated HaCaT cells, there was an 
80% inhibition in the level of TNF shed from these cells (Figure 5.2). When IL-1 was 
added to sham-irradiated cells, there was a 2.3-fold increase in TNF released compared 
to the corresponding untreated controls. However, when CHX was added to these 
treated un-irradiated cells, TNF levels were reduced by 90%. In the UVAB-irradiated 
HaCaT cells, there was a 1.9-fold increase in the level of TNF released (793.4 ng/mg 
cell protein) compared to un-irradiated controls. When CHX was added to these 
UVAB-irradiated cells, a 97% reduction in the amount of TNF released from the cells 
was observed. While increased levels of TNF (3936.7 ng/mg cell protein) were 
observed in IL-1 treated UVAB-irradiated cells (5.0-fold compared to untreated 
irradiated cells), the addition of CHX caused an 80% inhibition of the amount released.  
In Colo 16 cells, the amount of TNF released from sham-irradiated cells was 8.6 
ng/mg cell protein (Figure 5.2). When CHX was added to these cells, a 23% inhibition 
in the level of TNF shed from these cells was observed (Figure 5.2). When IL-1 was 
added to the sham-irradiated cells, a slight increase in TNF (81.9 ng/mg cell protein) 
release was observed. However, when CHX was added to these treated un-irradiated 
cells, there was a 90% reduction in the level of TNF released. UVAB-irradiation 
increased the level of TNF released (187.3 ng/mg cell protein) from the cells                  
21.7-fold, compared to that seen in un-irradiated controls. The addition of CHX to these 
irradiated cells resulted in a 50% reduction in the level of TNF released. However, 
when IL-1 was added to the UVAB-irradiated cells, 627.9 ng/mg cell protein TNF
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was released from the cell. The addition of CHX to these treated irradiated cells 
inhibited TNF
 
release by 70%.  
These results obtained suggest that the cell does not contain a reservoir of proTNF , 
and it is synthesized when required by the cell in response to external stimuli (e.g. 
UVAB-radiation and/or IL-1 ).                         
5.2.1.2.2 Effect of 1, 10 phe on TNF release
It is well known that TACE is a metalloprotease (125, 136-138, 271). The purpose of 
this experiment was to observe the effect 1, 10 phe (a metalloprotease inhibitor) has on 
the release of TNF from UVAB-irradiated HaCaT and Colo 16 cells in the presence 
and/or absence of IL-1 .  
It has been shown previously that maximal viability of the cells was observed at 100 
µM of 1, 10 phe (Figure 4.14). Therefore, cells were pre-treated with 1, 10 phe (100 
µM) for 24 h prior to being exposed to UVAB radiation (Section 2.4.3). Following 
UVAB-irradiation and addition of  IL-1 (10 ng/ml), the level of TNF in the cultured 
media 24 h post-irradiation was measured using an ELISA and expressed as a function 
of cell protein levels.   
In HaCaT cells, the addition of 1, 10 phe caused a 93% reduction in the level of TNF 
released from sham-irradiated cells (410.7 ng/mg cell protein) (Figure 5.3). While 
increased levels of TNF was observed in IL-1 -treated sham-irradiated cells (935.5 
ng/mg cell protein), the addition of 1, 10 phe resulted in a 91% inhibition. The level of 
TNF released from UVAB-irradiated cells (793.4 ng/mg cell protein) was higher than 
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Figure 5.3 Effect of 1, 10 phe on the release of TNF from UVAB-irradiated HaCaT 
and Colo 16 cells treated with IL-1 . Cells were exposed to                         
sham-irradiation or controls (C) and UVAB-irradiation (AB) in the presence 
(+) or absence (-) of phe (100 µM) and/or IL-1 (IL) (10 ng/ml). Media 
samples were collected 24 h post-irradiation. Results expressed are the 
mean ± SEM for three separate experiments. Statistical significance of the 
effect of 1, 10 phe on TNF release is represented as p<0.05 (*).    
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that seen for un-irradiated cells. When 1, 10 phe was added to these cells, the levels fell 
by 90%. The addition of IL-1 to the UVAB-irradiated cells induced TNF levels            
5.0-fold compared to the untreated irradiated cells. However, when 1, 10 phe was added 
to these cells, a 98% inhibition in the amount of TNF released from the cells was 
observed.  
In Colo 16 cells, the addition of 1, 10 phe caused a 75% reduction in the level of TNF 
released from sham-irradiated cells (8.6 ng/mg cell protein) (Figure 5.3). While 
increased levels of TNF
 
was observed in IL-1 -treated sham-irradiated cells (81.9 
ng/mg cell protein), the addition of 1, 10 phe resulted in a 97% inhibition. The level of 
TNF released from UVAB-irradiated cells (187.3 ng/mg cell protein) was higher than 
that seen for un-irradiated cells. When 1, 10 phe was added to these cells, the levels fell 
by 99%. The addition of IL-1 to UVAB-irradiated cells increased TNF levels 3.3-fold 
compared to the untreated irradiated cells. However, when 1, 10 phe was added to these 
cells, a 97% inhibition in the amount of TNF released from the cells was observed. 
In summary, the results obtained confirm that TACE is a metalloprotease as seen by the 
reduced levels of TNF shed from the cells in the presence of 1, 10 phe.
 
5.2.1.2.3 Effect of Dec RVKR cmk on TNF release
TACE is cleaved to its catalytically active form by the action of the proprotein 
convertase furin (144, 151, 154, 158). Therefore, in order to determine the effect furin 
has on the activation of TACE, Dec RVKR cmk was added to IL-1 treated             
UVAB-irradiated HaCaT and Colo 16 cells. A significant reduction in the level of 
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TNF
 
released from the cell would confirm that furin is involved in the activation of 
TACE. 
Cells were pre-treated with Dec RVKR cmk (100 µM) for 24 h prior to being exposed 
to UVAB radiation (Section 2.4.3). Following UVAB-irradiation and addition of  IL-1 
(10 ng/ml), the level of TNF in the cultured media 24 h post-irradiation was measured 
using an ELISA and expressed as a function of cellular protein levels.   
In HaCaT cells, following the addition of Dec RVKR cmk, a 63% reduction in the level 
of TNF released from sham-irradiated cells (410.7 ng/mg cell protein) was observed 
(Figure 5.4). While increased levels of TNF was observed in IL-1 -treated                     
sham-irradiated cells (935.5 ng/mg cell protein), a 87% inhibition was seen when Dec 
RVKR cmk was added to these cells. There was an increase in the level of TNF 
released from UVAB-irradiated cells (793.4 ng/mg cell protein), but in the presence of 
Dec RVKR cmk these levels fell by 43%. The addition of IL-1 to UVAB-irradiated 
cells induced TNF levels 5.0-fold compared to the untreated irradiated cells. However, 
when Dec RVKR cmk was added to the IL-1 -treated UVAB-irradiated cells, a 95% 
inhibition in the level of TNF release was observed.  
In Colo 16 cells, following the addition of Dec RVKR cmk a 23% reduction in the level 
of TNF released from sham-irradiated cells (8.6 ng/mg cell protein) was observed 
(Figure 5.4). While increased levels of TNF was observed in IL-1 -treated                  
sham-irradiated cells (81.9 ng/mg cell protein), a 17% inhibition was seen when Dec 
RVKR cmk was added to these cells. It should be noted that due to the low endogenous  
5. Effect of UVR on furin activation of TACE in human keratinocyte cell lines 
247  
   
Figure 5.4 Effect of Dec RVKR cmk on release of TNF from UVAB-irradiated 
HaCaT and Colo 16 cells treated with IL-1 . Cells were exposed to                
sham-irradiation or controls (C) and UVAB-irradiation (AB) in the presence 
(+) or absence (-) of Dec RVKR cmk (100 µM) and/or IL-1 (IL) (10 
ng/ml). Media samples were collected 24 h post-irradiation. Results 
expressed are the mean ± SEM for three separate experiments. Statistical 
significance of the effect of Dec RVKR cmk on TNF release is represented 
as p<0.05 (*). 
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levels of TNF released from un-irradiated cells, the degree of inhibition observed did 
not seem high. There was an increase in the level of TNF released from                         
UVAB-irradiated cells (187.3 ng/mg cell protein), but following the addition of Dec 
RVKR cmk these levels fell by 66%. The addition of IL-1 to UVAB-irradiated cells 
induced TNF levels 3.3-fold compared to the untreated irradiated cells. However, in 
the presence of Dec RVKR cmk, a 87% inhibition in TNF release was observed in 
these IL-1
 
treated UVAB-irradiated cells. 
These results show that Dec RVKR cmk inhibited TNF release from the HaCaT and 
Colo 16 cells under all conditions tested which suggests that furin is involved in TACE 
activation and maturation.  
5.2.1.2.4 Effect of MMP inhibitor (MMPI) on TNF release
Some MMPs e.g. the gelatinases (MMP-2 and-9) have been shown to cleave pTNF to 
yield the mature protein (343-345). The purpose of this experiment was to determine if 
MMPs also cleave TNF from UVAB-irradiated HaCaT and Colo 16 cells in the 
presence and/or absence of IL-1 . Thus, in this study, ELISAs were performed using 
the 2R-2-[(4-Biphenylsulfonyl) amino]-3-phenylpropionic acid (MMP inhibitor = 
MMPI). 
It has been shown previously that the concentration of this inhibitor (5 µM) was not 
cytotoxic to these cells (Figure 4.15). Cells were pre-treated with MMPI (5 µM) for 1 h 
prior to being exposed to UVAB radiation (Section 2.4.3). Following                     
UVAB-irradiation and the addition of IL-1 (10 ng/ml), the level of TNF released into 
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the cultured media 24 h post-irradiation was measured using an ELISA and expressed 
as a function of cellular protein levels.   
In HaCaT cells, the amount of TNF
 
released from the sham-irradiated controls was 
410.7 ng/mg cell protein. When the MMPI was added to these cells, there was a 91% 
inhibition of the amount of TNF released from the cells (Figure 5.5). When IL-1 was 
added to the sham-irradiated cells, there was a 2.3-fold increase in the level of TNF 
released from these cells compared to untreated controls. When these cells were 
irradiated with UVAB, 793.4 ng/mg cell protein of TNF was released which was 1.9x 
than seen in the untreated un-irradiated controls. When MMPI was added to the    
UVAB-irradiated cells, a 93% reduction in TNF release was observed. While IL-1 
enhanced the level of TNF released in UVAB-irradiated cells 5.0-fold to that seen in 
the untreated irradiated cells, MMPI caused a 26% drop in these levels after 8 h, 37% at 
16 h and 45% at 24 h.  
In Colo 16 cells, the amount of TNF released from sham-irradiated cells was 8.6 
ng/mg cell protein. When MMPI was added to these cells, there was a 2% inhibition of 
the amount of TNF released from these cells (Figure 5.5). When IL-1 was added to 
sham-irradiated cells, there was a 9.5-fold increase in the level of TNF released from 
these cells compared to untreated controls. When Colo 16 cells were irradiated with 
UVAB, 187.3 ng/mg cell protein of TNF was released which was 21.7x than seen in 
the untreated un-irradiated controls. Following the addition of MMPI to the                
UVAB-irradiated cells, a 75% reduction in TNF release was observed. While IL-1 
enhanced the level of TNF released in UVAB-irradiated cells 3.3-fold to that seen in 
the untreated  
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Figure 5.5 The effect of MMPI on the release of TNF from UVAB-irradiated HaCaT 
and Colo 16 cells treated with IL-1 . Cells were exposed to                        
sham-irradiation or controls (C) and UVAB-irradiation (AB) in the presence 
(+) or absence (-) of MMPI and/or IL-1 (IL). Results expressed are the 
mean ± SEM for three separate experiments. Statistical significance is 
represented as p<0.05 for the effect of MMPI on TNF release (*).   
5. Effect of UVR on furin activation of TACE in human keratinocyte cell lines 
251  
irradiated cells, MMPI caused a 55% drop in these levels after 8 h, 56% at 16 h and 
60% at 24 h. From this inhibition data, it is possible to determine the incubation time 
needed for MMPI to inhibit TNF
 
release by 50%. If the level of TNF released at each 
of the time points (8, 16 and 24 h) are expressed as % of that released in the uninhibited 
cells, we can plot these values as seen in Figure 5.6. 
In HaCaT cells it was not possible to determine the incubation time required for MMPI 
to induce a 50% inhibition of TNF released from these cells. In Colo 16 cells, a 50% 
reduction in TNF release from the cell was calculated to occur when the cells had been 
incubated with MMPI for 7.8 h. The results suggest that MMPs as well as TACE can 
cleave TNF on these cells.   
5.2.2 TACE protein expression 
5.2.2.1 Effect of UVR  
The effect of UVR on the expression of TACE in keratinocyte-derived cell lines (HEK, 
HaCaT and Colo 16 cells) was investigated using cell lysates run on western blots 
(Section 2.5). In all the cell lines examined, two forms of TACE were detected, 
proTACE (pTACE) and mature TACE (mTACE). Representative blots of the effect of 
UVR on TACE levels in the keratinocyte-derived cell lines are seen in Figure 5.7. The 
blots were probed with the ADAM 17 antibody which detects both pTACE and 
mTACE isoforms. In the western blots, 50 µg cell protein was added per lane and               
-actin was probed to quantify the amount of protein present in each sample.   
From the resultant image, fluorescent quantification of the bands was made using the 
Quantity one image analysis software.  The amount of TACE in control (un-irradiated) 
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Figure 5.6 Time course on the effect of MMPI on the release of TNF from               
UVAB-irradiated HaCaT and Colo 16 cells. Results expressed are the mean 
± SEM for three separate experiments.           
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Figure 5.7 A representative western blot showing the effect of UVR on the expression 
of pTACE and mTACE in HEK (i), HaCaT (ii) and Colo 16 cells (iii). In 
each lane, 50 µg of cell lysate was added and -actin was used to monitor 
the amount of protein added to each lane. Samples represent                        
sham-irradiated cells or controls (C), UVA-irradiated cells (A),                    
UVB-irradiated cells (B) and UVAB-irradiated cells (AB).   
cells was given a value of 100 (pTACE + mTACE) and from that, the changes in 
pTACE and mTACE levels could be calculated in the irradiated samples, and these 
were expressed as a percentage of that found in control cells. 
In HEK cells, the expression of pTACE in sham-irradiated controls was 42.8%, which 
was higher than that in cells exposed to UVA (17.8%), UVB (22.3%) and UVAB 
radiation (10.6%) (Figure 5.8i). mTACE expression was also lower in the UV-irradiated 
cells (irrespective of the UV type) when compared to that seen in sham-irradiated 
controls.  The level of TACE (pTACE and mTACE) in the HEK cells decreased in   
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Figure 5.8 Effect of UVR on the expression of pTACE and mTACE in HEK (i), 
HaCaT (ii) and Colo 16 cells (iii). Cells were exposed to sham-irradiation  
or controls (C), UVA (A), UVB (B) and UVAB (AB) radiation and cellular 
proteins were extracted 24 h post-irradiation. Results expressed are the 
mean ± SEM for three separate experiments. Statistical significance of the 
effect of UVR on the expression of TACE compared to controls is shown as 
p<0.05 (*).       
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response to UVR (47% in UVA, 43% in UVB and by 68% in UVAB) when compared 
to the  sham-irradiated controls. The main form of TACE found in all these cells was 
mTACE. 
In the sham-irradiated HaCaT cells, there was slightly more pTACE (53.4%) compared 
to mTACE (46.6%) (Figure 5.8ii). While pTACE levels were similar in                            
UVA-irradiated cells compared to un-irradiated controls, it fell in both                       
UVB- (24%) and UVAB-irradiated cells (14%).  On the other hand, mTACE expression 
was elevated in UVA-irradiated cells (67.7%) but lower in both UVB- (32.4%) and 
UVAB-irradiated cells (42.3%) when compared to the un-irradiated controls. The level 
of total TACE expression was 20% higher in UVA-irradiated cells but 40% lower in 
both UVB- and UVAB-irradiated cells when compared to that of the sham-irradiated 
controls. In these cells, mTACE was the predominant form seen in UV-irradiated 
HaCaT cells.  
In Colo 16 cells, the predominant form of TACE was mTACE (63%) in the                         
un-irradiated controls (Figure 5.8iii). There was a slight increase in pTACE levels in 
UVA- (40.2%), UVB- (62%) and UVAB-irradiated cells (63%) when compared to              
un-irradiated controls.  mTACE levels increased to 143.5%, 76% and 109% in            
UVA-, UVB- and UVAB-irradiated cells, respectively when compared to the                   
un-irradiated cells. The level of total TACE expression in Colo 16 cells increased 83% 
in UVA-irradiated cells, 38% in UVB-irradiated cells and 72% in UVAB-irradiated 
cells when compared to the sham-irradiated controls. The main form of TACE in all 
these cells was mTACE.  
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In conclusion, mTACE expression was higher than that of pTACE in all three 
keratinocyte-derived cell lines examined in this study. UVR-induced expression of 
pTACE and mTACE was higher in Colo 16 cells when compared to both HEK and 
HaCaT cells, where a reduction was seen.  While UVR did change the expression of 
TACE in all three cell lines examined, these changes were not statistically significant.   
5.2.2.2 Effect of Dec RVKR cmk on TACE levels 
In this study, the furin inhibitor, Dec RVKR cmk was added to the cells to observe if 
furin was responsible for the processing of pTACE to mTACE. In these experiments, 
the cells were pre-treated with Dec RVKR cmk (100 µM) for 24 h before they were 
exposed to UVR (Section 2.4.3). At the end of this period, the cell lysates were run on 
western blots (Section 2.5) and the changes in TACE protein expression measured.  
Representative western blots probed for TACE in UV-irradiated HaCaT and Colo 16 
cells pretreated with Dec RVKR cmk are shown in Figure 5.9. It can be seen that in 
those cells treated with the furin inhibitor, irrespective of the UV type, only mTACE 
was present on the gels. This result suggests that furin is involved in the maturation of 
TACE in these cells. 
In the control HaCaT cells, the predominant form of TACE was pTACE (53%) (Figure 
5.10i). The addition of Dec RVKR cmk caused a slight reduction in pTACE levels but 
significantly (p<0.05) reduced mTACE levels (4.5%) in these cells. Similar results were 
also seen in the UV-irradiated HaCaT cells irrespective of the type used. In all cases, 
there was a significant reduction in the levels of mTACE in these irradiated cells when 
they were treated with Dec RVKR cmk. In general, the level of mTACE fell to ~10%  
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Figure 5.9  A representative western blot showing the effect of Dec RVKR cmk on the 
expression of TACE in UV-irradiated HaCaT (i) and Colo 16 cells (ii). In 
each lane, 50 µg of cell lysates was added. -actin was used to monitor the 
amount of protein added to each lane. The cells were exposed to                  
sham-irradiation or controls (C), UVA (A), UVB (B) and UVAB (AB) 
radiation in the presence (+) or absence (-) of Dec RVKR cmk.   
that of the untreated cells irrespective of the UV dose. Of interest was that in UVB- and 
UVAB-irradiated cells, the level of pTACE were higher in those cells treated with Dec 
RVKR cmk than in the untreated cells. In UVA-irradiated cells, pTACE levels were 
lower in Dec RVKR cmk treated cells compared to the untreated cells.  
In the control Colo 16 cells, the predominant form of TACE was mTACE (63%) 
(Figure 5.10ii). The addition of Dec RVKR cmk caused a slight reduction in pTACE   
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Figure 5.10 Effect of Dec RVKR cmk on the expression of TACE in UV-irradiated 
HaCaT (i) and Colo 16 cells (ii). Cells were exposed to sham-irradiation or 
controls (C), UVA (A), UVB (B) and UVAB (AB) radiation in the presence 
(+) or absence (-) of Dec RVKR cmk. Results expressed are the mean ± 
SEM for three separate experiments. Statistical significance is represented 
as p<0.05 for the effect of Dec RVKR cmk treatment (*).      
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levels but significantly (p<0.05) reduced mTACE levels (6.0%) in these cells.  Similar 
results were also seen in the UV-irradiated Colo 16 cells irrespective of the type. In 
UVA-irradiated cells, the levels of pTACE were slightly higher in those cells treated 
with Dec RVKR cmk than in the untreated cells. In the UVB- and UVAB-irradiated                 
cells, pTACE levels were lower in Dec RVKR cmk treated cells compared to the 
untreated cells.  In all cases, there was a significant reduction in the levels of mTACE in 
these irradiated cells when they were treated with Dec RVKR cmk. In general, mTACE 
levels fell to ~8% to that of the untreated cells irrespective of the UV dose. On the 
contrary, the total levels of TACE in the treated UV-irradiated cells were about 40% 
that seen in the corresponding untreated cohorts. 
Of interest was that while pTACE was not higher in every treated UV-irradiated cell, 
the corresponding mTACE levels were drastically reduced (irrespective of the type and 
dose).   This may imply that in the absence of furin, pTACE may be the major form of 
TACE in the cells. In conclusion, these results suggest that furin is the main PC 
involved in the processing and activation of mTACE in HaCaT and Colo 16 cells and 
exposure to UV-irradiation has no effect on this process.    
5.2.2.3 Effect of CHX on TACE levels 
CHX was added to the cells to prevent the synthesis of TACE and from this we can 
calculate its half-life. In this study, the cells were pre-treated with CHX (100 µM) for 
24 h prior to being exposed to UVAB radiation (Section 2.4.3). UVAB radiation was 
used as it was shown to induce high levels of TNF
 
release in irradiated cells (Figure 
5.1). Following UVAB-irradiation, the cells were grown in culture for 24 h in the 
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presence of CHX. Cell lysates (50 µg) were run on western blots and TACE levels were 
quantified as described (Section 2.5). The level of TACE (pTACE and mTACE) in 
untreated control was 100%, and the values in the treated cells were expressed as a 
percentage of these values.  
In un-irradiated HaCaT cells, most of TACE exists in its proform (51.7%), the rest 
being in the mature form (Figure 5.11i). When these cells were treated with CHX, the 
levels of both pTACE and mTACE fell (34.8% and 42.7%, respectively) when 
compared to the untreated controls. In the UVAB-irradiated HaCaT cells, the level of 
total TACE in the cell fell 46% compared to un-irradiated cells. The majority of TACE 
found in the UVAB-irradiated cells was in the mature form (41.2%) with only 13% 
being in the proform. When CHX was added to these irradiated cells, pTACE levels fell 
to 11%, while that of mTACE fell to 17%. 
Based on the changes in the level of total TACE in the cell, its approximate half-life 
was calculated to be ~24 h. However in order to obtain a more accurate value, further 
time points would need to be investigated. 
In un-irradiated Colo 16 cells, most of the TACE was present in the mature form (64%), 
with the rest being in the proform (Figure 5.11ii). When these cells were treated with 
CHX, the levels of both pTACE and mTACE fell (27.1% and 60%, respectively) when 
compared to untreated controls. In the UVAB-irradiated Colo 16 cells, the level of total 
TACE in the cell increased by 69% compared to the un-irradiated cells. The majority of 
TACE present was in the mature form (108%) with only 61% being in the proform. 
When CHX was added to the irradiated cells, pTACE levels fell to 37%, while  
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Figure 5.11 Effect of CHX on the expression of TACE in UVAB-irradiated HaCaT (i) 
and Colo 16 cells (ii). Cells were exposed to sham-irradiation or controls 
(C) and UVAB-irradiation (AB) in the presence (+) or absence (-) of CHX. 
Results expressed are the mean ± SEM for three separate experiments. No 
statistical significance was observed for the effect of CHX on TACE 
expression.      
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mTACE fell to 12.3%. Based on the changes in the level of total TACE in the cell, its 
approximate half-life was calculated to be 46 h. However, in order to obtain a more 
accurate value, further time points would need to be investigated. 
In conclusion, these preliminary results suggest that TACE is not rapidly turned over in 
these cells and that CHX did not have a significant effect on the ratio of pTACE to 
mTACE in the cell, under the conditions examined.  
5.2.2.4 Effects of IL-1
 
on TACE expression  
Bashir et al. (77) recently showed that IL-1 stimulated the TNF release from             
UVB-irradiated keratinocytes. TACE is the main metalloprotease responsible for the 
processing of TNF (125, 136-138, 271). As a result of this I investigated the effect        
IL-1 had on the expression of TACE in these cells.  
UVAB was shown to induce the maximal release of TNF in HEK, HaCaT and Colo 16 
cells (Figure 5.1). In this study I investigated the effect of UVR in the presence or 
absence of IL-1 on the expression of TACE. In order to quantify changes in the level 
of TACE in the cells, western blots (Section 2.5) of cell lysates were run. 
In the control HEK cells, the predominant form of TACE was mTACE (58.1%). The 
addition of IL-1 caused a reduction in pTACE and mTACE levels (by 29% and 46%, 
respectively) in these cells (Figure 5.12i). Similar results were also seen in the               
UVA- and UVB-irradiated HEK cells treated with IL-1 compared to the corresponding 
irradiated untreated cells. However, in UVAB-irradiated cells treated with IL-1 , there 
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Figure 5.12 The effect of IL-1 on the expression of TACE in UVR-irradiated HEK (i), 
HaCaT (ii) and Colo 16 cells (iii). Cells were exposed to sham-irradiation  
or controls (C), UVA (A), UVB (B) and UVAB (AB) radiation in the 
presence (+) or absence (-) of IL-1 . Results expressed are the mean ± SEM 
for three separate experiments. No statistical significance was observed for 
effect of UVR on TACE expression in the absence of IL-1 . Statistical 
significance is represented as p<0.05 (*) for effect of UVR on TACE 
expression in the presence of IL-1 .        
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was an increase in pTACE (56%) and mTACE (60%) levels compared to that seen in 
the corresponding irradiated untreated cells. In general, while the level of total TACE 
(pTACE and mTACE) in the presence of IL-1 fell in sham- irradiated controls (75%), 
UVA- (54%) and UVB-irradiated cells (72%), it increased by 78% in the                          
UVAB-irradiated cells compared to the corresponding untreated cells.  
In the control HaCaT cells, the predominant form of TACE was pTACE (54.1%). The 
addition of IL-1 caused a reduction in pTACE and mTACE levels (by 42% and 35%, 
respectively) in these cells (Figure 5.12ii). Similar results were also seen in the              
UVA- and UVB-irradiated HEK cells treated with IL-1 compared to the corresponding 
irradiated untreated cells. However, in UVAB-irradiated cells treated with IL-1 , there 
was an increase in pTACE (67%) and mTACE (88%) levels compared to that seen in 
the corresponding irradiated untreated cells. In general, while the level of total TACE 
(pTACE and mTACE) in the presence of IL-1 fell in sham-irradiated controls (77%), 
UVA- (79%) and UVB-irradiated cells (71%), it increased by 275% in                        
the UVAB-irradiated cells compared to the corresponding untreated cells.  
In the control Colo 16 cells, the predominant form of TACE was mTACE (63.4%). The 
addition of IL-1 caused a reduction in pTACE and mTACE levels (by 9% and 28%, 
respectively) in these cells (Figure 5.12iii). Similar results were also seen in the              
UVA- and UVB-irradiated HEK cells treated with IL-1 compared to the corresponding 
irradiated untreated cells. However, in UVAB-irradiated cells treated with IL-1 , there 
was an increase in pTACE (79.3%) but not in mTACE (reduced by 33%) levels 
compared to that seen in the corresponding irradiated untreated cells. In general, the 
level of total TACE (pTACE and mTACE) in the presence of IL-1 fell in                    
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sham-irradiated controls (37%), UVA- (70%), UVB- (63%) and UVAB-irradiated cells 
(9.4%).  
These results suggest that IL-1 reduces the levels of both pTACE and mTACE in 
UVA- and UVB-irradiated HEK, HaCaT and Colo 16 cells, though it was not 
statistically significant. While IL-1 increased the levels of TACE in UVAB-irradiated 
HEK and HaCaT cells compared to their untreated irradiated counterparts, the opposite 
effect was seen in Colo 16 cells. The reasons for which are not clear.   
5.2.2.5 Combined effects of CHX and IL-1 on TACE expression 
IL-1 was shown to stimulate the expression of TACE in UVAB-irradiated cells 
(Figure 5.12). In this study, the effect of CHX on TACE expression in cells treated with 
IL-1
 
was determined. 
Cells were pre-treated with CHX (100 µM) for 24 h prior to being exposed to UVAB 
radiation (Section 2.4.3). Following irradiation and treatment with IL-1 , the cells were 
grown in culture for 24 h in the presence or absence of CHX. At the end of this period, 
cell lysates (50 µg) were run on western blots and TACE levels were quantified 
(Section 2.5). The level of TACE (pTACE and mTACE) in untreated control was 
100%, and the values in the treated cells were expressed as a percentage of these values.  
In un-irradiated HaCaT cells both pTACE and mTACE levels were lower when the 
cells were treated with IL-1 or CHX and IL-1 (Figure 5. 13i). However, in the 
UVAB-irradiated cells, IL-1 stimulated the expression of both pTACE and mTACE. 
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Figure 5.13 Effect of CHX on the expression of TACE in UVR-irradiated HaCaT (i) 
and Colo 16 cells (ii) treated with IL-1 . Cells were exposed to                    
sham-irradiation or control (C) or UVAB-irradiation (AB) in the presence 
(+) or absence (-) of CHX (CHX) and/or IL-1 (IL). Results expressed are 
the mean ± SEM for three separate experiments. No statistical significance 
was observed for effect of CHX on TACE expression.      
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The addition of CHX to these irradiated cells caused a slight reduction in both pTACE 
and mTACE levels. The level of total TACE (pTACE and mTACE) in the presence of 
CHX and IL-1 decreased in both sham-irradiated controls (13%) and UVAB-irradiated 
cells (14%) compared to the corresponding cells only treated with IL-1 . 
In un-irradiated Colo 16 cells both pTACE and mTACE levels were lower when the 
cells were treated with IL-1 or CHX and IL-1 (Figure 5. 13ii). In the                       
UVAB- irradiated cells, IL-1 stimulated the expression of both pTACE and mTACE. 
The addition of CHX to these irradiated cells caused a slight reduction in the levels of 
both pTACE and mTACE. The levels of total TACE (pTACE and mTACE) in the 
presence of CHX and IL-1 decreased in sham-irradiated controls (6.3%) and              
UVAB-irradiated cells (9%) compared to the corresponding cells only treated with            
IL-1 . 
In general, total TACE levels (pTACE and mTACE) were lower in the CHX-treated 
UVAB-irradiated cultures in the presence of IL-1 when compared to UVAB-irradiated 
cells treated only with IL-1 , though these changes were not statistically significant. 
The findings agree with that seen earlier (Figure 5.11) which suggests that the half-life 
of TACE in these cells is longer than that of furin (Chapter 3).  However, in order to 
determine this value a time course study would need to be performed.  
5.2.3 TACE and TNF
 
mRNA  
UVR has been shown to be a potent inducer of TNF gene expression in human 
keratinocytes (115). As well as up-regulating gene expression, UVR is also known to 
increase the amount of TNF shed from the cells (Figure 5.1) (77, 121, 122, 136, 276, 
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346). TNF
 
is released from the surface of the keratinocytes by the action of TACE 
(125, 136-138, 271). Therefore, the aim of this study was to observe the effect of UVR 
on TACE and TNF mRNA expression in HaCaT and Colo 16 cells.  In order to 
quantify the gene expression of furin, TACE and TNF qRT-PCR was used because of 
the low levels of mRNA detected in these cells (136).   
5.2.3.1 Effects of UVR 
In HaCaT or Colo 16 cells, the expression of TACE and TNF in untreated control cells 
was given the value of unity (Figure 5.14). The relative expression of the internal 
control gene ( actin) and target gene (TACE and TNF ) for each UV-irradiated sample 
was compared against the un-irradiated sample. This was calculated using the Pfaffl 
Correction method (Appendix A.8) (225).  
In HaCaT cells, only in the UVB-irradiated cells was there an increase (30%) in TACE 
mRNA levels seen 24 h post-irradiation (Figure 5.14i). In the UVA- and                     
UVAB-irradiated cells, TACE mRNA expression fell 60% and 80%, respectively. This 
result differed to previous studies which showed that TACE mRNA levels were 
elevated in response to both UVA (8 kJ/m2) or UVB (2 kJ/m2) radiation (136). The 
expression of TNF 24 h post-irradiation in HaCaT cells fell when they were exposed 
to UVA (90%), UVB (70%) or UVAB radiation (80%). These results differed to that 
seen previously where a rapid and strong induction of TNF mRNA was observed  
post-exposure to UVA or UVB (136), and UVAB radiation (277, 340).  
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Figure 5.14 Effect of UVR on TACE (i) and TNF mRNA induction/expression (ii) in 
HaCaT and Colo 16 cells. Cells were exposed to sham-irradiation (control), 
UVA, UVB and UVAB radiation and mRNA expression measured 24 h 
post-irradiation. Control mRNA levels (=1) are represented as a dotted line. 
Results expressed are the mean ± SEM for three separate experiments. 
Statistical significance of the effect of UVR on TACE and TNF mRNA 
levels was shown as p<0.05 (*).       
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In UV-irradiated Colo 16 cells, there was a decrease in TACE mRNA levels seen 24 h 
post-irradiation (Figure 5.14ii). In the UVA-, UVB- and UVAB-irradiated cells, TACE 
mRNA expression fell 66% 39% and 97%, respectively compared to the un-irradiated 
controls. The highest levels of TACE mRNA were observed in the UVB-irradiated 
cells. The expression of TNF
 
24 h post-irradiation in the Colo 16 cells was 
significantly higher when they were exposed to UVR (Figure 5.15ii). TNF mRNA 
levels were 6.5-fold, 8-fold and 23-fold higher in UVA, UVB- and UVAB-irradiation, 
respectively when compared to that seen in the un-irradiated controls.   
5.2.3.1.1 Time course of furin, TACE and TNF
Following on from the results obtained in Figure 5.14, a time course of furin, TACE and 
TNF mRNA expression post-irradiation was performed. Since, UVB induction of 
TACE and TNF mRNA expression was the highest at 24 h (Figure 5.14), in order to 
further expand this study, a time course gene induction (0-32 h) in response to               
UVB-irradiation was determined in HaCaT and Colo 16 cells (Figure 5.15). Results 
from this experiment were used to determine if there is a relationship between the 
mRNA levels of these three proteases. In this study, un-irradiated controls cells were 
given the value of unity at 0 h and mRNA expression was expressed as ratio to this 
value at the time points examined. 
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Figure 5.15 Time course of furin, TACE and TNF mRNA induction/expression in 
UVB-irradiated HaCaT (i) and Colo 16 cells (ii).  Control mRNA levels 
(=1) are represented as a dotted line. Results expressed are the mean ± SEM 
for three separate experiments. Statistical significance of the effect of UVB 
on furin, TACE and TNF mRNA mRNA levels is shown as p<0.05 (*).      
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Results from this study show that in UVB-irradiated HaCaT cells, furin mRNA levels 
slowly increased with time reaching 2.9-fold at 16 h before rapidly increasing to a 
maximal level (91-fold) at 24 h before falling back to 3.3-fold at 32 h (Figure 5.15i). 
TACE expression was relatively constant throughout this period of time (32 h) with 
levels remaining close to unity. TNF gene expression was observed in HaCaT cells           
4-24 h post UVB-irradiation. TNF
 
mRNA levels were maximal at 16 h (59-fold) post                         
UVB-irradiation, which was similar to results by Skiba et al. (136) who found that 
TNF mRNA induction was bimodal in HaCaT cells with maximal levels seen at 16 
and 24 h post UVB-irradiation. However, in this study a second peak at 24 h was not 
seen. Based on this information, correlation plots of furin, TACE and TNF mRNA 
levels were constructed (Figure 5.16). It can be seen from this figure that there does not 
appear to be any apparent correlation between the mRNA of these proteins in the UVB-
irradiated HaCaT cells.  
Furin mRNA levels in UVB-irradiated Colo 16 cells, were higher than that seen in           
un-irradiated controls over the period 12-24 h with maximal levels seen at 12 h                
(1.5-fold) (Figure 5.15ii). The expression of TACE mRNA in UVB-irradiated Colo 16 
cells was detected at minimal amounts and remained fairly constant throughout this 24 
h period. However, in the UVB-irradiated Colo 16 cells, TNF mRNA levels were 
rapidly induced reaching maximal levels by 8 h (12.1-fold) after which they fell back to 
3-fold at 16 h before subsequently rising again to 6.7-fold at 24 h post-irradiation.   
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Figure 5.16 Correlation between the expression of furin and TACE (i), furin and TNF 
(ii) and TACE and TNF mRNA (iii) in UVB-irradiated HaCaT cells. The 
levels of furin, TACE and TNF mRNA expressed in the cell extracts for 
each UV type were expressed as a ratio to that observed in sham-irradiated 
cells, the later was given a value of unity. 
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Figure 5.17 Correlation between the expression of furin and TACE (i), furin and TNF 
(ii) and TACE and TNF mRNA (iii) in UVB-irradiated Colo 16 cells. The 
levels of furin, TACE and TNF mRNA expressed in the cell extracts for 
each UV type were expressed as a ratio to that observed in sham-irradiated 
cells, the later was given a value of unity. 
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Based on this information, correlation plots of furin, TACE and TNF mRNA levels 
were constructed (Figure 5.17). It can be seen that a weak correlation was observed 
between furin and TNF (r2 = 0.321) and TACE and TNF mRNA (r2 = 0.351) but no 
correlation was observed between furin and TACE mRNA (r2 = 0.042) in the                 
UVB-irradiated Colo16 cells. In both HaCaT and Colo 16 cells, changes in the level of 
TACE, TNF
 
or furin mRNA expressed in UV-irradiated cells do not appear to be 
related to each other.    
5.2.3.2 Effects of IL-1 on mRNA expression 
The results from Figure 5.12 show that when IL-1 is added to the UV-irradiated cells it 
modulates TACE protein expression. IL-1 increased TACE levels in                       
UVAB-irradiated HEK and HaCaT cells but not in irradiated Colo 16 cells. The 
addition of IL-1 also enhanced the release of TNF in UV-irradiated                   
keratinocyte-derived cell lines (Figure 5.1). We also observed that UVAB radiation 
induced the maximal release of TNF from the cells. Therefore, we have used UVAB 
radiation to investigate the time course effect IL-1 has on furin, TACE and TNF
mRNA expression in irradiated HaCaT and Colo 16 cell lines.    
In HaCaT cells, furin mRNA levels fell below that of the sham-irradiated controls over 
the first 12 h before increasing to reach a maximal value at 16 h (5.3-fold) before falling 
to 4.2-fold at 24 h (Figure 5.18i). The expression of TACE mRNA in these cells was 
reduced throughout the 24 h period following exposure to UVAB in the presence of          
IL-1 . TNF mRNA levels on the other hand increased following exposure reaching   
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Figure 5.18 Time course of the effect of IL-1 on the expression of furin, TACE and 
TNF mRNA induction/expression in UVAB-irradiated HaCaT (i) and 
Colo 16 cells (ii).  Cells were exposed to UVAB radiation and mRNA 
expression measured over 24 h post-irradiation. Control mRNA levels (=1) 
were represented as a dotted line. Results expressed are the mean ± SEM for 
three separate experiments. Statistical significance of the effect of UVAB 
radiation in the presence of IL-1 on gene expression is shown as p<0.05 
for furin (*), for TACE (^) and for TNF (#).    
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maximal levels between 4 (6-fold) and 8 h (4.3-fold) before falling back to 1.1-fold by 
24 h. When plots of furin, TACE and TNF mRNA levels were constructed, no
 
correlation between the expression of any of the two proteins were observed (results not 
shown).  
In Colo 16 cells, mRNA expression of furin fell following UV exposure in the IL-1 
treated cells and remained low over the 24 h period (Figure 5.18ii). A similar result was 
also seen for TACE mRNA in these cells. The expression of TNF mRNA, on the other 
hand rose immediately following irradiation reaching a maximum level at 4 h (136-fold) 
before falling back to control levels by 24 h.  When plots of furin, TACE and TNF 
mRNA levels were constructed, no correlation between the expression of any of the two 
proteins were observed (results not shown).  
In conclusion, these results show that IL-1 significantly induces the early expression of  
TNF mRNA but not that of furin or TACE in UVAB-irradiated HaCaT and Colo 16 
cells. However, the time courses of TACE, TNF or furin mRNA induction does not 
appear to be related to each other.  
5.2.4 Summary 
This study investigated (a) the effect of UVR on furin activation of TACE, and (b) if  
changes in TACE activity were due to changes in furin expression and/or activity. The 
effect UVR on the release of TNF from human keratinocyte-derived cells was also 
examined. In this study, IL-1 increased TNF release in sham-irradiated HEK and 
HaCaT cells but not Colo 16 cells (Figure 5.1). UVAB-irradiated cells treated with              
IL-1 induced the greatest increase in TNF release in all cell lines.  Therefore, this UV 
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type was used to investigate further the mechanisms by which IL-1
 
induces TNF
release by irradiated cells.  Results using CHX suggest that the cell does not contain a 
reservoir of TNF , and this cytokine is synthesized when required by the cell (Figure 
5.2). Results using 1, 10 phe confirmed that TACE is a metalloprotease (341) (Figure 
5.3). The drop in TNF released from Dec RVKR cmk treated UVAB-irradiated cells 
suggest that furin is involved in TACE activation and maturation (Figure 5.4).  TNF
levels were also decreased in the presence of the MMPI which suggests that MMPs may 
also cleave TNF in these cells (Figures 5.5 and 5.6).  
Following exposure to UVR, mTACE expression was higher than pTACE in all three 
keratinocyte-derived cell lines (HEK, HaCaT and Colo 16) examined in this study 
(Figure 5.8). UVR only induced higher levels of total TACE in Colo 16 cells but not in 
HEK and HaCaT cells, where reduced levels were observed. IL-1 modulated the 
expression of pTACE and mTACE in the UVAB-irradiated cells, which suggests that 
its effect on TNF release is not due to increased TACE expression. CHX experiments 
show that TACE is not rapidly turned over in these cells (Figures 5.11 and 5.13).          
UVB-irradiation induced maximum TACE and TNF mRNA levels compared to UVA 
and UVAB in these cells 24 h post-irradiation (Figure 5.14). A time course of furin, 
TACE and TNF mRNA in UVB-irradiated cells showed that the expression of these 
genes were not related to each other (Figure 5.15). A similar result was also seen when 
IL-1 was added to UVAB-irradiated cells (Figure 5.16).    
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5.3 Discussion 
In this chapter I investigated some of the cellular changes elicited by UVR on the 
activation of TACE and TNF by furin in cultured keratinocyte-derived cell lines. In 
most of the experiments used in this study, only HaCaT and Colo 16 cells were used. 
HEK cells were not available in sufficient quantities and as such future studies should 
repeat these experiments using cultures of these primary cells.   
5.3.1 TNF
 
release 
TNF has a myriad of pro-inflammatory effects on the skin (77, 276). UVR has been 
shown to be a potent inducer of TNF and cytokine gene expression, which mediates 
signalling by human keratinocytes (30, 135, 136). Kock et al. (115) found that there was 
a significant level of TNF produced by human keratinocytes following low dose UVB 
(0.1 kJ/m2) exposure. We were not able to see a significant increase in TNF released 
by UVB-irradiated cells (2 kJ/m2) in this study (Figure 5.1). Streilein and colleagues 
(107, 123, 124) suggested that UVB indirectly induces TNF , which then causes 
morphologic and functional changes on LC resulting in the impairment of CHS. Bashir 
et al. (77) showed that up-regulation of TNF mRNA is a key early response to UVB 
by keratinocytes, and represents an important component of the inflammatory cascade 
in the skin.   
IL-1 is a family of polypeptide cytokines initially found to be produced by activated 
monocytes and macrophages that mediate a wide variety of cellular responses to injury 
and infection (236). IL-1 is a major epidermal cytokine that is constitutively 
synthesized by keratinocytes (273, 274) and fibroblasts (77) and it is released following 
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injurious stimuli like UV-irradiation (236, 237).  Bashir et al. (77) showed that IL-1
 
induces a synergistic induction of TNF by both UVB-irradiated keratinocytes and 
fibroblasts. In this study, ELISA was used to quantify TNF levels in the media of the 
irradiated cells in the presence and/or absence of IL-1 (Figure 5.1). An increase of 
TNF release was observed in the controls that were treated with IL-1 which was in 
agreement with that seen previously (77). A combination of UV-irradiation (UVA 
and/or UVB) in the presence of IL-1 , in particular UVAB-irradiation resulted in a 
significant increase in TNF shed from HEK, HaCaT and Colo 16 cells. This finding 
differed to that seen by Bashir et al. (77) who showed that only UVB-irradiation 
induced significant levels of TNF in the presence of IL-1 .  Results from my study 
showed that UVAB dose has a stronger effect on the cells probably due to the fact that 
when cells were irradiated with UVA (40 kJ/m2) followed immediately with 2 kJ/m2 of 
UVB; the later dose appeared to be of predominance, dominating the effect of UVA.  
The mechanism by which UVR (UVA and/or UVB) and IL-1 induce TNF in these 
cells is not known. Cytokines may act in an autocrine manner and thereby regulate their 
own synthesis. Proinflammatory cytokines like IL-1 in human keratinocytes and 
vascular endothelial cells and IL-1 in thymic stromal cells exhibit the capacity to 
induce autocrine up-regulation (240, 347-349). In addition, TNF is capable of 
increasing its own expression in ovarian tumour cells (350, 351). The expression of 
TNF is regulated at many levels, including transcription, post-transcription, message 
turnover, protein production, and protein release (352-354). Previous reports showed 
that TNF protein synthesis is likely due to an increase of the soluble form of TNF in 
response to septic stimuli (77, 276). TNF also promotes apoptosis, lymphocyte 
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activation, and hyperproliferative skin disorders (355-357). It is involved not only in the 
mediation of local inflammatory reactions within the epidermis but it may also enter the 
circulation and cause systemic effects (107, 115). Thus elevated levels of this cytokine 
and other skin-derived inflammatory molecules may lead to the induction of 
inflammation in irradiated skin (77, 276).  
In response to UVAB-irradiation, the highest increase of TNF
 
release was observed in 
HEK cells (32.9-fold) followed by HaCaT cells (4.2-fold) compared to the respective 
untreated irradiated cells (Figure 5.1). Colo 16 cells shed less TNF than did the HEK 
or HaCaT cells. This difference could be because the keratinocytes in the epidermis are 
continuously exposed to UV-irradiation (358). HEK cells which are the primary 
keratinocytes act as a trigger for the release of this cytokine as a result of inflammation. 
Together with IL-1 , TNF was one of the first cytokines found to be up-regulated in 
the skin following UV irradiation (236, 359). There are synergistic interactions between 
pro-inflammatory cytokines produced in the skin and in synergy with irradiated 
keratinocytes, leading to later augmentation of TNF production (77). It can be seen 
that TNF plays an important pro-inflammatory role in the skin, both due to (a) the 
direct effects of UVR and (b) the indirect effects of inflammatory cells that chemotax to 
the skin.  It is clear that UV-and inflammatory cell-derived cytokines further enhance 
TNF gene transcription in human skin cells (77), and this can further increase 
epidermal production of TNF .   
While, TNF is known to be cytotoxic to some tumour cell lines, it can mediate               
UV-induced tumorigenesis in others (30, 118). TNF is involved in all steps of 
tumourigenesis (tumour initiation, promotion, proliferation and invasiveness) (360). It 
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has a particularly important role in tumour microenvironment and promotes tumour cell 
migration and invasion, however, the mechanism by which TNF
 
facilitates these 
events remains elusive (361). In my study, Colo 16, being a tumour cell line shed less 
TNF than the other cell lines (Figure 5.1).  This was probably due to the ability of 
TNF to suppress immunity following UV exposure which could be dependent on 
several factors like the type, dose and mode of UVR, activation of signal pathways and 
the influence of other cytokines (5). Recently Wu et al. (361) emphasized on the 
contribution of TNF and the  NF- B pathway on tumour cell invasion and metastasis. 
Furthermore, the inflammatory nature of the tumour microenvironment can lead to 
additional genetic changes in cells associated with malignancy. A better understanding 
of signalling pathways generated by UVR in Colo 16 cells may provide an insight about 
the regulation of TNF release from these carcinogenic cells.    
In order to investigate further the mechanisms by which IL-1 induces TNF release 
from the irradiated cells, various inhibitors were tested. CHX was added to the cells to 
determine if the cell contains a reservoir of pTNF or it continuously synthesizes this 
cytokine. TNF levels were much lower in UV-irradiated Colo 16 cells compared to 
that of HaCaT cells irrespective of the different conditions and treatments (Figure 5.2). 
These results suggest that the cell does not contain a reservoir of proTNF , and this 
protein is synthesized when required by the cell in response to external stimuli such as 
UV-radiation or IL-1 .  Next, I added 1, 10 phe which is a broad spectrum 
metalloprotease inhibitor (304, 305) to the cells. There was a significant drop in TNF 
levels shed from treated UVAB-irradiated HaCaT (98% inhibition) and Colo 16 cells 
(97% inhibition) in the presence and/or absence of IL-1 (Figure 5.3). These results 
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suggest that TACE is a metalloprotease which agrees with that seen in other studies 
(113, 125, 126, 145, 220).   
TNF is released from the cells by proteolytic cleavage of its membrane-anchored 
precursor (341). TACE is the main protease responsible for the ectodomain shedding of 
TNF
 
(341). TACE is cleaved from its proform to its catalytically active form by furin 
(144, 151, 154, 158). Srour et al. (158) showed that Dec RVKR cmk blocked TNF
release from the cell by inhibiting PC-mediated TACE maturation in MonoMac-1 and 
THP-1 cells. In order to determine the effect of furin on TACE, the furin inhibitor (Dec 
RVKR cmk) was used in this study (154, 156, 266). As shown in Figure 5.4, in the 
treated UVAB-irradiated HaCaT cells low levels (95% inhibition) of this cytokine were 
observed. A similar finding was also seen in the Colo 16 cells. This result suggests that 
furin in involved in the activation and maturation of TACE, which agrees with that seen 
in previous studies (154, 156, 266).  
Previous studies have indicated that TACE and MMPs can process pTNF to generate 
bioactive TNF (126, 147, 345). There have also been reports that certain MMPs like 
gelatinases (MMP-2 and-9) can process precursor TNF (343-345). Haro et al. (345) 
observed that MMP-7 is involved in the release of sTNF from macrophages. Mohan et 
al. (138) showed that the specificity constants (kcat/Km) for TNF cleavage by the 
MMPs were approximately 100-1000-fold lower compared to that of TACE. While 
TACE cleaved TNF between Ala76 and Gln77,   MMP-9 cleaved TNF only between 
Ala74 and Gln75 (138). In keeping with this finding, we added MMPI to                      
UVAB-irradiated HaCaT and Colo 16 cells in order to confirm if MMPs (-2 and -9) 
also cleave TNF  (Figures 5.5). Results from this study suggested that MMPI gradually 
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inhibited the release of TNF over a period of 24 h in HaCaT cells and in Colo 16 cells, 
50% of TNF release was inhibited after 7.8 h (Figure 5.6). In conclusion,
 
these results 
suggest that apart from TACE, MMPs may also be involved in processing TNF in 
these cells. Future work should be undertaken to see if the TNF processed by MMP-2 
and -9 in these cells is biologically active. Gearing et al. (343) confirmed that 
biologically relevant processing of proTNF is achieved by MMPs and that, in vitro, 
production of mature, secreted TNF can be blocked by specific inhibitors of these 
enzymes. If this processing takes place on the cell surface, blocking it could 
theoretically lead to an accumulation of membrane-anchored proTNF , which is less 
biologically active than sTNF (110).  Like that of TACE, MMPs are activated by UVR 
and play a crucial role in skin tumour cell development and metastasis (187). Their 
mechanism may not only be directly related to the ability of these enzymes to degrade 
the ECM, but may also involve processing of bioactive molecules such as TNF .   
5.3.2 TACE expression and/or activity 
TACE is the main protease responsible for the ectodomain shedding of TNF (341). 
Therefore, the effect of UVR on TACE expression was investigated. Cell lysates were 
assessed by immunoblotting for pro and mature TACE using ADAM-17 antibody 
directed against the cytoplasmic domain of the enzyme, so both forms can be detected. 
Results from this study showed that the expression of pTACE fell in HEK and HaCaT 
cells following exposure to UVR (Figure 5.8). mTACE expression was higher than that 
of pTACE in the three keratinocyte-derived cell lines examined in this study. UVR 
induced expression of pTACE and mTACE was higher in Colo 16 cells when compared 
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to HEK and HaCaT cells, where reduced levels were observed.  This agreed with 
studies by Ge et al. (362) who showed that head and neck cancer cell lines and tissues 
contained remarkably higher quantities of TACE activity and TACE protein than seen 
in normal keratinocytes or oral mucosa. These authors suggested that increased TACE 
expression could be biologically and clinically relevant, and could be used as a 
biomarker of cancer prognosis (362).  
TACE has been shown to be synthesized as a zymogen, which is constitutively 
processed in the secretory pathway. Removal of the prodomain occurs after the protein 
exits the medial golgi, but before its arrival on the cell surface (363). TACE possesses 
the putative proprotein-convertase recognition sequence (RVKR) (126, 147), which is 
processed to the catalytically active form by the action of furin (144, 151, 154, 158). In 
order to confirm that furin was involved in cleaving TACE we used Dec RVKR cmk to 
see if furin inhibition has any effect on both TACE expression and activity. This 
inhibitor (Dec RVKR cmk) prevents the proteolytic activity of furin by covalently 
binding at its catalytic site (364). Endres et al. (154) confirmed that PC s are involved 
in prodomain removal of TACE in HEK293 cells.  In this study, Dec RVKR cmk was 
shown to inhibit the conversion of pTACE to mTACE expression in both HaCaT and 
Colo 16 cells (Figure 5.10).  
mTACE levels was expressed as a percentage of the total (mTACE and pTACE) 
observed in untreated un-irradiated (control) cells. The effect of Dec RVKR cmk 
treatment on the level of mTACE found in the irradiated cells can be seen in Table 5.1. 
The effect of Dec RVKR cmk treatment resulted in a 90% drop in mTACE levels in  
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control and UVA-irradiated HaCaT cells, but only a 70% drop in UVB- and                
UVAB-irradiated cells. The difference seen in the irradiated HaCaT cells is related to 
UVB exposure, the reason for which is unclear. However in the Colo 16 cells, it can be 
seen that Dec RVKR cmk treatment caused a 90% reduction in mTACE levels in 
irradiated cells irrespective of the UV type used. This reduction in mTACE levels            
(70-90%) confirms the role furin plays in its processing in these cells. The study was 
similar to reports published by Srour et al. (158) who suggested that the TACE enzyme 
is completely processed in furin-positive cell lines.   
In my study,  results using Dec RVKR cmk confirmed that a furin-like cleavage site is 
located on TACE which agrees with that seen previously (151). In future experiments, 
to determine if PC s cleave TACE (and/or MMPs) at the RVKR recognition site 
directly or act via an intermediate, in vitro cleavage assays like HPLC and/or mass 
spectrometry (MS) analysis can be used (158). This will help to determine the                   
furin-recognition site present between the proregion and the active enzyme sequence. 
As part of future experiments, PDX (365) and ppfurin (227) or siRNA approaches can 
be used to inhibit furin activation of TACE and/or MMPs following UV-irradiation in 
HEK, HaCaT and Colo 16 cell lines. Therefore, inhibition of these biologically active 
molecules (TACE and/or MMPs) should result in the impairment of cancer cell growth, 
survival, and invasion and in turn reduce the release of TNF which should decrease the 
incidence of skin cancer.  
Since CHX inhibits de novo protein synthesis (230, 269), it was added to the cells to 
prevent the synthesis of TACE. UVAB radiation was used as it was shown to induce 
high levels of TNF
 
release in irradiated cells (Figure 5.1). Based on the changes in the  
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level of total TACE in the cell, the approximate half-life was estimated to be ~24 h and 
~46 h in HaCaT and Colo 16 cells, respectively (Figure 5.11). This estimated half-life is 
greater than that of furin and it is present in the cell for a longer period of time. Even 
though only two time points were investigated in this study, the results suggest that 
CHX treatment reduced TACE protein levels in these cells. However, in order to 
determine the half-life of TACE in these cells, further time points would need to be 
investigated. 
As IL-1 has been shown to increase the levels of TNF shed from irradiated 
keratinocytes (Figure 5.1), it was not known whether this is related to increased TACE 
levels in the cell. Therefore changes in the level of TACE protein were quantified 
following exposure to UVR either, in the presence and/or absence of IL-1 . The results 
obtained suggest that IL-1 reduced the levels of pTACE and mTACE in UVA- and                     
UVB-irradiated HEK, HaCaT and Colo 16 cells (Figure 5.12). On the other hand, IL-1 
increased TACE (pTACE and mTACE) levels in UVAB-irradiated HEK and HaCaT 
cells but not in Colo 16 cells. The reason for which is not clear. The effect of IL-1 
treatment on total TACE (pTACE and mTACE) levels in the irradiated cells and the 
ratio of IL-1 treated cultures to that of untreated cultures are shown in Table 5.2. It can 
be seen from the table that the addition of IL-1
 
to the UVA- and UVB-irradiated cells 
(HEK, HaCaT and Colo 16 cells) caused a similar reduction in total TACE levels 
compared to that seen in the treated un-irradiated cells. In most cases this level of 
reduction was between 60-80%. However when IL-1 was added to UVAB-irradiated 
cells there was a significant increase in TACE levels in HEK and HaCaT cells 
compared to that seen to untreated UVAB-irradiated cells. These results  
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suggest that if a person did not apply a sunscreen that there would be an increase in 
TACE levels in the skin which would result in increased levels of TNF being released. 
Support for this can be seen in Figure 5.1 where IL-1
 
maximally increased the level of 
TNF secreted from UVAB-irradiated HEK and HaCaT cells. However if a person used 
a sunscreen before they were exposed to sunlight, the levels of TACE present in the 
epidermis would not be increased and the corresponding levels of TNF released from 
these cells would also be reduced. This concept is supported by the results seen in 
Figure 5.1, the level of TNF released from HEK cells was much lower when the cells 
were exposed to either UVA or UVB when compared to cells exposed to                      
UVAB-radiation.  
Results from Table 5.2 also show that the ratio of total TACE levels in IL-1 treated 
cultures were highest in UVAB-irradiated HEK cells followed by HaCaT cells and Colo 
16 cells.  This result is in line with the level of TNF released from each of these cell 
lines (Figure 5.1). Therefore, these results suggest that maximum TACE and TNF
increase was observed in the primary keratinocytes (HEK), being the normal skin and 
the Colo 16 cell, being the tumour cell has the least expression of TACE. This may in 
turn have a decreased effect on TNF release thereby not stimulating inflammation. 
Previous results (Figure 3.9) showed that the addition of IL-1 had a suppressive effect 
on furin protein expression in all three cell lines. Therefore, results from these two 
studies (Figures 3.9 and 5.12 and Table 5.2) suggest that according to the proposed 
pathway (Figure 1.14), the effect of IL-1 on furin or TACE protein expression does 
not consequently up-regulate TNF levels. Hence, these results suggest that the increase 
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in TNF release in the presence of IL-1 could be either due to transcriptional 
regulation or other factors in the inflammatory cascade (77).  
IL-1 was shown to stimulate the expression of TACE in UVAB-irradiated cells 
(Figure 5.12). The effect CHX had on TACE expression in cells treated with IL-1 was 
investigated. Total TACE (pTACE and mTACE) levels in the presence of CHX and          
IL-1 decreased 14% and 9% in UVAB-irradiated HaCaT and Colo 16 cells, 
respectively compared to cells treated with IL-1
 
alone (Figure 5.13). Therefore, these 
results suggest that IL-1 has no significant effect on the synthesis of TACE protein in 
CHX treated UV-irradiated HaCaT or Colo 16 cells compared to that seen in the 
untreated irradiated cells in the presence of IL-1 .
The UVAB dose used in this study (Figures 5.11 and 5.13) is a combination of the 
respective UVA and UVB components present in one MED of UV light. It would be of 
interest in future to observe the effect higher single UV dose (e.g.  2 MED) has on 
TACE expression and the effect this may have on the release of TNF from the cell. At 
this stage it is not known if higher UV doses increase or decrease TACE expression. 
Since most people would be exposed to a cumulative daily exposure of UVR when they 
are outdoors, the effect multiple doses of  1 MED radiation 24 h apart on TACE 
protein expression and in turn its effects on other downstream events in keratinocyte-
derived cells would also warrant investigation.  It is unknown if multiple exposures to 
low UV doses have on the expression of TACE in irradiated skin cells.   
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5.3.3 TNF
 
and TACE mRNA expression 
Some metalloproteases have been reported to be activated in epidermal cells after UVR 
(342). However, it is unknown whether UV-irradiation regulates TACE expression in 
skin cells. Kawaguchi et al. (139) showed a significant rise in the level of TACE 
mRNA expression in lesional psoriatic skin compared with non-lesional skin. In this 
study, there was an increase (30%) in TACE mRNA levels seen 24 h post-irradiation in 
UVB-irradiated HaCaT cells. In UV-irradiated Colo 16 cells, there was a decrease in 
TACE mRNA levels seen 24 h post-irradiation. In the UVA-, UVB- and                           
UVAB-irradiated cells, TACE mRNA expression fell 66% 39% and 97%, respectively 
compared to the un-irradiated controls.  (Figure 5.14). This result differed to that of 
Skiba et al. (136) who showed that TACE mRNA was induced by UVA-irradiation (8 
kJ/m2).  
UVR has been shown to induce TNF gene expression in human keratinocytes (115). 
Bashir et al. (77) showed that TNF expression and secretion in keratinocytes was 
induced by UVB (0.3 kJ/m2) but not by UVA irradiation and this induction was 
mediated through increased TNF gene transcription (77) (126). Brink et al. (346) and 
Leverkus et al. (347) have shown a rapid and strong induction of TNF mRNA               
post-exposure to UVB (0.15 kJ/m2) in both human skin and SCC12F cells. Clingen et 
al. (366) also showed that irradiation of keratinocytes by UVB induces TNF mRNA 
and protein production. The results from my study showed that maximal TNF mRNA 
levels were induced by UVB-irradiation compared to UVA- and UVAB-irradiation in 
both HaCaT and Colo 16 cells (Figure 5.14). These results suggest that UVB 
significantly induces maximum mRNA expression of TACE and TNF in these cells. 
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UV-irradiation has been reported to induce and activate the transcription factors AP-1 
and NF- B  (367, 368), and the promoter of the TNF
 
gene contains consensus binding 
sites for AP-1 and NF- B (369). Bazzoni et al. (370) suggested that after UV-irradiation 
TNF gene is transcriptionally activated. Recent studies suggest that AP-1 plays a 
critical role in increasing TNF transcription in UVB-irradiated keratinocytes (77, 276). 
AP-1 inhibitor suppresses the expression of TNF- mRNA in endogenous cells (77, 
276) and cells transfected with the TNF- promoter which confirms the mechanism of 
UVB and IL-1 induction of TNF- mRNA is through AP-1-mediated transcriptional 
up-regulation. 
In order to investigate the relationship between TACE, TNF and furin mRNA levels, a 
time course TNF gene induction in response to UVB-irradiation was undertaken in 
HaCaT and Colo 16 cells (Figure 5.15). Distinct time courses for mRNA induction were 
generated for each gene of interest, which provided a valuable insight into the 
expression of these proteases at the molecular level in keratinocytes following exposure 
to UVB-irradiation. Skiba et al. (136) showed that maximum induction of furin mRNA 
in HaCaT cells was detected immediately (0 h) post UVB-irradiation (~5-fold) after 
which the levels subsequently declined. On the contrary, results from my study showed 
that in UVB-irradiated HaCaT cells, furin mRNA levels slowly increased with time to a 
maximal level (90-fold) at 24 h before falling back to 3.3-fold at 32 h (Figure 5.15).  
Skiba et al. (136) showed that in HaCaT cells exposed to 2 kJ/m2 UVB, maximum 
TACE gene expression was observed immediately 0 h post-exposure. In this study, in 
UVB-irradiated HaCaT cells, TACE mRNA expression was relatively constant 
throughout the 24 h time course and was detected in very low amounts. Though the 
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dose of UVB used in my study and the one by Skiba et al. (136) were the same, the 
difference in results may be attributed to two main reasons; the different methods 
(SYBR® Green ERTM qRT-PCR in this study vs TaqManTM RT-PCR in Skiba et al. 
(136)) and/or analysis (Pfaffl correction method in my study vs CT method Skiba et 
al. (136)). TNF gene expression was detected in HaCaT cells 4-24 h post UVB-
irradiation. TNF
 
levels were maximal at 16 h (59-fold) post UVB-irradiation. This was 
similar to results by Skiba et al. (136) who showed that TNF mRNA induction 
appeared to be significantly modulated in a dose-dependent manner at 16 and 24 h post 
UVB-irradiation.  
There are no reports in the literature about the effect of UVR on mRNA expression in 
Colo 16 cells. The results from my study suggest that the expression of the furin gene in 
UVB-irradiated Colo 16 cells was higher than controls with a maximum induction at 12 
h (1.6-fold) (Figure 5.15). The expression of TACE mRNA in UVB-irradiated Colo 16 
cells remained fairly constant throughout the same period. However, TNF mRNA 
levels were rapidly induced being maximal at 8 h (12.1-fold) after which it fell back to 
6.7-fold at 24 h post-irradiation.  This study differed to the one by Leverkus et al. (347) 
who showed that TNF mRNA in the epidermis was rapidly up-regulated after UVB 
(300 J/m2) radiation with maximal induction within 4-12 h post-irradiation and                             
post-transcriptional mechanisms play a major role in UV-induced TNF mRNA 
induction. Therefore, these results suggest that increased mRNA induction of furin, 
TACE or TNF was not associated with increased protein expression. Correlation 
analysis were done in HaCaT (Figure 5.16) and Colo 16 (Figure 5.17) cells in order to 
confirm if mRNA levels of these genes of interest had any association to one another. 
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These results show that in UVB-irradiated HaCaT cells, a weak correlation was 
observed between furin and TACE and TNF mRNA but no correlation was observed 
between furin and TNF .  In the UVB-irradiated Colo16 cells, a weak correlation was 
observed between furin and TNF and TACE and TNF mRNA but no correlation was 
observed between furin and TACE mRNA. In future studies, DNA gene microarrays 
can be used to verify the mRNA induction of furin, TACE and TNF to                       
 
UVB-irradiation in a time course experiment (0-32 h). This dose needs to be chosen as 
it induced highest mRNA induction in a time course experiment (Figure 5.15).  
There is evidence that TNF and IL-1 can induce the expression of TNF mRNA in 
keratinocytes (371). IL-1 further augments TNF transcription through mechanisms 
independent of AP-1(77, 276). The effect of IL-1 on the mRNA expression was 
investigated post UVAB-irradiation in this study (Figure 5.18). For this purpose, the 
UVAB dose was chosen as it synergistically increases TNF release (Figure 5.1).  A 
time course gene induction of furin, TACE and TNF mRNA levels in response to 
UVAB in the presence of IL-1 was undertaken (Figure 5.18). In HaCaT cells, furin 
mRNA reached a maximum at 16 h (5.3-fold) after which it fell at 24 h. The expression 
of the TACE gene in these cells was reduced throughout the 24 h period following 
exposure to UVAB in the presence of IL-1 . TNF mRNA levels increased following 
exposure reaching maximal levels between 4 and 8 h before falling back at 24 h. In 
Colo 16 cells, mRNA expression of furin fell following UV exposure and remained low 
over the 24 h period (Figure 5.16 ii). A similar result was also seen for TACE mRNA in 
these irradiated cells. The expression of TNF mRNA rose immediately following 
irradiation reaching a maximum at 4 h before it fell back to control levels by 24 h.  
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The result seen above differs to studies by Imaizumi et al. (372) who showed that in 
human unbilical vein endothelial cells (HUVEC), stimulated with IL-1 , expression of 
TNF
 
mRNA reached maximal levels 8 h after stimulation and decreased between 16 to 
24 h. Though this study has been used as a comparison, it should be noted that HUVEC 
was not exposed to UVR and the significance of the results from my study is the effect 
of IL-1 on TNF mRNA in UV-irradiated skin cells.  Therefore, these results show 
that addition of IL-1 induces TNF mRNA expression from UVAB-irradiated HaCaT 
and Colo 16 cells. However, the time course of furin, TACE and TNF mRNA 
induction in UVAB-irradiated cells in the presence of  IL-1 does not appear to be 
related and no direct association was evident between the time course of TACE and 
furin mRNA induction. These results show that while effect of IL-1 up-regulates 
TNF mRNA induction, it has no effect on the induction of furin and/or TACE mRNA. 
Therefore, while induction of TNF mRNA is due to the effect of IL-1 , increase in the 
release of TNF protein is not due to the increased effect of IL-1 on furin (Section 
3.2.2.2.1) or TACE (Section 5.2.2.4) as discussed earlier. In conclusion the key finding 
from this study was that the effects of IL-1 were on TNF and not on furin and TACE.
 
5.3.4 Conclusion  
5.3.4.1 Effect of UVR on furin activation of TACE 
In conclusion, results from this study highlights on some key areas of interest. If IL-1 
is added to UV-irradiated cells there is an increase in TNF release and TNF mRNA
induction which suggests that many of the immediate biological responses to excessive 
sun exposure could be mediated by this cytokine. Together with IL-1 , TNF was one 
of the first cytokines found to be up-regulated in the skin following UV irradiation (236, 
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359). It was subsequently discovered that keratinocytes and mast cells were the sources 
of TNF
 
(115, 373). Once expressed, TNF has a myriad of different effects on a 
variety of cell types. It increases MHC class I expression on endothelial cells and 
dermal fibroblasts (374); induces the production of IL-1 (375); increases the 
expression of adhesion molecules, including ICAM-1, VCAM-1 and E-selectin (376); 
and it promotes formation of sunburn cells (89). By up-regulating adhesion molecules 
on endothelial cells, TNF helps support the migration of neutrophils and macrophages 
to UV-exposed skin. Thus, if their local inflammatory milieu changes, they can become 
more pathogenic, capable of participating in an autoreactive immune response. 
Therefore, the role of TNF in inflammation and immunologic reaction have been 
shown to be either beneficial protective or pathologic, depending on target cells, and 
magnitude of the inflammatory reaction (107).   
It seems likely that the large increase in TNF secretion after UVAB-irradiation results 
from changes at various levels, including mRNA transcript stabilization and enhanced 
release of mature protein from the cell surface. Because UVR is also known to induce 
keratinocyte apoptosis, perhaps through autocrine stimulation (89), it would be 
interesting to observe if TNF mRNA is preferentially  up-regulated in pre-apoptotic 
cells. The addition of IL-1 did not increase either TACE protein or mRNA expression 
which suggests that it does not exert its effects on this enzyme. Dec RVKR cmk inhibits 
TNF release in vitro and may have potential to be used in reducing tumour metastasis 
in vivo. Bassi et al. (268) showed that inhibition of furin activity by Dec RVKR cmk 
caused a significant decrease in both substrate processing and in vitro invasiveness. Dec 
RVKR cmk inhibited release of TNF because it has been shown to inhibit TACE 
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processing and activation. This study suggests that furin is a key factor in the 
maturation of TACE and in the conversion of pTACE to mTACE. Therefore, inhibition 
of furin reduced TACE activation which in turn decreases release of TNF . This study 
also confirmed that TACE is the main enzyme involved in the processing of TNF
 
and 
MMPs may also play a part. Therefore, future development of specific furin inhibitors 
or siRNA techniques targeting furin and/or TACE would find use in not only reducing 
the inflammatory effect seen in UV-irradiated skin cells but also that of SCC being able 
to metastasise and spread to other sites in the body.   
5.3.4.2 Comparing cell types 
The three keratinocyte cell lines (HEK, HaCaT and Colo 16) respond differently when 
exposed to UVR. Based on previous findings (228, 229), we used HaCaT cells as a 
model cell to study the effects of UV-irradiation in keratinocytes. However, results from 
this study show that there are differences between the effect of UV types and doses on 
cell function in the keratinocyte-derived cell lines examined in this study (Table 5.3). 
These are described below.  
5.3.4.2.1 HEK vs HaCaT and Colo 16 cells  
TNF release was highest in UV-irradiated HEK cells in the presence of IL-1
compared to that of HaCaT cells.  On the other hand, expression of TACE levels was 
the lowest in these cells unlike that seen in HaCaT cells where moderate levels were 
observed. There is a possibility of the HaCaT cells being a precancerous cell and the 
difference in TACE and TNF levels could have occurred as part of the immortalization  
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of these cells. While comparisons have been made based on these two studies, results 
obtained suggest that these immortalized cell lines may not be a suitable model for 
studying HEK cells which are primary keratinocytes.  
Comparing HEK to Colo 16 cells, opposite effects were observed. While little TNF
 
was shed from the Colo 16 cells, maximal levels of TACE expression were observed in 
these cells. When the level of TACE in sham-irradiated (control) cell lines were 
compared (results not shown), it can be seen that Colo 16 cells expressed the highest 
amounts followed by HaCaT cells with HEK having the lowest levels. TACE is a 
protease over-expressed in tumours and is implicated in carcinogenesis and tumour 
growth. This could be the reason why highest TACE levels were observed in the SCC 
(Colo 16 cells) (Figure 5.8). This indicates that TACE could be a potentially important 
cancer biomarker (362). Future studies on TACE activity in a range of cancer cell lines 
(HNSCC) and comparing them to HEK cells might help understand the biology and 
expression of this protein.   
5.3.4.2.2 HaCaT vs Colo 16 cells 
While TNF levels were moderate in UV-irradiated HaCaT cells in the presence of           
IL-1 , minimal amounts of this cytokine was released from UV-irradiated Colo 16 
cells.  The mechanisms by which IL-1 induces TNF release from HaCaT and Colo 16 
cells in the presence of various inhibitors (CHX, 1, 10 phe and Dec RVKR cmk) were 
similar. While MMPI gradually inhibited the release of TNF over a period of 24 h in 
HaCaT cells, in Colo 16 cells, 50% of TNF release was inhibited after 7.8 h. In HaCaT 
and Colo 16 cells, furin played an important role in the processing and activation of 
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mTACE and exposure to UV-irradiation had no effect on this process. On the addition 
of CHX, TACE was not rapidly turned over in these cells and it did not have a 
significant effect on the ratio of pTACE to mTACE in the cell, under the conditions 
examined. IL-1
 
had no significant effect on the synthesis of TACE protein in CHX 
treated UVAB-irradiated HaCaT or Colo 16 cells compared to that seen in the untreated 
irradiated cells in the presence of IL-1 . While TACE mRNA levels were low 
throughout the time period tested in both these cell lines, TNF mRNA was maximal at 
16 h in HaCaT cells and 8 h in Colo 16 cells.    
Based on the studies done, results suggest that the behavior of HaCaT cells in response 
to UVR under different treatments and conditions is similar to that of Colo 16 cells. 
This could be because the HaCaT cells possess a mutated form of  p53 and it is known 
that constant repeated UV exposure does reduce p53 levels in epidermal keratinocytes 
(377) which may act as a trigger for these cells to become carcinogenic in situ. 
Disturbance to the cells due to the effects of UVR could lead to malfunction of the cell, 
disruption of homeostasis, altered gene expression, regulation of cytokines and loss of 
cell cycle control, all of which can cause the cell to become carcinogenic (29). On the 
other hand, the profile of Colo16 cells reflects the carcinogenic nature of these cells. In 
Colo 16 cells maximum mTACE expression was seen which may result in enhanced 
downstream effects by having higher levels of protease activity in the cell. These cells 
secrete a broad spectrum of cytokines (378). It is unknown if p53 in these cells are 
functional. The cancerous nature of these cells probably arises from a possible cross talk 
of different cytokines, a wide array of chemical reactions and signalling interactions of 
the cells in response to sun exposure.  
Conclusions and future directions  
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6 Conclusion 
It is well recognized that exposure to high doses of UVR causes physical, cellular and 
molecular damage, resulting in erythema, immunosuppression and carcinogenesis, 
among other biological aberrations (42, 379, 380).   
6.1 Furin 
This study focused on the effect of UVR on furin expression and/or activity and its 
subsequent activation on MMPs and TACE. Furin is a PC which is known to process 
many metalloproteases, including MMPs and TACE, which in turn, when activated, 
process a wide range of biological molecules crucial for cell function and growth (151, 
169, 266, 267).   
6.1.1 Effects of UVR  
Results from this study suggest that UVR up-regulates furin mRNA and protein 
expression in these keratinocyte-derived cells. The levels of furin protein and mRNA 
were much higher in HaCaT cells than in Colo 16 cells which suggest that following 
exposure to UVB-irradiation (24 h post exposure), increased furin protein levels may be 
a result of its increased mRNA levels. Colo 16 cells harbor furin protein for much longer 
than HaCaT cells, which may contribute to their increasing metastatic potential (174). 
This is because one of the proteases furin processes, MMP, is known to cleave the ECM, 
allowing for metastasis to occur (265).  Of interest is that this, if occurring under in vivo 
conditions, may contribute to the metastasis of SCC in a skin cancer patient. Expression 
of PCs correlates with rapid growth, invasiveness, or metastatic potential of malignant 
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cell lines (268, 293, 381-383). These correlative studies provided evidence indicating a 
paramount role for PCs in cancer development and progression. Studies using furin 
inhibitors have been shown to inhibit the growth of tumour cell lines in vitro (168, 227)  
and as such may have the potential to be used as anti-tumour agents.   
6.1.2 Furin activation of MMPs 
In this thesis, higher levels of furin activity were observed in Colo 16 cells than in 
HaCaT cells. This agrees with that seen in other studies, where furin levels were higher 
in tumour cells compared with their non-tumorous counterparts (144, 227). Increased 
furin expression is associated with enhancement of metastatic spread due to elevated 
expression and activation of MMPs. The specific furin inhibitor Dec RVKR cmk was 
used in this study in order to determine the role of furin in the expression and activity of 
MMPs. From the results obtained, it was evident that furin plays a key role in the 
maturation of MMPs in these keratinocyte-derived cell lines.   
6.1.3 Furin activation of TACE 
This study confirmed that the changes in TACE activity are due to the conversion of 
pTACE to mTACE mediated by furin. An elevation in TACE activity would see an 
increase in TNF being released from the cells. TACE was shown to be the main 
enzyme involved in the release of TNF from these keratinocyte-derived cells but 
MMPs may also be involved. Once TACE is activated it can cleave a number of 
important molecules such as TNF , TNFRI, TNFRII and TGF
 
(125). Thus, the 
development of specific furin inhibitors would find use in not only reducing the 
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inflammatory effect seen in UV-irradiated skin cells but also that of SCC being able to 
metastasise and spread to other sites in the body. This may in turn help to reduce the 
incidence of skin cancer among the general population. 
Therefore, from the results obtained from this study, a model on the role furin plays in 
the UV-irradiated keratinocyte cells is shown in Figure 6.1. It highlights the role furin 
plays in the activation of MMPs and TACE in skin cells. In this model furin cleaves and 
activates TACE, which in turn can process TNF
 
from its preproform.  Keratinocytes 
secrete TNF following exposure to UVB radiation, and this is enhanced if IL-1 is 
present (Figure 5.1) (77).  Furin also cleaves MMPs from their respective proforms 
(Figure 4.17), and the expression and activity of these proteases are elevated when the 
cells have been exposed to UVB radiation, and they are enhanced if either IL-1
 
(MMP-9) or TNF (MMP-2) is present.    
6.2 Keratinocyte-derived cells 
In order to understand the effects of UVR on different keratinocyte-derived cell lines, 
HEK (primary keratinocytes), HaCaT cells (immortalized keratinocytes) and Colo 16 
cells (squamous cell carcinoma-SCC) were examined. Results from this study show that 
there are differences between the effect of UV types and doses on cell function on these 
different keratinocyte-derived cell lines. The differences in the profile of these cells have 
been summarized at the end of the discussion section in Chapters 3, 4 and 5.  
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Figure 6.1 The role furin plays in the maturation of TACE and MMPs in skin cells. The 
effect of UVR on the expression of the enzymes and mTNF in the cell is 
represented by dashed lines, if it is enhanced it is represented by (+). The 
role of IL-1 on MMPs and TNF is represented by a blue line, if it is 
enhanced it is represented by (+). The role of IL-1 on TACE in                    
UVAB-irradiated keratinocytes is represented by a blue line, if it is 
enhanced it is represented by (+).    
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Previous studies comparing the effect of treatments between HaCaT and primary 
keratinocyte cultures, and HaCaT and human keratinocytes in vivo, reported that the 
results were comparable and a good correlation existed between the two cell lines (228, 
229). Therefore, based on such findings, we chose to use HaCaT cells as a model to 
study the effects of UV-irradiation in keratinocytes. Some studies could not be 
completed due to the unavailability of the primary keratinocytes (HEK). The response of 
HaCaT cells to UVR differs to that of HEK which suggest that these immortalized cell 
lines may not be a suitable model to study primary keratinocytes. This finding is 
supported by studies by Muthusamy (RMIT PhD Thesis, 2010) who showed that there 
were significant differences in UV-induced signalling pathways in the HEK and HaCaT 
cells.  Therefore, in light of these and Muthusamy s findings the use of HaCaT cells as a 
model for primary keratinocytes is not recommended. On the other hand, Colo 16 cells 
were chosen to investigate what effect tumorigenesis has on the cellular response to UV 
exposure in keratinocytes. Colo16 exhibits a different profile to that of HEK cells and 
shares many similarities to that of HaCaT cells. This finding suggests that maybe 
HaCaT cells should be considered to be like a precancerous solar keratosis cell line, as it 
more closely reflects that of a SCC than it does a primary noncancerous cell line.   
6.3 Future directions 
The results from this study assist our understanding about the effect UVR has on the 
expression and activity of furin and of the enzymes that it cleaves and activates: MMPs 
and TACE. These results highlight differences between the effect the different UV types 
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and doses have on cellular function of the keratinocyte-derived cell lines examined in 
this study.   
6.3.1 Effect of UVR on furin 
In the experiments performed in this study, a UV cabinet that housed 6 UV fluorescent 
lamps (Section 2.3.3) was used. Poon et al. (141) used an Oriel 1000 W solar stimulator 
equipped with twin 240-400 nm dichroic mirrors and an atmospheric attenuation filter to 
produce an ssUV spectrum. These spectra are compared with standard sunlight as 
defined by COLIPA (1994). Therefore, as part of our future studies, experiments should 
be repeated using a solar stimulator (e.g. Vilber Lourmat solar stimulator) so the effect 
of sunlight (ssUV) on the cells can be examined.  
In this study, the UVA dose (40 kJ/m2) and UVB dose (2 kJ/m2) used represented the 
respective UVA and UVB components found in one minimal erythemal dose (MED) 
(224). The UVAB dose used in this study was a combination of the respective UVA and 
UVB doses. These doses (Section 2.3.4 and Table 2.1) were chosen because they 
represent the dose of sunlight most people would be exposed to in a single exposure 
period when they are outdoors (174).  
Huynh et al. (174) used low doses UVA (2 kJ/m2) and/or UVB (0.2 kJ/m2) radiation to 
study furin expression on cultured HaCaT and Colo 16 cells. These results suggested 
that low doses did not have any effect on cell viability but furin expression appeared to 
be biphasic following irradiation. Skiba et al. (136) also used low dose UVA (2 kJ/m2) 
and/or low dose UVB (0.2 k J/m2) in order to study effects of UV on mRNA expression 
on a variety of genes in HaCaT cells. Therefore, in future studies, it would be interesting 
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to observe if a single or multiple exposure to low dose UV would also modulate the 
expression and activity of furin and its subsequent downstream activation of MMPs and 
TACE if the experiment was conducted over a larger time period (48-72 h). This would 
help determine the smaller doses over a longer time period will have the same effect on 
protease activity when compared to that observed when the cells were exposed to a 
single high dose as used in this study.   
6.3.2 Cell culturing 
Most of the experiments used in this study have been performed using immortalized 
keratinocyte (HaCaT) and SCC (Colo16) cells. All the experiments performed in this 
thesis should be repeated using HEK cells. We have made used of a conventional 
monolayer (2-dimensional) cell culture system for culturing HEK cells. A better in vitro 
model that mimics an in vivo environment can be made use of in future. NanoCulture 
Plate (NCP) is a novel experimental system developed for the three-dimensional cell 
culture (384, 385). These NCP cell culture systems have been ideal for 3D culturing of 
tumour cells as well as primary cells (384, 385). Therefore, it may be more appropriate 
to use these commercially purchased 3D cell culture systems for culturing primary 
keratinocytes if possible in future. It would also be worthwhile performing co-culture 
experiments (keratinocyte-fibroblast) (386) or using skin explants or reconstructed skin 
models (387) to observe the effect UVR has on the interaction between these skin cells.  
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6.3.3 Cell viability 
Although cell viability determination using trypan blue exclusion is a relatively easy, 
fast and cost-efficient method, there are limitations to this method. Trypan blue stains 
dead cells blue as these cells lose their membrane integrity. However, this does not help 
differentiate between apoptotic and necrotic cells. The trypan blue dye is cytotoxic and 
can cause cell death if there is a delay in performing viability counts. Similarly, cells in 
early stage of apoptosis are not stained blue as the plasma membrane is still intact (260). 
Therefore, this can give rise to inaccurate results. As part of future experiments, cell 
survival rates can be determined using methods such as MTS assay or flow cytometry. 
The staining methods which could be used in flow cytometry include acridine orange 
and EtBr or Hoechst 33342 and propidium iodide (260, 262). These methods might help 
differentiate and quantify the number of viable, apoptotic, late-stage apoptotic and 
necrotic cells in treated cell population respectively, by cell sorting and ultrastructural 
examination of electron micrographs (260). Therefore, the identity of each distinct 
fluorescent population (whether live, apoptotic, or necrotic) can be determined by 
sorting and examination of cellular morphology by electron microscopy. Further, it may 
also be possible to collect viable, apoptotic and necrotic cell populations using flow 
cytometry and use these in experiments to observe if there are changes in the levels of 
enzyme activity in these different cell populations.   
6.3.4 Furin expression and activity 
Furin and other PC family members process inactive precursor proteins to their 
functional or mature form. These molecules include members of the ADAM family, 
growth receptors, growth factors, hormones, plasma proteins, MMPs and ECM 
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components (144, 146, 156, 167). Furin mediates a wide range of processing events, 
which, in pathological situations, may exacerbate  disease states such as tumours (168). 
In this study, I looked at the effect UVR had on furin expression and its subsequent 
activation of TACE and MMPs.  
Western blots were used to investigate the expression of proteins of interest (furin, 
MMP-2 and -9 and TACE) in irradiated keratinocyte-derived cell lines. In future, 
confocal fluorescent microscopy can be used to ascertain the distribution and 
localization of furin in the irradiated skin cells. Furin staining was detected by 
immunofluorescent localization within the epidermis by Pearton et al. (156) on tissue 
sections. The antibody to the cytoplasmic domain (c-fur) showed strong staining in the 
basal and granular layers with less staining in the spinous layers. The same can be 
repeated in cell culture monolayers for TACE and MMPs using appropriately labelled 
antibodies. Schlöndorff et al. (363) performed confocal immunofluorescence to define 
the steady state localization of TACE in COS-7 cells using antibodies raised against the 
extracellular domains of TACE and found that majority of TACE was localized in a 
perinuclear compartment, with some diffuse localization consistent with surface and ER 
staining. Onoue et al. showed detection of MMP-9 in primary human keratinocytes 
culture was induced by 3 kJ/m2 UVB-irradiation using immnufluorescence. Flow 
cytometry can also be used to observe if membrane localization takes place in the cell. 
In future, furin activity can be determined by using the fluorogenic substrate (Pyr-Arg-
Thr-Lys-Arg-AMC) and measuring the fluorescene of AMC released at 370 and 450 nm 
(171). In order to investigate the effect of various treatments on the activity of furin in 
processing various biological substrates (TACE and/or MMP and other growth factors), 
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the fluorogenic tetrapeptide boc-Arg-Val-Arg-Arg-MCA (Boc-RVRR-MCA) could also 
be used (283-286). These experiments will confirm if changes in activity in the 
irradiated cells are due to changes in furin levels or its kinetic parameters (Km and Vmax). 
Proprotein convertases such as furin are expressed in many human tumour cell lines and 
primary tumours (173). Therefore, in order to expand on our current study, it would be 
ideal to do a comparison of furin, MMP and TACE levels in HEK cells and various 
other SCC cell lines (e.g. HNSCC, CHO, HT1080 cell lines) to see if the levels of these 
proteins correlate to the metastatic nature of these cells.  Furin has been detected in 
melanocytes (156) but the effect UVR has on its activity and/or expression and that of 
the proteases it activates in human melanocyte cell lines is unknown. Therefore, similar 
studies can be repeated on melanocytic cell lines like malignant melanoma (MM96L) or 
primary melanocytes and results from this study would give us an improved 
understanding of the activation of these proteases and their downstream effects and how 
these may differ as a result of tumorigenesis. Further, CHX can be used to determine the 
half-life period of furin, MMP and TACE in these cells lines (HEK, HNSCC and/or 
melanocytes) such that the turn over time of these proteins can be established. This 
would give us an idea about the turnover time of these proteases in the different cell 
lines. Further experiments also can be performed to determine if increased cellular 
expression of furin subsequently activates MMPs and TACE in these cell lines.   
6.3.5 MMP activity and expression 
Previous studies have reported differences in the effect of UVR on MMP activity on 
fibroblasts compared to that seen on keratinocytes (179, 209, 217). Interactions between 
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epidermal-dermal cells via soluble factors provide important signals in regulating the  
re-epithelialization of wounded skin (388, 389). Witte et al. (388) performed 
keratinocyte-fibroblasts co-culture experiments in order to understand substrates and 
culture conditions. In keeping with this finding, as part of future studies, performing           
co-culture experiments with fibroblasts and keratinocytes a might provide a better 
answer regarding the differences in the effect of UVR on MMP activity and/or 
expression and how these changes relate to that of furin in irradiated skin cells. This 
would also help understand the interaction between the cells and the molecules they 
release and the effect this may have with respect to skin cancer or other skin 
inflammatory conditions.   
6.3.6 Inhibitor studies 
Different inhibitors including Dec RVKR cmk (furin convertase inhibitor), 1, 10 
phenanthroline (1, 10 phe) (metalloprotease inhibitor), cycloheximide (CHX) (protein 
synthesis inhibitor) and 2R-2-[(4-Biphenylsulfonyl) amino]-3-phenylpropionic acid 
(MMPI) inhibitor have been used in some experiments in this study. Dasgupta et al. 
(113) in their review discussed about the development and designs of many potent and 
selective novel TACE inhibitors. These include succinate-based dual TACE and MMP 
inhibitors, macrocyclic inhibitors, hydroxamic acid GW 9471 (219), -Lactam 
hydroxamates (151), -Benzamido TACE inhibitors, PKF-242-484 (390) and                  
PKF-241-466 (391). Therefore, some of these TACE inhibitors could be used in future 
to inhibit TACE and/or MMPs. In order to achieve inhibition of protein/mRNA 
expression of target genes (furin, MMP-2 and-9 and TACE), Small interfering RNA 
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(siRNA) could be used. Tellier et al. (171) used siRNAs strategies targeting furin,  
MT1-MMP and MMP-2 which resulted in inhibition of the activation of their proposed 
signalling pathway. Such studies could be done using keratinocyte cell lines to confirm 
the role these proteins play in the cell.  
Previous studies have reported the 1anti-trypsin portland ( 1PDX) and PC prosegments 
to be relevant PC inhibitors (173, 227, 392). 1PDX has been shown to inhibit the 
processing of many proteins in the cell such as TGF (393), IGF 1R (383), VEGF-C 
(394) as well as the maturation of the surface glycoproteins of infectious pathogens 
among others (365). Bassi et al. (173) demonstrated that overexpressing 1PDX in 
different SCC cell lines effectively reduced the processing of MMP-2 and significantly 
reduced invasiveness and in vivo tumorigenecity.  
Although 1PDX demonstrated to be an exteremely efficient furin inhibitor, PC s own 
propeptides or prosegments (ppfurin) are the only naturally known PC inhibitors (227). 
Previous in vitro studies have demonstrated that PC prosegments can inhibit 
intracellularly the processing of some growth factors and growth factor receptors 
directly involved in cancer development (395, 396). Therefore, as part of future 
experiments, PDX and ppfurin can be used to inhibit furin activation of MMPs and 
TACE following UV-irradiation in these keratinocyte-derived cell lines. The results 
obtained from this study can then be compared to the results obtained in this study using 
Dec RVKR cmk. This would help determine the specificity of these different furin 
inhibitors and understand the similarities and/or differences in the way TACE and 
MMPs are activated in these cells. Also, targeting furin could be a potential additional 
modality for cancer therapy.  
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6.3.7 Cell migration studies  
The in vitro scratch assay used in this study both in the presence and absence of 
inhibitors was a straightforward, easy, well-developed  and economical method to study 
cell migration in vitro (310). The limitations of the in vitro scratch assay are that it takes 
a relatively longer time to perform than some other methods. Two to three days are 
needed for the formation of cell monolayer and then up to 48 h for cell migration to 
close the scratch. Last, relatively large amount of cells and chemicals will be required 
for the assay as it is usually performed in a tissue culture dish. Maquoi et al. (175) tested 
the potential influence of the furin inhibitor (Dec RVKR cmk) on HT1080 cell invasion 
and migration using cell culture inserts. In the  chemoinvasion assays, type IV           
collagen-coated membranes were used whereas uncoated membranes were employed for 
chemotaxis assays. Lapierre et al. (392) determined cell migration of MDA-MB-231 
breast cancer cells using 24-well microchemotaxis chamber alone or precoated with 
collagen type IV. Another way to expand on this study performed on this thesis would 
be to use one of the above mentioned methods for chemotaxis or a Boyden chamber 
assay, as no chemical gradient is established.   
6.3.8 TACE activity  
Proinflammatory molecules have been shown to have important roles in the 
pathogenesis of skin cancer, as determined from clinical or experimental animal studies, 
and the activity or quantities of many of these are affected by UVR (35, 67).  It is known 
that inflammatory mediators such as IL-1 , TNF
 
and IL-6 are involved in melanoma 
formation (71).  It is not known if TNF can regulate its expression in the UV-irradiated 
cells via an autocrine mechanism and if other cytokines are directly or indirectly 
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involved in this process. Imaizumi et al. (372) suggested that sTNF
 
may be involved in 
autocrine activation of endothelial cells, and TNF retained in cell membrane may serve 
as a juxtacrine system to activate target cells on the endothelial surface. In order to 
confirm if the increase in TNF release is due to increased TACE levels in the cell or 
changes in its kinetic parameters (Km and Vmax), the flurogenic substrate                        
MCA-PLAQAV-DPA-rSSSR-NH2 could be used to determine this information 
following  UV-irradiation of the cells (397). TACE activity will be distinguished from 
that of the matrix metalloproteases through the use of inhibitors such as TIMP-1, -2 and 
-3 (398).  TIMP-3 at concentrations of 1 M have been shown to inhibit >90% TACE 
activity (398) and can be used in similar designed experiments in this study. TAPI-1 
(399) and -2 (400) and Batimastat (also known as BB-94) (401) can be used in future 
studies to differentiate TACE and MMP activity. The effect of UVA and/or UVB on the 
expression of TACE on the cell surface will be quantified by flow cytometry using 
TACE antibodies.    
6.3.9 TNF expression 
The effect of UVR and that of TNF on gene expression in the skin cells can also be 
observed using microarray analysis. DNA microarrays are a powerful tool for studying 
the molecular basis of interactions on a large scale. It has been shown previously that 
UVB irradiation of HaCaT cells induced genes involved in cell survival and cell cycle 
progression  (402).  However, no information on the change in cytokine gene expression 
was obtained due to the absence of these genes on the array chip (402).  In order to 
evaluate the role TNF may play in gene expression, irradiated cells can also be treated 
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with TACE inhibitors, and/or neutralising TNF
 
antibodies.  Appropriate matched 
controls can also be used in this study.  TNF can be added to the cells to observe its 
effect on gene expression.  The results of these studies should indicate to what extent 
does TNF modulate gene expression in UV-irradiated cells, and it is possible that it 
plays no role in this process, or has a delayed effect.  It is not possible to undertake this 
comparison if only a single time point is used. Therefore, a time course experiment             
(0-24 h) will need to be performed to observe changes in the global expression of genes 
in the cell. 
In our study, qRT-PCR was used to determine gene expression. It was a highly sensitive 
and reproducible method which was used to analyse mRNA levels of proteases and 
TNF in these keratinocyte-derived cell lines following exposure to UV-irradiation.  
This study can be repeated using cultures of skin cells and the results can be used to 
quantify the results obtained from the cDNA microarray study outlined above.  This 
study should help clarify the roles UV and TNF play in cytokine gene expression seen 
in skin cells following UV irradiation.  
6.4 Summary 
Therefore, future studies could give us a better understanding of the effects of UVR on 
these proteases and in elucidating their downstream effects. PCs may also serve as a 
useful marker for cancer as well as a molecular target for cancer therapy (227). 
Therefore the results from future studies may lead to the development of specific PC or 
metalloprotease inhibitors capable of reducing TNF release from UV-irradiated skin 
cells. This may in turn lead to a decrease in UV-induced immunosuppression and in due 
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course a reduction in incidence of skin cancer. Future efforts in understanding the 
mechanisms underlying UV-induced immunosuppression may lead to potential 
therapeutic targets to reduce TNF
 
release.       
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A. Appendix 
A.1 Appendix 1 - Inhibitor solutions 
A.1.1 Furin (Dec RVKR cmk) inhibitor 
Amount supplied by the manufacturer = 1 mg 
Stock solution = 1 mg/ml = 1 mM solution (dissolved in 1 ml of sterilized H2O) 
Required working concentration = 100 µM  
1/10 dilution of 1 mM = 100 µM (0.1 mM) 
Therefore, add 100 µl of the stock solution to 900 µl of media to have final 
concentration of 0.1 mM.  
A.1.2 1, 10 phenanthroline (1, 10 phe) inhibitor 
Molecular weight: 198.2 g 
198.2 g/l = 1 M solution 
Stock solution = 0.01982 g/10 ml = 10 mM solution (filter using 0.22 µm filter) 
Required working concentration (1/100 dilution of 10 mM) = 100 µM (0.1 mM) 
Therefore, add 10 µl of the stock solution to 990 µl of media to have final concentration 
of 0.1 mM.  
A.1.3 Cycloheximide (CHX) inhibitor  
Molecular weight = 281.39 g 
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Stock solution = 10 mg/10 ml (filter using 0.22 µm filter) 
Required working concentration = 10 µg/ml (1/100 dilution factor) 
Therefore, add 10 µl of the stock solution to 990 µl of media to have final concentration 
of 0.01 µg/ml.  
A.1.4 MMP inhibitor (MMPI) 
Stock solution = 5 mM (5 mg dissolved in 2.67 ml DMSO) 
Required working concentration needs to be in a range of 10 to 50 fold that of its half 
maximal inhibitory concentration (IC50) value (5 µM).  
MMP-2 = IC50 value is 310 nM 
MMP-9 = IC50 value is 240 nM 
Working concentration can be prepared using a two step dilution as shown below: 
1 ml of stock into 9 ml of media (1:10) 
0.1 ml of the above solution into 9.9 ml of media (1:1000) to have a final concentration 
of 5 µM.       
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A.2 Appendix 2 - Output of UV lamps 
The UV detector measured the output of the lamps in mW. The example below shows 
the calculations used to determine the exposure times to achieve the specific UV doses.  
Example:  
UV output of UVB lamp = 5.68 mW/cm2 
UVB dose required = 2 KJ/m2  
Calculation: 
5.68 mW/ cm2 = 0.00568 W/cm2 
0.00568 W/cm2 = 56.8 W/m2 (Note 1 W = 1 J/s) 
Therefore, 56.8 W/m2 = 56.8 J/s/m2  
Therefore, 1 sec of UVB exposure gives a dose of 56.8 J/m2 
For 2 kJ/m2 of UVB dose the exposure time is, 
2 kJ/m2 = 2000 J/m2 
2000 J/m2 / 56.8 J/s/m2 = 35.2 s  35 s      
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A.3 Appendix 3 - Cell viability 
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A.4 Appendix 4 - Cell scratch analysis 
An average of the reading of 3 separate experiments was calculated with a ruler as 
shown in Figure A.1.   
    Figure A.1 Time course of recovery of cell scratch experiment in Colo 16 cells.  
Sample calculation:  
Distance between the scratch in control sample at 48 h = 2.1 mm (Average of 3 readings)    
Distance between the scratch in UVB sample at 48 h = 1.9 mm (Average of 3 readings)                 
Therefore, distance cells migrated (mm) post UVB-irradiation against controls is           
0.2 mm (2.1 mm -1.9 mm).          
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A.5 Appendix 5 - RNA quantification 
An absorbance of 1 unit at 260 nm corresponds to 40 µg RNA.  
Volume of RNA sample = 200 µl and has been diluted 70x. 
It has an absorbance reading of 0.8523.  
Then, concentration of RNA in the sample = 40 x A260 x dilution factor 
                                                                       = 40 x 0.8523 x 70 
                                                                       = 2386.44 µg/ml                  
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A.6 Appendix 6 - Reconstitution of the primers 
From the attached Certificate of Analysis (GeneWorks, Adelaide, Australia), the number 
of moles for each primer is supplied. These primers were reconstituted in nuclease-free 
H2O to make a 100 µM stock solution.  
Add (number of nmoles* x 10) µl of nuclease-free H2O as shown in Table A.1 and 
dissolve. 
To convert µg to µmoles: µmoles primers = µg primers/MW primers  
Example:  
10 µl of the stock + 190 µl of nuclease-free H2O = 200 µl (working solution) 
Freeze stock and working samples at -20oC       
                           Table A.1 Reconstitution of primers.   
Primers nmoles* Volume of H2O to 
be added (µl)*  
actin forward 25.8 x 10  258  
actin reverse 38.2 x 10 382 
Furin forward 51.4 x 10 514 
Furin reverse 38.4 x 10 384 
TACE forward 38.2 x 10 382
TACE reverse 40.2 x 10 402 
MMP-2 forward 54.5 x 10 545 
MMP-2 reverse 32.3 x 10 323 
MMP-9 forward 34.3 x 10 343 
MMP-9 reverse 32.2 x 10 322 
TNF forward 45.6 x 10 456 
TNF reverse 58.4 x 10 584 
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A.7 Appendix 7 - Amplification efficiency (E) 
Preparation of samples: 
10 µl cDNA sample each from sham, UVA, UVB, UVAB-irradiated cell cultures was 
pooled into a microfuge tube to give a final volume of 40 µl 
This tube contains 50 ng/µl pooled cDNA = 1/4 dilution in nuclease free H2O  12.5 ng 
In order to measure amplification efficiency of target genes (Furin, TACE, MMP-2, 
MMP-9 and TNF ) and reference gene ( actin) 5 point serial dilutions is required as 
follows: 
1st tube: 40 µl of pooled cDNA + 120 µl of nuclease free H2O = 160 µl  12.5 ng 
2nd tube: 16 µl from the 1st tube + 144 µl of nuclease free H2O = 1.25 ng/µl 
3rd tube: 16 µl from the 2nd tube + 144 µl of nuclease free H2O = 0.0125 ng/µl 
4th tube: 16 µl from the 3rd tube + 144 µl of nuclease free H2O = 0.00125 ng/µl 
5th tube: 16 µl from the 4th tube + 144 µl of nuclease free H2O = 0.000125 ng/µl 
Each one of the diluted samples was then treated as cDNA samples for the PCR run in 
triplicates with each one the genes. 
Example:  actin amplification efficiency  
actin = y = (-3.833) (This equation from the standards is generated by the icycler 
software). 
Then, using the equation below, amplification efficiency of  actin is calculated. 
E = POWER (10,(-1/(3.833))  = 1.823443 1.82% 
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Therefore, 1.82% is the amplification efficiency of  actin which is used to calculate 
mRNA expression as shown in Appendix A.8.                 
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A.8 Appendix 8 - mRNA expression 
mRNA expression of the target gene within the unknown sample to be expressed relative 
to the sham-irradiated control gene expression has been calculated. For each sample, a 
Threshold cycle (CT) value was obtained for the target gene and the 18s rRNA controls. 
The CT for 18s rRNA was subtracted from the CT of the target gene to obtain a delta CT 
( CT) value for each sample.  
Ref gene:  actin
Target genes: Furin/TACE/MMP-2/MMP-9/TNF
Controls: sham-irradiated samples 
Treated samples: UV-irradiated samples (± CHX) or (± IL-1 ) 
Three threshold (Ct) values are generated for each sample for each gene under the 
specified conditions. 
Average of these values is calculated and is called Ave Ct 
Ref gene - target gene for controls and Ref gene - target gene for treated sample is 
calculated ( Ct)
Formula: 
Ratio of mRNA expression = (E target) Ct target (control-treated)
                                                  (E ref) Ct ref (control-treated)     
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Example: 
Controls No of exp -actin 
Target 
gene 
0 h  Ct 1 15.00 23.40
 
Ct 2 14.70 23.30
Ct 3 14.70 22.90
Average CT (Ave) 14.80 23.20 
CT 0.00 -8.40
UV-irradiated 
cells No of exp -actin 
Target 
gene 
4 h  Ct 1 15.20 21.50
Ct 2 15.10 21.90
Ct 3 15.00 22.00
Average CT (Ave) 15.10 21.80  
CT 0.00 -6.70
Final Concentration: 
Amplification efficiency for -actin is 1.82 
Amplification efficiency for Furin is 1.65 (Note: amplification efficiency for furin is 
calculated as described in A.7) 
Control at 0 h= (POWER(1.82, -8.40))/(POWER(1.82, -8.40))  
UV-irradiated cell at 4 h = (POWER(1.65, -6.70))/(POWER(1.82, -8.40))  
Therefore, based on the above formula, the final concentration is:       
Time point 
Target 
gene 
Control (0 h) 1 
UV-irradiated cells 
(4h) 5.34 
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A.9 Appendix 9 - Protein half-life calculation 
Furin protein half-life (T(1/2)) (see section 3.2.2.1) was calculated as follows. 
Formula: 
k = (-LN(24 h value/0 h value)*-1/24)  
(Note: 24 h because the half-life in this experiment is calculated over a 24 h time period) 
Therefore,  T(1/2) = Ln(0.5)/k 
Example: CHX + Control 
At 24 h: 4.58 
At 0 h: 87.48 
Therefore, k = (-LN(4.58/87.48))*-1/24 = (-0.12) 
T(1/2) = LN(0.5)/(-0.12) = 5.64 h        
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A.10 Appendix 10 Publications and conference proceedings  
A.10.1 Publications 
1) Ravi, R. & Piva, T.J. (2010); The role of furin in inflammation and 
carcinogenesis. (Resubmitted to J Biomed. Sci) (Appendix A.11).  
A.10.2 Conference proceedings 
A.10.2.1 Oral presentations 
1) Ravi, R. & Piva, T.J. (2007); The effects of UV radiation on TACE activity in 
human keratinocytes cell lines. 9th MEPSA Meeting, Hobart. Abs 27. 
2) Ravi, R. & Piva, T.J. (2008); The effect of UV radiation on furin activity in 
human keratinocyte cell lines. 4th Australian Health and Medical Research 
Congress Meeting, Brisbane. Abs 298. 
3) Piva, T.J. & Ravi, R. (2009); The effects of UV radiation on furin activation of 
TACE in human keratinocyte cell lines. Redox Processes in Chemistry, 
Biology and Medicine Meeting, Sydney (Dec 1-4). Abs 54.  
A.10.2.2 Poster presentations 
1) Muthusamy, V., Ravi, R. & Piva, T.J. (2009); The role of cell signalling 
pathways in TNF release from UV-irradiated keratinocyte-derived cells. 15th 
International Photobiology Congress, Dusseldorf, Germany. Abs P31. 
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2) Ravi, R., Muthusamy, V. & Piva, T.J. (2009); The effect of UV radiation on 
Furin activation of MMPs in human keratinocyte cell lines. 15th International 
Photobiology Congress, Dusseldorf, Germany. Abs P33. 
3) Ravi, R. & Piva, T.J. (2009); The effect of UV radiation on furin activation of 
matrix metalloproteases in human keratinocyte cell lines. Melbourne Protein 
Group Meeting, Monash University. Abs 24. 
4) Ravi, R. & Piva, T.J. (2009); The effects of UV radiation on furin activation of 
MMPs in human keratinocyte cell lines. Redox Processes in Chemistry, 
Biology and Medicine Meeting, Sydney (Dec 1-4). Abs T20.            
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A.11 Appendix 11-The effect of UV radiation on furin activity in human skin cells   
Review 
The role of furin in skin inflammation and carcinogensis   
Rethika Ravi & Terrence J Piva*§ 
School of Medical Sciences, RMIT University, Bundoora, Vic 3083, Australia      
*These authors contributed equally to this work  
§Corresponding author  
Email addresses: 
RR: rethika.ravi@rmit.edu.au
 
TJP: terry.piva@rmit.edu.au
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Abstract 
It is widely acknowledged that the ultraviolet (UV) component of sunlight is the main 
carcinogen implicated in the formation of skin cancer. In response to UV radiation, skin 
cells secrete a range of bioactive molecules including Interleukin-6 and Tumour 
Necrosis Factor  (TNF ). TNF it is known to cause inflammation in the skin, and does 
not appear to be directly related to UV-induced immunosuppression that is observed.  
Inflammation plays a significant role in creating an environment where cells that have 
mutated DNA can become carcinogenic.  TNF itself is cleaved from its membrane-
bound precursor by the action of the metalloprotease, Tumour Necrosis Factor  
Converting Enzyme (TACE). While UVB radiation has been shown to increase the 
release of TNF from irradiated skin cells, it is not known whether this increase is due to 
increased TACE activity and/or expression. However, before TACE is activated it is 
cleaved from its preproform by the action of a proprotein convertase, furin. Furin also 
cleaves a number of proteases in the cell including matrix metalloproteases (MMPs). It 
is known that following exposure to UVB ration that the levels of MMP activity in the 
skin is increased. While furin is expressed in skin cells, the effect UV radiation has on its 
expression and/or activity and that of the proteases it activates in keratinocytes is not 
fully known.  The increase in the release of some bioactive molecules from UV-
irradiated skin cells, may not be related to their expression but to the activation of furin, 
which in turn activates many proteases in the cell.  In the longer term, elevated furin 
levels in a mutated cell, may enhance TACE thereby increasing the release of TNF
from the cells which sustains the inflammatory environment allowing for the 
development of carcinogenic cells.  As furin also activates MMP activity, these cells 
may go onto to become metastatic.  Therefore the development of specific furin 
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inhibitors, thorough reducing the release of inflammatory molecules and MMP activity 
may offer a new therapy to reduce not only UV-induced inflammation in the skin but 
that of skin cancer as well.   
Background 
Skin cancer represents a major, and growing, public health problem [1]. It is the most 
common type of cancer in fair skinned populations. The three most common forms of 
skin cancer are basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and 
malignant melanoma (MM). BCC and SCC are together known as non melanoma skin 
cancers (NMSC) [2-4]. BCCs and SCCs are derived from keratinocytes, whereas 
melanoma is derived from melanocytes. SCCs can undergo metastasis, BCCs rarely if 
ever, while melanomas can be highly metastatic. [3, 4] 
It is widely acknowledged that sunlight, or ultraviolet (UV) radiation is the main 
carcinogen implicated in the formation of skin cancer. UV radiation can be divided into 
three components: UVC (100-280 nm), UVB (280-320 nm) and UVA (320-400 nm). 
Ozone depletion, seasonal and weather variations affect the amount of UV radiation 
reaching the Earth s surface [1, 5]. All of the UVC and most of the UVB radiation 
emitted from the sun is effectively blocked from reaching the Earth s surface by the 
stratospheric ozone layer. The component of UV light that reaches the Earth s surface 
consists of 90-95% UVA and 5-10% UVB [6, 7]. The penetration of shorter-wavelength 
UVB radiation is predominantly confined to the epidermis while UVA penetrates into 
the dermis because of its longer wavelength [8].  
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UVB can cause sunburn, inflammation, cataract formation, DNA mutations and 
membrane damage as well as skin cancer [6, 9, 10]. It is known that UVB directly 
damages DNA and can induce Reactive Oxygen Species (ROS) by interactions with 
chromophores in the skin [11]. The DNA damage seen in epidermal cells caused by 
UVB irradiation typically results in the formation of cyclobutane pyrimidine dimers 
(CPD) and pyrimidine (6-4) photoproducts. Mutations of this kind are frequently found 
in p53, p16, PTCH and INK4 /CDKN2A genes of skin cancer patients [12]. 
UVA can cause premature skin ageing, wrinkle formation, blotching and induces 
sunburn cell formation in the epidermis, as well as skin cancer [6, 10]. UVA affects 
keratinocytes at a transcriptional level by altering the expression of genes involved in 
apoptosis, cell cycle, DNA repair, signal transduction, RNA processing and translation, 
cell structure and metabolism [13]. It can cause DNA damage by the generation of ROS 
[11, 14] that results in a wider range of genomic damage e.g. single-stranded breaks, 
protein-DNA crosslinks, and oxidative base damage (e.g. 8-oxo-7,8-dihydroxyguanine) 
[15]. ROS can also cause lipid peroxidation resulting in membrane and protein damage 
[11, 14]. They can also initiate signal transduction processes leading to rapid synthesis 
and release of prostaglandin E2 and isoprostanes [16] as well as induction of new gene 
products such as cytokines, heme oxygenase-1, cyclooxygenase and intercellular 
adhesion molecules [17] and inflammatory mediators such as TNF [18-20].  TNF is 
cleaved from its preproform by the action of the metalloprotease Tumour Necrosis 
Factor Converting Enzyme (TACE) [21].  TACE along with other enzymes such as 
matrix metalloproteases (MMP), are must be cleaved from their respective proform by 
the action of proprotein convertases such as furin [22]. 
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For many years UVB was considered to be the main contributor toward skin cancers, 
based largely on the DNA action spectrum of UV radiation [19], but UVA has more 
recently been acknowledged as playing an important role in skin carcinogenesis. This is 
in keeping with the growing body of evidence that direct molecular targets of UV other 
than DNA are important to carcinogenesis. UVA, although it does not produce an 
inflammatory response at doses normally encountered by people, also produces ROS and 
so, unsurprisingly, activates many of the same signalling pathways as UVB. It is clear 
that doses of UVB, UVA and solar stimulated UV too low to cause inflammation are 
able to induce mutations. However, this does not exclude a role for ROS from 
inflammatory cells contributing to skin carcinogenesis, but it may be important for 
tumour progression [19].  The inflammation seen in the skin following UV radiation 
involves the action of many molecules.   
UV-induced Inflammation 
It has been shown that UV at high doses can induce inflammation which results in the 
appearance of macrophages and other lecucocytes in the skin [23].  Along with the 
appearance of these cells, many mediators of inflammation are also seen including 
prostaglandins [17], nitric oxide (NO) [24] and ROS [11, 14, 16], and cytokines such as 
interleukin (IL) -1, interferon (IFN) - , and TNF (Figure 1).  It has been 
shown that ROS can cause DNA strand breaks as well as lipid peroxidation, membrane 
and protein damage [11, 14, 15, 28].  A list of immunomodulatory molecules whose 
expression is upregulated by UV radiation is seen in Table 1 [6, 18, 28-33].  
Proinflammatory molecules have been shown to have important roles in the pathogenesis 
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of skin cancer, as determined from clinical or experimental animal studies, and the 
activity or quantities of many of these are affected by UV radiation [19, 28].   
Even in tumours, which have not been caused by UV radiation, can produce an inflamed 
environment [26, 34, 35].  It is known that inflammatory mediators such as IL-1, TNF
and IL-6 are involved in melanoma formation [36].  IInflammation has also been shown 
to play a role in non melanoma skin cancer as well [23, 37-39].  In a recent study, male 
mice were shown to be more sensitive to UVB-induced skin carcinogenesis than female 
mice [2], which is consistent with men having a higher incidence of skin cancer than 
women [19]. In this study, an inflammatory dose of UVB was used to induce the 
cancers.  Damian et al. [40]  found that while women developed a larger inflammatory 
response to UVB, men were found to have lower antioxidant protection in the skin 
resulting in a higher level of oxidative damage to DNA, and are more sensitive to UV 
immunosuppression than women. This would suggest that UV-induced 
immunosuppression and DNA damage but not inflammation are associated with the 
formation of skin cancers in men compared to women [19]. 
IL-1 and Il-1 are both induced in keratinocytes exposed to UVB radiation [29, 41].  
IL1 has also been shown to enhance the expression and release of TNF from UVB-
irradiated keratinocytes [42-44], while IL1 enhances the expression of MMP-9 in these 
irradiated cells [45].  Apart from IL1 it has been shown that UVB can stimulate MMP9 
expression in human skin via the induction of Activator protein-1 and NF B activities 
[46].  
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Apart from inducing cytokines, UVB radiation has been shown to increase 
cyclooxygenase (COX) -2 expression and activity in keratinocytes [19, 25, 47].  High 
levels of COX-2 activity have been observed in human epithelial skin cancers which are 
increased in response to UVB radiation [48].  The addition of nonsteroidal anti-
inflammatory drugs (NSAIDs) has been shown to inhibit COX-2 activity and subsequent 
PGE formation in the skin, and they have been used in the treatment of actinic keratosis 
(AK) [49], BCC, SCC and melanoma [50], which suggests that COX-2 plays a role in 
the formation of these tumours.  Recent studies using IL-12-deficient mice, have found 
that they have higher levels of inflammation and increased incidence of skin cancers 
than wild type controls which suggest that IL-12 may play an important role in 
modulating the inflammatory response seen in the skin [38]. 
Upregulation of TNF is a key early response to UVB by keratinocytes [6, 44, 51, 52] 
and represents an important component of the inflammatory cascade in skin. UVB 
irradiation induces TNF mRNA expression in both keratinocytes and dermal fibroblasts 
within a few hours following irradiation [44, 51].  IL-1 stimulates TNF expression 
[42] and release particularly in skin where there is substantial preformed IL-1 [44]. 
Recently, Bashir et al. [42] found that TNF expression and secretion in keratinocytes 
was induced by UVB but not by UVA irradiation. This induction was mediated through 
increased TNF gene transcription [42].  The IL1 formed in the epidermis and dermis 
can in turn induce mast cells to secrete inflammatory cytokines, such as TNF and IL1 , 
as well as prostaglandins which can enhance the inflammation caused by direct UV 
exposure on the epidermal cells [18, 19].  The histamine released from the mast cells can 
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induce vasodilation of the surrounding blood venules which assists in the leucocytes 
undergoing diapedesis and entering the region [18, 19]. T 
TNF that has been secreted from the keratinocytes in the epidermis or fibroblasts in the 
dermins has been shown to induce a myriad of pro-inflammatory effects on the skin.  
There are synergistic interactions between pro-inflammatory cytokines produced in the 
skin and in synergy with irradiated keratinocytes, leading to later augmentation of TNF
production in the irradiated tissue.  UVB radiation has been shown to induce IL-6 and 
IL-8 synthesis and release from irradiated keratinocytes and fibroblasts [18, 33, 38, 41].  
IL-8 assists in the homing of leucocytes from surrounding blood venules into the 
inflamed region, while IL-6 is known to trigger the activation of monocytes and other 
infiltrating leucocytes to secrete cytokines and chemokines [18].   
TNF has been shown to induce adhesion molecules and chemokines in the surrounding 
epithelial cells, resulting in the recruitment of inflammatory leucocytes from surrounding 
blood vessels via diapedesis [18, 19, 53-55]. These inflammatory cells secrete additional 
cytokines that form a positive feedback loop in further upregulating TNF and 
downstream TNF -induced chemokines, cytokines, and other pro-inflammatory 
pathways in irradiated skin [6, 42, 56].  These effects elicited by the infiltrating 
inflammatory cells occur some hours after UV irradiation, and this prolongs the 
observed inflammation.  In addition, UVB radiation also induces inducible nitric oxide 
synthase (iNOS) activity in dermal endothelial cells, which play an important role in 
UVB-induced inflammation observed in skin, This induction of iNOS has been shown to 
occur via a TNF -dependent pathway [42, 52, 57].   
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It can be seen that TNF plays an important pro-inflammatory role in the skin, both due 
to (a) the direct effects of UV radiation and (b) the indirect effects of inflammatory cells 
that chemotax to the skin.  It is clear that UV- and inflammatory cell-derived cytokines 
further enhance TNF gene transcription in human skin cells [42, 51], and this can 
further increase epidermal production of TNF .  However, clustering and internalization 
of TNF receptors may lessen the response to the TNF protein over time, and this may 
account for why persistent TNF in culture supernatants do not sustain TNF mRNA 
upregulation over time [19].  For further information on the complex interplay of 
cytokines, chemokines and other mediators in UV-induced inflammation please read the 
following reviews [19, 46, 47].   
Tumor Necrosis Factor 
TNF , which was formerly known as cachexin or cachectin, is a member of the TNF 
ligand superfamily [56, 58-60]. It is a type II transmembrane glycoprotein of 234 amino 
acids possessing an extracellular carboxy-terminus and a cytoplasmic amino group [59, 
60]. TNF can exist in two forms; a 26 kDa membrane-bound form (mTNF ) and a 17 
kDa soluble form (sTNF ). sTNF is cleaved from its membrane bound precursor 
between Ala76 - Val77 by the action of the metalloprotease TACE [21, 60-62]. 
TNF , is mainly produced by macrophages and to a lesser extent by other cells including 
leucocytes, dendritic cells, keratinocytes, melanocytes and fibroblasts [6, 21, 44, 59, 60]. 
It plays a crucial role in the pathogenesis of psoriasis, mainly by inducing the expression 
of ICAM-1 on keratinocytes and other cell adhesion molecules (e.g. vascular adhesion 
molecules, E-selectin) on dermal microvascular endothelium [56].  TNF is also 
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involved in apoptosis, cellular proliferation, differentiation, inflammation, 
tumorigenesis, apoptosis, viral replication, immune response to extracellular stimuli as 
well as local and systemic inflammation [21, 43, 51, 59, 63, 64].  
Most of the cellular actions described for TNF correspond to the secreted, soluble form 
of mature TNF .  There is increasing evidence that mTNF is also biologically active 
and that it may be responsible for the localised action of this cytokine [59].  Both forms 
of TNF can specifically bind to one of two receptors: a 55-kDa (p55 or CD120a 
receptor) form designated TNF-Rl; and a 75-kDa (p75 or CD120b receptor) form 
designated TNF-R2 [21, 64].  These two receptors are transmembrane glycoproteins, 
which display a high degree of structural homology and are expressed on most cell types 
[65].  
TNFRI is expressed on a wide range of cell types and its signalling mediates 
cytotoxicity, cell proliferation, antiviral activity and many of the proinflammatory 
actions of TNF [58, 59]. TNFRII is expressed on a more limited range of cells, 
including leukocytes, endothelial cells, LC and epithelial cells but its actions are less 
clear  [58, 59]. Membrane-bound TNFRI and TNFRII can be cleaved by TACE to 
release the soluble forms of these receptors and this process is activated by IL-10 [59]. 
The soluble forms of TNFR has been postulated to act as (a) an antagonist to the surface 
receptors by competing for sTNF or (b) an agonist by stabilizing the TNF trimer; 
therefore maintaining saturating concentrations in the extracellular fluids [59, 66].   
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Studies have shown that when TNF is bound to the TNFRI receptor it plays a role in  
UVB-induced apoptosis in keratinocytes, (also known as sunburnt cells) [57, 67]. 
Transgenic mice deficient for either TNFRI and/or TNFRII have been shown to be less 
susceptible to UVB-induced skin tumours than the wild type controls [68]. Through the 
use of TNF-R1 [64, 69, 70]  and TNF-R2 [64, 69] gene-targeted mutant mice, it has been 
shown that TNF-R1 plays a decisive role in the host s defence against microorganisms, 
while TNF-R2 plays a role in the induction of tissue necrosis. Using agonist and 
antagonist antibodies specific for each receptor, it has also been indicated that TNF
binding to TNF-R2 does not potentiate the cytotoxicity of TNF-R1, but instead regulates 
the rate of TNF association with TNF-RI [64, 71]  which suggests that TNF-RI is the 
main mediator of TNF action in the cell. 
Dermal injection of TNF results in the accumulation of dendritic cells in draining 
lymph nodes [64, 72], suggesting that this cytokine may serve as a stimulus for the 
migration of Langerhans cells (LC) from skin to regional lymph nodes [64, 65]. Streilein 
and colleagues [64, 73, 74] suggested that UVB indirectly induces TNF , which then 
causes morphologic and functional changes on LC resulting in the impairment of contact 
hypersensitivity (CHS). They also demonstrated that intradermal injection of TNF
immobilizes LC with the epidermis, leading to impaired induction of CHS [64]. 
Morphologic damage of LC caused by TNF has also been reported by others [64, 75]. 
It has been shown that UVB exposure and intradermal TNF injection have similar 
morphologic and functional effects on epidermal Langerhans cells [64, 74]  suggesting 
that local UVB-induced impairment of CHS is mediated by TNF . In studies using  
TNF-R1(-) mutant mice it has been shown that TNF is not involved in UVB-induced 
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immunosuppression [75, 76].  UVB-induced immunosuppression is implicated in the 
pathogenesis of skin cancers, and is postulated to be mediated in part by cis-urocanic 
acid (cis-UCA) [77, 78]. trans-Urocanic acid, a deamination product of histidine, is a 
major chromophore present at a high concentration in the epidermal keratinocytes in the 
stratum corneum  [78].  
Upon exposure to UVR, trans-UCA undergoes a photoisomerization to its  
cis-isomer until equilibrium is reached with the two isomers being in approximately 
equal quantities. In humans, this occurs after 1 minimal erythemal dose (MED) of UVR, 
which is the lowest dose required to induce a just visibly perceptible erythema [77, 78]. 
cis-UCA has been shown that it does not exert its immunosuppressive effects through 
TNF , but through other factors such as prostaglandin E2 [77].  Amerio et al. [76] 
showed that in TNFR1 and TNFR2 (TNFR2; p75) double knockout mice, TNF plays 
only a limited part in UVB-induced immunosuppression and that it cannot be considered 
among the major mediators of cis-UCA-induced immunosuppression.  While it is now 
clear that TNF may not play a major role in UV-induced immunosuppression [64, 65, 
76] it does play a significant role in UV-induced immunosuppression [19] as well as in 
other inflammatory diseases such as rheumatoid arthritis, psoriasis or systemic lupus 
erythematosus [26, 42].    
TACE 
TNF is cleaved from its preproform by the action of the metalloprotease TACE [61].  
This enzyme is a member of the disintegrin and metalloprotease (ADAM) family of 
proteases, and is also known as ADAM 17 or CD156q [61, 62, 79-81]. ADAM proteases 
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belong to the adamalysin/reprolysin subfamily of the metzincin superfamily, and contain 
a Zn2+-dependent catalytic domain [61, 81]. Currently the ADAM family comprises 
more than 30 members, although many are not fully characterized [61, 82, 83]. 
TACE is a multi-domain type I transmembrane protein of 824 amino acids in length and 
was first purified, characterized and cloned in 1997  [62, 79, 83].  While the amino acid 
sequence of TACE shows relatively low homology [62, 84] to other ADAM family 
members, its structure contains all the domain regions (Figure 2) which are characteristic 
for this family of metalloproteases [62, 79, 84].  The prodomain of TACE is similar to 
that of other ADAMs and MMP and, is thought to act as an inhibitor of the protease 
activity via the cysteine switch mechanism [84].  Before TACE can become biologically 
active the prodomain region must be removed. 
The catalytic domain contains the zinc-binding consensus motif HEXGHXXGXXHD 
involved in coordinating Zn2+ with His residues and creating the active site of the 
enzyme[84, 85]. The role of the disintegrin domain in TACE is not known.  Analysis of 
the amino acid sequence of TACE also indicates the presence of an EGF-like domain 
and a unique crambin-like domain, which contains a cysteine switch. However, its roles 
are not fully understood. The cysteine-rich domain may be important for enzyme 
maturation or substrate recognition [61, 79]. The cytoplasmic tail of TACE contains a 
potential phosphorylation site [86]  and an SH3-binding site [84]. 
TACE is synthesized as an inactive zymogen, which is subsequently proteolytically 
processed to the catalytically active form. In order for TACE to be activated it must first 
be cleaved from its 120 kDa proform (proTACE) into its 90 kDa mature form by the 
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removal of its prodomain [81, 87-89]. The cleavage of which occurs at the furin cleavage 
site RVKR (Arg-Val-Lys-Arg) localized between the pro- and the catalytic domain. The 
removal of the prodomain is due to the action of a furin-type proprotein convertase [81, 
87, 88]  and possibly other intracellular proprotein convertases (PC) such as Paired basic 
amino acid cleaving enzyme (PACE) 4, PC1, PC2, PC5/6 and PC7/8 [22, 84, 88, 90]. 
In mammalian cells, proTACE is located in the endoplasmic reticulum and the proximal 
golgi body whereas the mature form is located both intracellularly and on the cell 
membrane [88, 90]. TACE maturation is closely linked to the transport of proTACE 
through the medial golgi, where upon exit, prodomain removal occurs before the enzyme 
reaches the cell s surface [81]. TACE maturation is negatively influenced by the phorbol-
12-myristate-13-acetate (PMA), which decreases the amount of mature protein in treated 
cells [90, 91].  
TACE has been shown to cleave a wide range of molecules including TGF , 
amphiregulin, neuregulins, growth hormone receptor, both TNF receptors, L-selectin, 
amyloid precursor protein and IL-6R [81, 82, 92-94]. TACE-knockout mice are less 
efficient at processing TNF on the cell membrane compared to wild type controls [61, 
82]. These mice have elevated levels of mTNF as well as reduced levels of sTNF 
compared to wild-type controls, which suggests that TACE is the main protease 
responsible for its processing. Although some matrix metalloproteases (MMP) can cleave 
TNF , the cleaved products are inactive due to hydrolysis occurring at different sites 
within the molecule [61, 85, 94].  
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Some metalloproteases are activated in epidermal cells following UV radiation [95-97]. 
Piva and coworkers found that there were a number of proteases whose activity was 
upregulated in UVC- or UVB-irradiated HeLa cells [96, 97].  These enzymes included 
aminopeptidases and a TGF ase [96, 97].  On re-evaluation of their data, the TGF ase 
is most likely TACE, because (a) the later enzyme is known to cleave TGF among 
other growth factors [85, 93] and (b) the substrate used in these studies was a 
nonapeptide based on the N-terminal cleavage site of TGF [95-97]. In cells undergoing 
UV-induced apoptosis, the level of cell surface protease activity (aminopeptidase and 
TGF ase ) was shown to be higher than that seen in viable or necrotic cells [96].  The 
results of these studies were the first to show that TACE activity was elevated in cells 
exposed to UV radiation.  Recently Skiba et al. [27] reported that UVA and UVB 
irradiation increased TACE mRNA levels in HaCaT cells, with higher induction induced 
by UVA. The expression patterns for both UVA and UVB radiated cells generally 
appeared to be constant, although mRNA levels were significantly higher than controls, 
throughout the 48 h period following exposure [27]. 
In UV-irradiated HaCaT cells, it has been shown that TACE is responsible for the 
increased cleavage of EGF family members [98, 99].  Inhibition of TACE activity by 
metalloprotease inhibitors reduced the release of these growth factors, resulting in an 
increase in apoptotic cell death [98, 99].  It appears that TACE mediates a EGF 
receptor/AKT signalling pathway in these cells that is activated as a result of its cleavage 
of EGF family members.  In HaCaT cells exposed to UVA-radiation TACE mediated 
EGF receptor activation and cell cycle progression, which suggests that UVA, at non 
lethal doses, has the potential to be a skin cancer promoter [98, 99].  In support of the 
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role TACE may play in skin cancer development, it was shown to be overexpressed in a 
large number of skin cancer cells lines compared to non tumour cells [98, 99].  It is also 
known that members of the EGF family are overexpressed in skin cancers [100], and this 
could be a mechanism by which skin cancer growth is stimulated by autogenic growth 
factors.  The result of these recent studies suggest that inhibition of the action on TACE 
following UV radiation may prevent the stimulation of the surviving irradiated cells, 
which has the potential in reducing the incidence of skin cancer that may arise from 
prolonged sun exposure.  What is not clear is that the increase in TACE activity seen in 
these irradiated skin cells is due to increased levels or a change in its activity.  The 
proprotein convertase furin is known to activate TACE [88, 90] as well as matrix 
metalloproteases [22, 101] may play a role in this process.   
Furin 
Furin, also known as PACE is a 94 kDa, type I transmembrane, Ca2+-dependant serine 
protease [22, 91, 101].  It is a mosaic protein consisting of a series of multifunctional 
domains. At its N-terminal region, a signal peptide directs the translocation of the 
growing peptide chain to the endoplasmic reticulum and the secretory pathway [87, 101, 
102]. Next, the pro-region initially folds onto the native protein, thereby keeping the 
enzyme in a zymogen or inactive state [101, 102]. The pro-region is cleaved early in the 
endoplasmic reticulum by an intramolecular autocatalytic process, where it then 
associates with the catalytic domain and helps to guide the protein through the 
endoplasmic reticulum and golgi apparatus for its enzymatic activation  [101, 102].  
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Furin carries structural information within the cysteine-rich region (CRR) that facilitates 
shedding of its ectodomain [101, 102]. The CRR could participate in the shedding 
process by imparting a conformation to furin facilitating recognition and cleavage by its 
sheddase[101, 102].  The CRR could be considered either as functional regions involved 
in cell adhesion [82] interacting with specific target proteins or influencing conformation 
enabling dimerization or shedding of membrane proteins [101, 102]. The CRR is 
followed by a trans-membrane region that anchors the enzyme in the membrane of the 
trans golgi network (TGN) or the cell membrane. The cytosolic tail contains the 
information necessary for furin s sorting to various intracellular compartments [87, 101, 
102]. In the epidermis, furin can exist either as: (a) a mature 97 kDa membrane bound 
enzyme or (b) a smaller 75 kDa form that lacks the transmembrane domain [101]. This 
suggests that post-translational cleavage at the C-terminus takes place in the cell [22, 
101, 102]. 
Furin is a ubiquitously expressed member of the PC family. This family is related to the 
bacterial subtisilin[22] and consists of seven distinct members (PC1-PC7) that vary in 
regards to their tissue and subcellular distribution as well as enzymatic and biochemical 
properties [101]. Furin and other PC family members functions to process inactive 
precursor proteins to their functional or mature form. These molecules include growth 
receptors, growth factors, hormones, plasma proteins, MMP and extracellular matrix 
components [22, 101, 102]. The PC family members play a crucial role in a variety of 
physiological processes and are involved in the pathology of diseases such as cancer and 
viral infection [102-104]. 
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Of these family members, furin, PACE 4, PC5/6 and PC7/8 are widely expressed in the 
epidermis whereas PC2 and PC1/3 are limited to neuroendocrine tissues and PC4 is 
restricted to the testis [22]. The PC enzymes recognize basic motifs, cleaving after paired 
basic residues (PC2 and PC1/3); or after a canonical Rx (R/K) R (Arg-x-(Arg/Lys)-Arg) 
motif (furin and PACE4) [22, 101, 103]. Both PC7 and furin share an overlapping 
substrate specificity and therefore the selectivity of substrate proteolysis depends on 
their cellular localization. As intracellular trafficking is regulated by their cytosolic 
domains, which contain different sorting motifs, it is likely that the cellular localization 
of PC7 differs to that for furin [90]. 
Furin/PC expression and processing can increase the incidence and severity of the cancer 
phenotype [104, 105]. Overexpression of PACE4 resulted in mouse squamous cell 
carcinomas acquiring a more aggressive phenotype [105, 106]. Proteolytic degradation 
of the extracellular matrix (ECM) components is a central event of tumour invasion and 
metastasis [102-104]. Several classes of proteases, including serine proteinases, cysteine 
proteinases and matrix metalloproteinases (MMPs), have been implicated in the tumour 
cell invasive process. Of these, MMPs appear to be primarily responsible for much of 
the ECM degradation observed during invasive processes [105, 106]. They can 
contribute to tumour growth not only by degradation of the ECM but by the release of 
sequestered growth factors or the generation of bioactive fragments VEGF, bFGF or 
TGF- , the suppression of tumour cell apoptosis and the destruction of immune-
modulating chemokine gradients [106-108].   
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MMPs are also implicated in cell migration, proliferation, and tissue remodeling and 
thereby may also play a role in growth and development, angiogenesis, and 
atherosclerosis [109-111]. Exposure to UV radiation elevates MMP production in human 
skin, implicating sunlight as a major factor in photoageing [25, 112]. Regulation of 
MMP activity involves both the control of zymogen activation and the inhibition of the 
active enzyme by specific inhibitors such as TIMPs [25, 112]. MMPs are synthesized as 
latent proenzymes which are converted into mature, catalytically active forms by 
proteolytic cleavage of the N-terminal propeptide mediated by serine proteases, such as 
furin, or by membrane-type MMPs (MT-MMPs) [105, 110, 113].  TNF has been 
shown to induce proMMP-2 in human dermal fibroblasts [114], while IL-1 induced 
proMMP-9 levels in fibroblasts and keratinocytes [115].  Activation of pro-MMP2 takes 
place at the cell surface and involves interactions with active MT1-MMP, which is itself 
activated through rapid trafficking to the cell surface and proteolytic processing [110]. 
Maquoi et al. [116] demonstrated that furin-inhibitor reduces the level of mature            
MT1-MMP, which is paralleled by a decrease in pro-MMP-2 activation as well as in cell 
invasiveness, which suggests that furin plays a role in this process. 
MMP-2 (also known as gelatinase A or 72-kDa type IV collagenase) and MMP-9 (also 
known as gelatinase B or 92-kDa type IV collagenase) has been frequently associated 
with the invasive and metastatic potential of tumour cells [104-106, 112, 117].  MMP-9 
[118, 119], has been reported to play important roles in the pathophysiologies of many 
skin conditions such as wound healing [120], and angiogenesis [92]. On the other hand, 
the expression of MMP-2, is regulated independently of MMP-9 [118, 119].  The close 
correlation observed between MMP-2 activation and metastatic progression in various 
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tumours suggests that MMP-2 is a master switch triggering tumour spread [116]. 
Onoue et al. [119] has suggested that MMP-9 secreted from keratinocytes after UVB 
irradiation might result from apoptotic events. However, the specific roles of the 
gelatinases, including their expression patterns following UV radiation is not known. 
MMP-1, which is produced by both dermal fibroblasts and epidermal keratinocytes, 
cleaves type I collagen into specific fragments. These fragments can then be further 
hydrolysed by MMP-2 and MMP-9 [117, 120]. Steinbrenner et al. [117] found that UVA 
irradiation dose-dependently decreased the steady-state mRNA levels of MMP-2 and 
MMP-9 and lowered the gelatinolytic activity of both enzymes in cell culture 
supernatants.  
Apart from MMPs, furin and other PCs are also involved in the maturation of TACE 
(Figure 3).  proTACE is proteolytically processed by both furin and PC7 to its mature 
form most likely to increase its proteolytic activity [88, 90]. The maturation of TACE 
occurs during the transit of the protein through the late golgi compartment suggesting 
that prodomain removal is performed by a furin-type proprotein convertase [81, 90].  As 
increased amounts of mature TACE are detected in furin over-expressing cells, it would 
be that proTACE is a better substrate for furin than it is for PC7 [90]. 
Moss et al. [79] showed that when baculovirus-infected insect containing fragments of 
TACE sequence with its prodomain, it resulted in the production of recombinant active 
TACE which suggested that pre TACE was cleaved by a furin-like enzyme. Similar 
results were obtained by using cells overexpressing TACE [59, 88, 91] which confirmed 
the role furin plays in this process [88, 91]. This finding was conformed as the cell 
permeable furin inhibitors decanoyl-Arg-Val-Lys-Arg-chloromethylketone                        
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(Dec-RVKR-cmk) and PDX inhibited the formation of mature TACE in Cos7 cells [88] 
and keratinocytes [22].  It can be concluded from these studies that furin cleaves TACE 
in many different cells including keratinocytes. 
Furin mRNA, protein and enzyme activity has been observed in human epidermal 
keratinocytes [22, 27, 105, 121, 122]. Skiba et al. [27] found that UVA and UVB 
radiation caused an increase in furin mRNA levels immediately following exposure in 
HaCaT cells. UVB irradiation was shown to induce higher levels of furin mRNA 
expression [27]. The time course for furin mRNA levels in cells irradiated with low dose 
of UVA and high dose of UVB was similar to that for TNF , whereas maximal TNF 
and furin mRNA induction were detected 8 h post-irradiation [27]. Although                          
UV-irradiation does appear to have an effect on furin gene expression, no direct 
relationship was apparent between TACE and furin mRNA induction. A recent study has 
shown that following exposure to UVA and UVB, furin levels in HaCaT cells fell with 
respect to time [122]. It is unknown whether this change in furin levels was that of the 
immature and/or mature enzyme.  Through its effect on stimulating TACE formation and 
the resultant effect this has on TNF released by the cell, furin activity has an influence 
on the inflammation seen in the skin following exposure to UV radiation.  If there are 
cells in the skin which become cancerous as a result of DNA damage, some may go onto 
become metastatic due to increased MMP activity [105]. This increase in levels of 
activated MMPs on the surface of the cell could be due to either increased expression of 
proMMP protein and/or increased furin activity.  The role furin plays in the development 
of skin cancer suggests that it may play a significant role, and as such the development 
of specific inhibitors may offer a new therapy to treat these tumours. 
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Conclusion 
While it has been shown that UVA and UVB radiation cause different effects on the 
immune response this could be related to the activity of cell surface metalloproteases 
found on the skin cells. Although the effect of TNF in UV-induced inflammation has 
been well documented, little is known if the changes in TACE activity is due to 
increased protein levels or a change in enzyme activity.  The inflammatory environment, 
seen in the skin, following exposure to UV radiation is known to stimulate the 
development of mutated cells which possess DNA damage caused directly by UV 
radiation or indirectly through the generation of ROS.  Apart from increasing the release 
of TNF , TACE also cleaves EGF family members, which would stimulate the growth 
of these mutated cells, which over time may become cancerous.  Similar to that of 
TACE, MMPs are also activated by UV radiation and also play a crucial role in skin 
tumour cell development and metastasis. Furin and other proprotein convertases have 
been shown to play an important role in activating both TACE and MMP in skin cells. It 
is known that UV induces furin mRNA in skin cells, though protein levels do not appear 
to change with respect to time, which suggests a rapid turnover of the enzyme. Further 
study is needed on how UV radiation activates these enzymes in the cell. The 
development of specific furin/PC inhibitors has the potential to reduce the carcinogenic 
effects of sunlight by preventing the activation of TACE and MMPs and their 
subsequent downstream effects. Such compounds may have the potential to offer  
therapies in the treatment of skin cancer.  
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Figure legend 
Figure 1:  The inflammatory response seen in the skin following exposure to UV 
radiation, as adapted from [18].  Inflammation can be induced as a direct result of UV 
exposure on epidermal cells, or due to the release of secreted molecules, which in turn 
induce the release of inflammatory mediators from the dermis, as well as attracting 
inflammatory cells from circulation into this region of the skin. The infiltrating 
monocytes and macrophages, which enter the irradiated skin tissue in turn secrete 
mediators that prolong the inflammatory response.  See text for details and references. 
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          Figure 2: The amino acid and multidomain structure of TACE [85]. 
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Figure 3:  The role furin plays in the maturation of TACE and MMPs in skin cells.  Furin 
cleaves and activates TACE, which in turn can process TNF from its preproform.  
Keratinocytes secrete TNF following exposure to UVB radiation, and this is enhanced 
if IL-1 is present.  Furin also cleaves MMPs from their respective proforms, and the 
expression and activity of these proteases are elevated when the cells have been exposed 
to UVB radiation, and they are enhanced if either IL-1 (MMP-9) or TNF (MMP-2) is 
present.  The effect of UVB radiation on the expression of the enzymes and pTNF in 
the cell is represented by dashed lines, if it is enhanced it is represented by (+), and if it 
is unknown (?).  See text for details and references. 
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Mediator Produced By Function References
TNF
Keratinocytes 
Mast cells 
Dermal fibroblasts 
Langerhans cells 
Langerhans cell migration, sunburn cell 
information, stimulates prostaglandin 
(PG) synthesis, changes in adhesion 
molecule expression 
[29, 33]  
IL-1
Keratinocytes 
Langerhans cells 
Simulates PG synthesis, increases TNF 
and IL-6, inhibited by IL-1 receptor 
antagonist 
[33] 
IL-1
Keratinocytes 
Langerhans cells 
Langerhans cell migration [29, 33]  
IL-6 
Keratinocytes, 
Langerhans cells 
Fever 
Severe sunburn 
[6, 33]  
IL-10 
Keratinocytes 
(mouse) 
Macrophages 
(human) 
Melanocytes 
Blocks cytokine production by T cells, 
macrophages and NK cells 
Decreases antigen presentation, 
Increases IL-1 receptor antagonist 
[33] 
[6, 30, 33]  
IL-I2p40 
(not 
bioactive) 
Keratinocytes, 
Dendritic cell, 
Langerhans cells 
Decreases Th1 response 
Decreases antigen presentation 
[33] 
IFN T cells Triggers apoptosis 
T-cell mediated tumour cell destruction 
[32]  
PGE2 Keratinocytes, 
Mast cells 
Erythema 
Decreases antigen presentation 
Increases IL-4, decreases IL-12 
[33] 
Histamine Mast Cells Increases release of PG 
Inhibit lymphocyte functions like IL-2 
and IFN
[6, 33]   
      Table 1: Cutaneous mediators in skin cells whose expression is upregulated by UV  
radiation.  
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